
<html lang="en"     class="pb-page"  data-request-id="569b2a47-34cf-4631-89c4-e6cdad46dcec"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm3010724;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-20;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor" /></meta><meta name="dc.Creator" content="Jose María  Cid" /></meta><meta name="dc.Creator" content="Gary  Tresadern" /></meta><meta name="dc.Creator" content="Juan Antonio  Vega" /></meta><meta name="dc.Creator" content="Ana Isabel  de Lucas" /></meta><meta name="dc.Creator" content="Encarnación  Matesanz" /></meta><meta name="dc.Creator" content="Laura  Iturrino" /></meta><meta name="dc.Creator" content="María Lourdes  Linares" /></meta><meta name="dc.Creator" content="Aránzazu  Garcia" /></meta><meta name="dc.Creator" content="José Ignacio  Andrés" /></meta><meta name="dc.Creator" content="Gregor J.  Macdonald" /></meta><meta name="dc.Creator" content="Daniel  Oehlrich" /></meta><meta name="dc.Creator" content="Hilde  Lavreysen" /></meta><meta name="dc.Creator" content="Anton  Megens" /></meta><meta name="dc.Creator" content="Abdellah  Ahnaou" /></meta><meta name="dc.Creator" content="Wilhelmus  Drinkenburg" /></meta><meta name="dc.Creator" content="Claire  Mackie" /></meta><meta name="dc.Creator" content="Stefan  Pype" /></meta><meta name="dc.Creator" content="David  Gallacher" /></meta><meta name="dc.Creator" content="Andrés A.  Trabanco" /></meta><meta name="dc.Description" content="Advanced leads from a series of 1,2,4-triazolo[4,3-a]pyridines with mGlu2 receptor PAM activity are reported. By modification of the analogous imidazo[1,2-a]pyridine series, the newly reported lead..." /></meta><meta name="Description" content="Advanced leads from a series of 1,2,4-triazolo[4,3-a]pyridines with mGlu2 receptor PAM activity are reported. By modification of the analogous imidazo[1,2-a]pyridine series, the newly reported lead..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 16, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3010724" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3010724" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3010724" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3010724" /></link>
        
    
    

<title>Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3010724" /></meta><meta property="og:title" content="Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0016.jpeg" /></meta><meta property="og:description" content="Advanced leads from a series of 1,2,4-triazolo[4,3-a]pyridines with mGlu2 receptor PAM activity are reported. By modification of the analogous imidazo[1,2-a]pyridine series, the newly reported leads have improved potency, in vitro ADMET, and hERG as well as good in vivo PK profile. The optimization of the series focused on improving metabolic stability while controlling lipophilicity by introducing small modifications to the scaffold substituents. Analysis of this series combined with our previously reported mGlu2 receptor PAMs showed how lipophilic ligand efficiency was improved during the course of the program. Among the best compounds, example 20 (JNJ-42153605) showed a central in vivo efficacy by inhibition of REM sleep state at a dose of 3 mg/kg po in the rat sleep–wake EEG paradigm, a phenomenon shown earlier to be mGlu2 mediated. In mice, compound 20 reversed PCP-induced hyperlocomotion with an ED50 of 5.4 mg/kg sc, indicative of antipsychotic activity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3010724"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3010724">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3010724&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3010724&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3010724&amp;href=/doi/10.1021/jm3010724" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8770-8789</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301064b" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301077m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-<i>a</i>]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jose+Mar%C3%ADa++Cid">Jose María Cid</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Tresadern">Gary Tresadern</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juan+Antonio++Vega">Juan Antonio Vega</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ana+Isabel++de+Lucas">Ana Isabel de Lucas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Encarnaci%C3%B3n++Matesanz">Encarnación Matesanz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Iturrino">Laura Iturrino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+Lourdes++Linares">María Lourdes Linares</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ar%C3%A1nzazu++Garcia">Aránzazu Garcia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9+Ignacio++Andr%C3%A9s">José Ignacio Andrés</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregor+J.++Macdonald">Gregor J. Macdonald</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Oehlrich">Daniel Oehlrich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hilde++Lavreysen">Hilde Lavreysen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anton++Megens">Anton Megens</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Abdellah++Ahnaou">Abdellah Ahnaou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wilhelmus++Drinkenburg">Wilhelmus Drinkenburg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claire++Mackie">Claire Mackie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Pype">Stefan Pype</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Gallacher">David Gallacher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andr%C3%A9s+A.++Trabanco">Andrés A. Trabanco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Neuroscience Medicinal Chemistry and <sup>‡</sup>Molecular Sciences, Janssen Research & Development, Janssen-Cilag S.A., Jarama 75, 45007 Toledo, Spain</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>§</sup>Neuroscience Medicinal Chemistry, <sup>∥</sup>Neuroscience Biology, <sup>⊥</sup>Discovery ADME/Tox, <sup>#</sup>Project Management Office, and <sup>∞</sup>Center of Excellence for Cardiovascular Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium</span></div><div class="corresp-info"><strong>*</strong>Phone: +34 925 245767. Fax: +34 925 245771. E-mail: <a href="/cdn-cgi/l/email-protection#147e777d70547d60673a7e7a7e3a777b79"><span class="__cf_email__" data-cfemail="254f464c41654c51560b4f4b4f0b464a48">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3010724&amp;href=/doi/10.1021%2Fjm3010724" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8770–8789</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 16, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 July 2012</li><li><span class="item_label"><b>Published</b> online</span>16 October 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 October 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3010724" title="DOI URL">https://doi.org/10.1021/jm3010724</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8770%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJose%2BMar%25C3%25ADa%2BCid%252C%2BGary%2BTresadern%252C%2BJuan%2BAntonio%2BVega%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D20%26contentID%3Djm3010724%26title%3DDiscovery%2Bof%2B3-Cyclopropylmethyl-7-%25284-phenylpiperidin-1-yl%2529-8-trifluoromethyl%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyridine%2B%2528JNJ-42153605%2529%253A%2BA%2BPositive%2BAllosteric%2BModulator%2Bof%2Bthe%2BMetabotropic%2BGlutamate%2B2%2BReceptor%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8789%26publicationDate%3DOctober%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3010724"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1971</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">56</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3010724" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): A Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jose&quot;,&quot;last_name&quot;:&quot;María Cid&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Tresadern&quot;},{&quot;first_name&quot;:&quot;Juan&quot;,&quot;last_name&quot;:&quot;Antonio Vega&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Isabel de Lucas&quot;},{&quot;first_name&quot;:&quot;Encarnación&quot;,&quot;last_name&quot;:&quot;Matesanz&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Iturrino&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Lourdes Linares&quot;},{&quot;first_name&quot;:&quot;Aránzazu&quot;,&quot;last_name&quot;:&quot;Garcia&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Ignacio Andrés&quot;},{&quot;first_name&quot;:&quot;Gregor&quot;,&quot;last_name&quot;:&quot;J. Macdonald&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Oehlrich&quot;},{&quot;first_name&quot;:&quot;Hilde&quot;,&quot;last_name&quot;:&quot;Lavreysen&quot;},{&quot;first_name&quot;:&quot;Anton&quot;,&quot;last_name&quot;:&quot;Megens&quot;},{&quot;first_name&quot;:&quot;Abdellah&quot;,&quot;last_name&quot;:&quot;Ahnaou&quot;},{&quot;first_name&quot;:&quot;Wilhelmus&quot;,&quot;last_name&quot;:&quot;Drinkenburg&quot;},{&quot;first_name&quot;:&quot;Claire&quot;,&quot;last_name&quot;:&quot;Mackie&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Pype&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Gallacher&quot;},{&quot;first_name&quot;:&quot;Andrés&quot;,&quot;last_name&quot;:&quot;A. Trabanco&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;8770-8789&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3010724&quot;},&quot;abstract&quot;:&quot;Advanced leads from a series of 1,2,4-triazolo[4,3-a]pyridines with mGlu2 receptor PAM activity are reported. By modification of the analogous imidazo[1,2-a]pyridine series, the newly reported leads have improved potency, in vitro ADMET, and hERG as well as good in vivo PK profile. The optimization of the series focused on improving metabolic stability while controlling lipophilicity by introducing small modifications to the scaffold substituents. Analysis of this series combined with our previously reported mGlu2 receptor PAMs showed how lipophilic ligand efficiency was improved during the course of the program. Among the best compounds, example 20 (JNJ-42153605) showed a central in vivo efficacy by inhibition of REM sleep state at a dose of 3 mg/kg po in the rat sleep–wake EEG paradigm, a phenomenon shown earlier to be mGlu2 mediated. In mice, compound 20 reversed PCP-induced hyperlocomotion with an ED50 of 5.4 mg/kg sc, indicative of antipsychotic activity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3010724&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3010724" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3010724&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3010724" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3010724&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3010724" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3010724&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3010724&amp;href=/doi/10.1021/jm3010724" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3010724" /></input><a href="/doi/pdf/10.1021/jm3010724" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3010724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3010724%26sid%3Dliteratum%253Aachs%26pmid%3D23072213%26genre%3Darticle%26aulast%3DCid%26date%3D2012%26atitle%3DDiscovery%2Bof%2B3-Cyclopropylmethyl-7-%25284-phenylpiperidin-1-yl%2529-8-trifluoromethyl%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyridine%2B%2528JNJ-42153605%2529%253A%2BA%2BPositive%2BAllosteric%2BModulator%2Bof%2Bthe%2BMetabotropic%2BGlutamate%2B2%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D20%26spage%3D8770%26epage%3D8789%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291713" title="Polyacrylamide">Polyacrylamide</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jmcmar.2012.55.issue-20/production/jmcmar.2012.55.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Advanced leads from a series of 1,2,4-triazolo[4,3-<i>a</i>]pyridines with mGlu2 receptor PAM activity are reported. By modification of the analogous imidazo[1,2-<i>a</i>]pyridine series, the newly reported leads have improved potency, in vitro ADMET, and hERG as well as good in vivo PK profile. The optimization of the series focused on improving metabolic stability while controlling lipophilicity by introducing small modifications to the scaffold substituents. Analysis of this series combined with our previously reported mGlu2 receptor PAMs showed how lipophilic ligand efficiency was improved during the course of the program. Among the best compounds, example <b>20</b> (JNJ-42153605) showed a central in vivo efficacy by inhibition of REM sleep state at a dose of 3 mg/kg po in the rat sleep–wake EEG paradigm, a phenomenon shown earlier to be mGlu2 mediated. In mice, compound <b>20</b> reversed PCP-induced hyperlocomotion with an ED<sub>50</sub> of 5.4 mg/kg sc, indicative of antipsychotic activity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63521" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63521" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glutamate is considered the major excitatory neurotransmitter in the mammalian central nervous system (CNS) of vertebrates, contributing excitatory input to as many as half of all central synapses. It plays a major role in numerous physiological functions such as learning and memory but also sensory perception, development of synaptic plasticity, motor control, respiration, and regulation of cardiovascular function. An imbalance in glutamatergic neurotransmission is believed to be at the center of various neurological and psychiatric diseases.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7">(1-7)</a> Glutamate acts via activation of ionotropic or metabotropic glutamate receptors (iGlu or mGlu). The former includes ion channels such as NMDA, AMPA, and kainate receptors responsible for fast excitatory transmission, whereas the latter are a family of eight class C G-protein-coupled receptors contributing to the fine-tuning of synaptic efficacy.<a onclick="showRef(event, 'ref1 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref1 ref8 ref9">(1, 8, 9)</a> Glutamate activates mGlu receptors through binding at an orthosteric site in the amino terminal domain. This induces a conformational change in the receptor, resulting in activation of the G-protein and intracellular signaling pathways.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">The eight mGlu receptors are classified into three groups based upon sequence homology, pharmacological profile, and preferential signal transduction pathway.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> The mGlu2 receptor, which belongs to the group II subfamily along with mGlu3, has proven to be of particular importance in neuropharmacology. Preferentially expressed on presynaptic nerve terminals mGlu2 receptor negatively modulates glutamate and GABA release and is widely distributed in the brain.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> High levels of mGlu2 receptors are seen in brain areas such as prefrontal cortex, hippocampus, and amygdala where glutamate hyperfunction may be implicated in disorders and diseases such as anxiety and schizophrenia.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17">(14-17)</a> It is therefore considered that activation of group II mGlu receptors may offer anxiolytic and/or antipsychotic effects.<a onclick="showRef(event, 'ref2 ref4 ref18'); return false;" href="javascript:void(0);" class="ref ref2 ref4 ref18">(2, 4, 18)</a></div><div class="NLM_p">The first generation pharmacological tools were conformationally constrained analogues of glutamate acting as agonists at both mGlu2 and mGlu3 receptors.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Preclinical studies performed with mGlu2/3 receptor agonists such as (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740) showed robust anxiolytic-like<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and antipsychotic-like effects in animal models.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Clinical data strengthen the rationale for group II receptor intervention as a treatment for schizophrenia. (1<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>S</i>)-2-Thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid 4-[(2<i>S</i>)-2-amino-4-(methylthio)-1-oxobutyl]amino-2,2-dioxide monohydrate (LY2140023), the oral prodrug of the mGlu2/3 agonist (−)-(1<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>S</i>)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039), showed improvement of both positive and negative symptoms in schizophrenia in a double-blind placebo-controlled study in schizophrenic patients.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Importantly, treatment with LY2140023 was safe and well-tolerated. It did not affect prolactin levels nor induce extrapyramidal symptoms or weight gain, in contrast to many of the current atypical antipsychotic medications.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">Given the promise offered by mGlu2 receptor activation, there is increased interest in identifying small molecules that activate the receptor. A preferred approach is via positive allosteric modulators (PAMs) that bind at an alternative site to orthosteric agonists. This strategy offers many potential benefits: avoidance of amino acid like motifs that can be detrimental for CNS penetration, opportunity for greater chemical diversity, potential for improved selectivity, as the orthosteric site is highly conserved, and reduced likelihood of receptor desensitization, as PAMs typically activate the receptor only in the presence of glutamate and will respond to physiological neurotransmitter fluctuations.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a> The number of reports on mGlu2 receptor PAM chemical series has increased over the past years.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Within our laboratories we have pursued a series of isoquinolones<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> and 1,5-pyridones<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> (<b>1</b> and <b>2</b>, respectively, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a). Those compounds were reported to be selective and moderately potent mGlu2 receptor PAMs; however, balancing potency and metabolic stability remained a challenge. We have very recently reported structurally related 3-cyanopyridones (<b>3</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a).<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(32-34)</a> This scaffold delivered compounds with improved potency and druglike properties, and the latest results will soon be reported elsewhere.</div><div class="NLM_p">These 3-cyanopyridone series were derived from HTS performed at the start of our program. However, with a need to expand the SAR, identify new chemotypes, and also gain more insight on the target, molecular modeling approaches were employed to help identify and prioritize new chemical scaffolds. An overlay model revealed shared pharmacophoric features between reported series which were expected to be required for alternative motifs. On the basis of this model and methods of shape and electrostatic similarity, a novel series of imidazopyridines<a onclick="showRef(event, 'ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38">(35-38)</a> was discovered. The imidazopyridine serves as a surrogate for the pyridone core, in which the oxygen lone pair is replaced by a nitrogen lone pair of the imidazole ring, the ring centers of pyridone and pyridine overlap well, and the pendent groups are distributed along a similar vector. The series proved capable of delivering compounds with appealing pharmacological profile. However, exploration was mainly limited to compounds having trifluoroethyl as R<sup>1</sup> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b), which was one of the few groups conferring acceptable potency and metabolic stability. Therefore, we considered improving metabolic stability by reducing lipophilicity with the introduction of an additional nitrogen atom, causing little disruption to overall molecular shape and features. This delivered the new 1,2,4-triazole template, which is the subject of this report (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Structures of mGlu2 PAM reported molecules (<b>1</b>–<b>3</b>). (b) Evolution from pyridone series to 1,2,4-triazolopyridine series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">First, to test the viability of the imidazopyridine to triazolopyridine swap hypothesis, an initial set of imidazopyridines (<b>4</b>, <b>6</b>, and <b>8</b>) and their corresponding 1,2,4-triazolo[4,3-<i>a</i>]pyridines pairs (<b>5</b>, <b>7</b>, and <b>9</b>) were prepared (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In this set of compounds, both phenylpiperidine and cyano were selected as the most suitable substitutions to allow complete comparisons across the series. The reduction of the lipophilicity in the triazolopyridines did indeed correlate with an improvement of the metabolic stability of the compounds in both human and rat species. Interestingly, the in vitro potency was also retained. Herein we report the synthesis and structure–activity relationship (SAR) development of novel triazolopyridines<a onclick="showRef(event, 'ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41">(39-41)</a> as the culmination of the exploration around the imidazopyridine series. This exploration led to the identification of 3-cyclopropylmethyl-7-(4-phenyl-piperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-<i>a</i>]pyridine (JNJ-42153605, <b>20</b>), one of the most potent and selective mGlu2 PAMs identified in our program. Compound <b>20</b> influenced rat sleep–wake organization by decreasing REM sleep and reversed PCP-induced locomotor activity in mice. Hence, compound <b>20</b> is seen as a powerful pharmacological tool to gain more insight on the target as well as a suitable candidate for further development.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Comparative Data for a Representative Set of Imidazopyridines (<b>4</b>, <b>6</b>, <b>8</b>) and Triazolopyridines (<b>5</b>, <b>7</b>, <b>9</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0011.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center" char=".">clogP</th><th class="colsep0 rowsep0" align="center" char=".">mGlu2 EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">mGlu2 <i>E</i><sub>max</sub> (%)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">HLM (%)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">RLM (%)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">4.41</td><td class="colsep0 rowsep0" align="char" char=".">501</td><td class="colsep0 rowsep0" align="char" char=".">225</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="char" char=".">3.38</td><td class="colsep0 rowsep0" align="char" char=".">696</td><td class="colsep0 rowsep0" align="char" char=".">247</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left"><sup><i>n</i></sup>Pr</td><td class="colsep0 rowsep0" align="char" char=".">4.49</td><td class="colsep0 rowsep0" align="char" char=".">155</td><td class="colsep0 rowsep0" align="char" char=".">254</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left"><sup><i>n</i></sup>Pr</td><td class="colsep0 rowsep0" align="char" char=".">3.91</td><td class="colsep0 rowsep0" align="char" char=".">299</td><td class="colsep0 rowsep0" align="char" char=".">272</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">4.35</td><td class="colsep0 rowsep0" align="char" char=".">125</td><td class="colsep0 rowsep0" align="char" char=".">259</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">3.33</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="char" char=".">277</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Values are the mean of at least two experiments.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">HLM and RLM data refer to % of compound metabolized after incubation with human or rat liver microsomes for 15 min at 5 μM.</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58731" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58731" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Triazolopyridines <b>5</b>, <b>7</b>, <b>9</b>–<b>28</b> were synthesized following the routes outlined in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch5" aria-label="5">5</a>. For the exploration of the R<sup>1</sup> group in cyano substituted triazolopyridines (<b>5</b>, <b>7</b>, <b>9</b>–<b>12</b>), 3-cyano-2–4-dibromopyridine (<b>29</b>) was chosen as starting material. Reaction of <b>29</b> with 4-phenylpiperidine (<b>30</b>) yielded the C-4 substitution product <b>31</b> with complete regioselectivity. Treatment of <b>31</b> with hydrazine under microwave heating led to the key 2-pyridylhydrazine intermediate <b>32</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), which was converted into the target 8-cyanotriazolopyridines by cyclization with several acid derivatives (orthoesters, acid chlorides, and carboxylic acids) under the reaction conditions shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, DMF, rt, 1 h; (b) NH<sub>2</sub>NH<sub>2</sub>, THF, 160 °C, 15 min, microwave; (c) EtC(OEt)<sub>3</sub>, xylenes, 180 °C, 2 h; (d) (i) R<sup>1</sup>COCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> or CHCl<sub>3</sub>, rt, 1–16 h; (ii) POCl<sub>3</sub>, CH<sub>3</sub>CN, 150 °C, 10 min, microwave; (e) CF<sub>3</sub>CH<sub>2</sub>CO<sub>2</sub>H, DIPEA, CCl<sub>3</sub>CN, PS-PPh<sub>3</sub>, 1,2-dichloroethane, 150 °C, 18 min, microwave; (f) HC(OEt)<sub>3</sub>, xylenes, 180 °C, 2 h; (g) CH<sub>2</sub>O, pyrrolidine, AcOH, 80 °C, 16 h.</p></p></figure><div class="NLM_p">The triazolopyridines <b>14</b>–<b>17</b> substituted with a chlorine atom at position C-8 were prepared following a route similar to that described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. In this case, reaction of 2,3-dichloro-4-iodopyridine <b>34</b> with the piperidine derivatives <b>30</b> and <b>35</b> followed by nucleophilic substitution of the C-2 chlorine in <b>36a</b>,<b>b</b> with hydrazine led to the 2-pyridylhydrazine derivatives <b>37a</b>,<b>b</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Subsequent cyclization of <b>37a</b>,<b>b</b> with the corresponding acid derivatives resulted in the target molecules <b>14</b>–<b>17</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIPEA, CH<sub>3</sub>CN, 110 °C, 16 h; (b) NH<sub>2</sub>NH<sub>2</sub>, EtOH, 160 °C, 20 min, microwave; (c) (i) R<sup>1</sup>COCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) POCl<sub>3</sub>, CH<sub>3</sub>CN, 150 °C, 10 min, microwave; (d) Et(OEt)<sub>3</sub>, xylenes, 180 °C, 2 h; (e) (i) CF<sub>3</sub>CH<sub>2</sub>CO<sub>2</sub>H, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) CCl<sub>3</sub>CN, PS-Ph<sub>3</sub>P, DIPEA, 1,2-dichloroethane, 100 °C, 16 h.</p></p></figure><div class="NLM_p">Derivatives <b>18</b> and <b>19</b> were prepared by Buchwald coupling of the corresponding amine (<b>41</b><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and <b>42</b>) with the 8-chloro-7-iodotriazolopyridine <b>40</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The synthesis of <b>40</b> was achieved in three steps by reaction of hydrazine with <b>34</b> followed by acylation and subsequent cyclodehydration of the formed intermediate <b>39</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NH<sub>2</sub>NH<sub>2</sub>, 1,4-dioxane, 70 °C, 16 h; (b) CyPrCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (c) 160 °C, 180 min; (d) Pd(AcO)<sub>2</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 95 °C, 16 h.</p></p></figure><div class="NLM_p">The C-8 trifluoromethyl substituted triazolopyridines, bearing a cyclopropylmethyl substituent in the triazole ring (<b>20</b>, <b>24</b>–<b>28)</b>, were prepared as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Chlorine displacement in 2,4-dichloro-3-trifluoromethylpyridine <b>43</b> with benzyl alcohol yielded <b>44</b> with complete regioselectivity. Introduction of hydrazine in <b>44</b> to give <b>45</b> followed by treatment with POCl<sub>3</sub> led to the 7-chlorotriazolopyridine <b>46</b>. Nucleophilic substitution of the activated choro atom in <b>46</b> with several piperidines (<b>30</b>, <b>47</b>, <b>48</b>) and cyclic amines (R′R″NH = tetrahydroisoquinoline, dihydroisoindoline, and <i>rac</i>-3-phenylpyrrolidine) led to the target compounds <b>20</b> and <b>24</b>–<b>28</b>.</div><div class="NLM_p">Finally, compounds <b>21</b>–<b>23</b> were obtained after nucleophilic substitution of <b>39</b> with the piperidines <b>30</b> and <b>35</b> followed by introduction of the hydrazine and standard cyclization processes with the corresponding acid derivatives.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnOH, NaH, DMF, rt, 1 h; (b) NH<sub>2</sub>NH<sub>2</sub>, 1,4-dioxane, 160 °C, 30 min, microwave; (c) (i) CyPrCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) POCl<sub>3</sub>, CH<sub>3</sub>CN, 150 °C, 5 min, microwave; (d) amine, DIPEA, CH<sub>3</sub>CN, 90–180 °C, 10 min to 24 h.</p></p></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>30</b>, NaH, DMF, rt, 1 h or <b>35</b>, DIPEA, CH<sub>3</sub>CN, 110 °C, 4 h; (b) NH<sub>2</sub>NH<sub>2</sub>, THF, 160 °C, 45 min, microwave; (c) (i) R<sup>1</sup>COCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) POCl<sub>3</sub>, MeCN, 150 °C, 10 min; (d) (i) CyPrCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) CCl<sub>3</sub>CN, PS-Ph<sub>3</sub>P, PS-DIPEA, 1,2-dichloroethane, 150 °C, 10 min, microwave.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Representative compounds illustrating the SAR for this triazolopyridine series along with functional activity, metabolic stability, and hERG data are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. The triazolopyridine exploration began with the elaboration of the R<sup>1</sup> substitution. For these variations the cyano and phenylpiperidine substituents at R<sup>2</sup> and R<sup>3</sup> were left constant (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, compounds <b>5</b>, <b>7</b>, <b>9</b>–<b>13</b>). Initial SAR showed that the R<sup>1</sup> substituent has an important effect on the potency (EC<sub>50</sub> <a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a>). Lengthening the alkyl chain from an ethyl to <i>n</i>-propyl led to a more than 2-fold increase in potency as exemplified with compounds <b>5</b> (696 nM) and <b>7</b> (299 nM). However, the increased size of the alkyl chain was detrimental for the metabolic stability in rat liver microsomes (RLMs) which increased from 7% (<b>5</b>) to 40% metabolized (<b>7</b>). A more balanced profile was found for compounds <b>9</b> and <b>10</b> which combined better metabolic stability with increased potency. Interestingly, α-branching to the triazole ring was detrimental for mGlu2 PAM activity as shown with compound <b>11</b> (1230 nM). More diverse R<sup>1</sup> substitutions were explored as exemplified by the ether (<b>12</b>) and amine (<b>13</b>) analogues. These compounds, although metabolically stable, displayed decreased activity (468 nM for <b>12</b> and 1120 nM for <b>13</b>). This suggests that polar groups are not well tolerated for activity in the R<sup>1</sup> region, which is in agreement with the moderate activity observed for compound <b>5</b> which has a less lipophilic R<sup>1</sup> alkyl chain. Of note, the cyanotriazolopyridines <b>5</b> and <b>9</b> showed weak inhibition of the hERG channel at 3 μM in a patch clamp assay, 20% and 33%, respectively.</div><div class="NLM_p">Next, our exploration focused on the R<sup>2</sup> substituent and was guided by SAR previously established for the imidazopyridine series.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In that case chlorine appeared to be beneficial for potency with an approximate 2-fold increase compared to the cyano group. The increase in activity correlated with the 0.9 log unit increase in lipophilicity by moving from cyano to chloro. This same approach was attempted in the triazolopyridine series; however, in this case the effect of the chlorine on the potency was not as consistent as for the imidazopyridine series. While the chloro analogue <b>16</b> showed a 2-fold increase compared to its cyano pair <b>5</b> (386 nM vs 696 nM, respectively), other chloro analogues (<b>14</b>, <b>15)</b> displayed potency comparable to that of their equivalent cyano versions (<b>9</b>, <b>10</b>). Unfortunately, chloro analogues were prone to be more metabolically unstable than cyano analogues. Furthermore, chlorine seemed to be detrimental for hERG liability (<b>16</b>, 43% vs <b>5</b>, 20% or <b>14</b>, 71% vs <b>9</b>, 33%), potentially a consequence of the increased lipophilicity.</div><div class="NLM_p">Interestingly, the increase in hERG inhibition caused by the chlorine could be mitigated in some analogues by the introduction of additional groups at the 4-position of the 4-piperidine. Thus, compound <b>17</b>, having a 4-fluoro-4-phenylpiperidine R<sup>2</sup> substituent, showed improvement of the hERG profile (<b>17</b>, 42% vs <b>14</b>, 71%). This 4,4-disubstitution of the piperidine ring also led to a 2-fold decrease in potency and slightly higher metabolic turnover. Nevertheless <b>17</b> was considered to have an overall better profile than <b>14</b>. The same trends were found with the 4-phenyl-4-trifluoromethylpiperidine analogue <b>18</b>, which also showed a remarkable reduction of hERG inhibition when compared to the corresponding pair <b>15</b> (<b>18</b>, 42% vs <b>15</b>, 99%). Although a similar 2-fold decrease in functional activity was found for <b>18</b>, its metabolic profile was similar to that of <b>15</b>. Replacement of the piperidine R<sup>2</sup> substituent by a piperazine led to a 9-fold decrease in mGlu2 PAM activity (<b>19</b>, 944 nM vs <b>15</b>, 102 nM).</div><div class="NLM_p">A breakthrough was achieved by the identification of the CF<sub>3</sub> group as an optimal replacement for the R<sup>2</sup> cyano and chloro substituents. A significant increase in potency was found over the R<sup>2</sup> cyano and chloro subclasses (<b>20</b> vs <b>10</b> or <b>15</b> and <b>21</b> vs <b>5</b> and <b>16</b>). In particular, compound <b>20</b> was found to be the most potent mGlu2 PAM identified so far, with an EC<sub>50</sub> of 17 nM and <i>E</i><sub>max</sub> of 285%.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> This increase in potency promoted by the R<sup>2</sup> CF<sub>3</sub> substituent was consistent across several R<sup>1</sup> and R<sup>3</sup> variations.<a onclick="showRef(event, 'ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41">(39-41)</a> In addition the positive effect of the CF<sub>3</sub> group was accompanied by acceptable metabolic stability and reduced hERG inhibition.</div><div class="NLM_p">Fine tuning around the structure of <b>20</b> did not result in compounds with an improved profile. For instance, shorter (<b>21</b>) and longer (<b>22</b>) R<sup>1</sup> alkyl groups were tolerated in terms of potency and metabolic stability with the more lipophilic <b>22</b> being more potent than <b>21</b> (<b>21</b>, 116 nM; <b>22</b>, 24 nM). However, lengthening the alkyl chain had a detrimental effect on hERG inhibition (<b>20</b>, 56% vs <b>22</b>, 91%). Opposite the finding in the R<sup>3</sup> chloro subclass (<b>17</b>), the introduction of fluorine at the C-4 position of the piperidine did not result in an improved hERG profile for the trifluoromethyltriazolopyridine <b>23</b> (<b>23</b>, 84% vs <b>20</b>, 57%). Fused variations of the 4-phenylpiperidine, such as <b>24</b> and <b>25</b>, turned out to be detrimental for activity (149 and 400 nM, respectively) as well as for metabolic stability. Ring contraction of the piperidine into pyrrolidine <b>26</b> led to an 80-fold drop in mGlu2 PAM potency together with worse metabolic stability. Finally, SAR on the aryl substituent of the piperidine ring in <b>20</b> is illustrated with compounds <b>27</b> and <b>28</b>, showing that increased lipophilicity is well tolerated for activity (<b>27</b>, 10 nM) while detrimental for hERG inhibition (91%). Increased polarity such as in <b>28</b> led to compounds with decreased activity (<b>28</b>, 519 nM). In summary, a good understanding of the SAR and the effects of lipophilicity led to compounds with optimal in vitro profile combining potency, metabolic stability in both human and rat species, and acceptable preliminary cardiovascular profile.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Functional Activity, Metabolic Stability, and hERG Data of Representative mGlu2 Receptor PAMs <b>5</b>, <b>7</b>, <b>9</b>–<b>28</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0012.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0013.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0014.gif" alt="" id="GRAPHIC-d885e1573-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Values are the mean of at least two experiments.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">HLM and RLM data refer to % of compound metabolized after 15 min at 5 μM.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Experiments were performed using HEK293 cells stably transfected with the hERG potassium channel. Whole-cell currents were recorded with an automated patch-clamp system (PatchXpress 7000A). Three concentrations of compound were tested (0.1, 0.3, and 3 μM; <i>n</i> = 3) and compared to vehicle (0.1% DMSO; <i>n</i> = 3). Data are presented as % inhibition at the highest concentration tested (3 μM).</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Not tested.</p></div></div><div></div></div><div class="NLM_p">As discussed here and in recent articles describing other series,<a onclick="showRef(event, 'ref32 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref32 ref35 ref36">(32, 35, 36)</a> we have sought to balance primary in vitro activity and lipophilicity. The detrimental effects of increased lipophilicity on many ADMET parameters<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and druglikeness are well-known.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> shows mGlu2 PAM pEC<sub>50</sub> activity versus calculated log <i>P</i> and log <i>D</i> (pH 7.4) for molecules from multiple chemical series pursued within our mGlu2 PAM program. The plots include examples from previously reported pyridone, isoquinolone, and imidazopyridine series as well as the triazolopyridines reported herein. Such plots provide an interesting way to analyze compounds; for instance, those in the top left quadrant would be preferred because they are most active while having lower clogP. The molecules in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> are color-coded according to the rank order in which they were registered in our database, reflecting the progression of the project over time: blue being the oldest and red the newest registered compounds. As might be expected for small-molecule target interactions, clogP shows a weak correlation with in vitro activity, with a Pearson correlation coefficient of 0.36 (<i>r</i><sup>2</sup> = 0.13). This highlights the difficulty that was faced throughout the program to maintain lipophilicity in check. It can be seen that potency improved during the course of the program, with later compounds (red) generally having higher activity compared to earlier examples (blue). The Pearson correlation coefficient between the mGlu2 PAM pEC<sub>50</sub> and compound registration rank order was 0.51. This is reflected in the SAR in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, which shows more potent examples than previously reported, for instance, compound <b>20</b>. It appears that later molecules, those colored red, have higher clogP, suggesting that improved potency arose at the cost of increased lipophilicity. However, among the more recent compounds there was a large set of intentionally designed basic molecules. Therefore, for this data set the calculated log <i>D</i> at pH 7.4 is a better measure for lipophilicity (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b). In this case, for compounds that were registered later log <i>D</i> values were lower, suggesting reduced apparent lipophilicity and a more optimal potency lipophilicity balance.</div><div class="NLM_p">Parameters such as lipophilic ligand efficiency (LLE, pEC<sub>50</sub> minus log <i>D</i>)<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and lipophilicity-corrected ligand efficiency (LELP, ratio log <i>D</i>/LE)<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> have emerged as useful tools for lead optimization to address and monitor the lipophilicity and potency balance.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> We examined how these parameters evolved for molecules synthesized during the project (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Interestingly, both LLE and LELP improved over the course of the program with the newer molecules (red) tending to have higher LLE and lower LELP values. LLE values greater than 5 are typically preferred, and some of the later molecules reach such levels, with compound <b>20</b> having an LLE of 5.2.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> LELP values, which are more suitable for optimization of fragments, are preferred to be lower. Although there are limitations for molecules with log <i>D</i> < 1, it can be seen that there were many compounds with preferred values less than 10; for instance, compound <b>20</b> had LELP of 9.8. The retrospective analysis of these parameters showing their improvement throughout lead optimization suggests that they can be useful for guiding medicinal chemistry decision making.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) mGlu2 PAM pEC<sub>50</sub> activity versus clogP (Biobyte). (b) mGlu2 PAM pEC<sub>50</sub> activity versus log <i>D</i> at pH 7.4 (ACD, version 12.0). Molecules are color-coded by order of registration in our internal database, the earliest compounds being blue and later compounds red. Plots combine data generated from several previously reported series: pyridones, isoquinolones, imidazopyridines, and triazolopyridines reported here. Inactive compounds for which exact pEC<sub>50</sub> could not be determined because of concentration limits were removed from the analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Plot of LLE versus MW. (b) Plot of LELP versus MW. Molecules are color-coded by order of registration in our internal database, the earliest compounds being blue and later compounds red. Molecule <b>20</b> is highlighted in green. Plots combine data generated from several previously reported series: pyridones, isoquinolones, imidazopyridines, and triazolopyridines reported here. Inactive compounds for which exact pEC<sub>50</sub> could not be determined because of concentration limits were removed from the analysis. To account for basic compounds, ACDLabs, version 12.0, log <i>D</i> at pH 7.4 was used for LLE and LELP calculations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next investigated the ability of a representative set of compounds to cross the blood–brain barrier (BBB). Plasma and brain levels measured 1 h after dosing at 10 mg/kg are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. The cyano subclass (<b>5</b>) was much less brain penetrant (<i>B</i>/<i>P</i> = 0.2) than chloro or CF<sub>3</sub> subclasses (6.5- to 9-fold higher <i>B</i>/<i>P</i> ratios for <b>14</b>, <b>15</b>, and <b>20</b>). This improvement for the chloro and CF<sub>3</sub> subseries may well be explained by a reduction of the TPSA and/or higher lipophilicity as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effect of CN, Cl, and CF<sub>3</sub> Substitution on Brain and Plasma Levels after 1 h of a Single Dose at 10 mg/kg in the Swiss Mouse</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0015.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Data are expressed as the geometric mean values of at least two runs.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">clogP calculated with Biobyte software.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Compound dosed po in 0.5% Methocel suspension.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Compound dosed sc in 1 mg/mL in 20% HP-β-CD + HCl solution at pH 4.</p></div></div><div></div></div><div class="NLM_p">To ascertain the druglike properties of the series, further in vivo PK work was conducted with the most promising compounds (<b>17</b>, <b>18</b>, <b>20</b>, and <b>21</b>). Data for relevant PK parameters are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. The most optimal PK data were obtained for compounds <b>17</b> and <b>20</b> with moderate to good plasma exposures after oral (po) administration (AUC of 5987 and 1804 ng·h/mL, respectively) combined with acceptable intravenous (iv) PK parameters, resulting in moderate to good bioavailability (<i>F</i>). In contrast, compounds <b>18</b> and <b>21</b> had a less favorable PK, with higher clearance (Cl) after iv dosing and shorter half-lives (<i>T</i><sub>1/2</sub>) resulting in more limited plasma exposures.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. PK Data for Compounds <b>17</b>, <b>18</b>, <b>20</b>, and <b>21</b> in Rat after Oral and Intravenous Administration<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">Vd<sub>ss</sub>(L/kg)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0–inf</sub>(ng·h/mL)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub>(ng/mL)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center"><i>B</i>/<i>P</i> <a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">5987</td><td class="colsep0 rowsep0" align="char" char=".">807</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">77</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">1159</td><td class="colsep0 rowsep0" align="char" char=".">289</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1804</td><td class="colsep0 rowsep0" align="char" char=".">482</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">1009</td><td class="colsep0 rowsep0" align="char" char=".">359</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="left">1.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Study in male Sprague–Dawley rat dosed at 10 mg/kg po and 2.5 mg/kg iv, formulated in 20% HP-β-CD at pH 4.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Values are the mean of three animals.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Ratios calculated after 1 h of a single dose at 10 mg/kg sc in 1 mg/mL in 20% HP-β-CD + HCl solution at pH 4 in the Swiss mouse.</p></div></div></div><div class="NLM_p">On the basis of these results, compound <b>20</b> showed the best overall profile among all analogues prepared, combining an excellent mGlu2 PAM activity (15 nM) with acceptable PK profile and brain penetration. In addition, <b>20</b> was assessed for its selectivity for the mGlu2 receptor (data shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) and was found to not have agonist or antagonist activity toward other mGlu receptor subtypes up to 30 μM (>50-fold vs mGluR2) and also showed no or negligible affinity or activity at any of the targets in the CEREP<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a>panel of receptors (>100-fold selectivity for mGlu2 receptor). Therefore, <b>20</b> is a selective mGlu2 receptor PAM. Altogether, compound <b>20</b> represented suitable candidate to progress to further studies including in vivo pharmacology.</div><div class="NLM_p">The link between sleep abnormalities and neurological and psychiatric disorders is widely reported. For instance, disturbances in rapid eye movement (REM) sleep are frequently seen in patients with major depressive disorder, and many clinically effective antidepressants produce common changes in sleep pattern such as reduced REM sleep and REM sleep onset latency. Glutamate concentrations fluctuate across different vigilance states, suggesting that glutamate in the forebrain may play a role in the sleep process.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Given the relationship between the mechanism of sleep and glutamate signaling, sleep–wake neurophysiological measures can offer a highly reliable, sensitive, and translational index of brain activity and target engagement. We have previously shown that mGlu2 receptor activation with the agonist LY354740 and PAM 3′-([[2-cyclopentyl-6,7-dimethyl-1-oxo-2,3-dihydro-1<i>H</i>-inden-5-yl]oxy]methyl)biphenyl-4-carboxylic acid (BINA) elicited common changes in the rodent's sleep–wake pattern (i.e., selectively suppress REM sleep), which supports an important role for the mGlu2 receptor in the regulation of REM sleep<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and that combining both compounds produces synergistic effects. Subsequently we reported similar results for examples from our 1,4-pyridone and imidazopyridine series.<a onclick="showRef(event, 'ref32 ref36'); return false;" href="javascript:void(0);" class="ref ref32 ref36">(32, 36)</a> In addition, reports from groups elsewhere confirm that mGlu2 activation by agonists or allosteric potentiators has consistent and robust effects seen in sleep–wake EEG.<a onclick="showRef(event, 'ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54">(52-54)</a> Therefore, we have evaluated the central activity of <b>20</b> in the sw-EEG paradigm, and the present results were in accordance with our earlier findings. Accordingly, <b>20</b> at a dose of 3 mg/kg (po) was centrally active and suppressed REM sleep during the first 2 h after administration without clear effects on the other sleep–wake stages (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, bottom right panel). In addition, <b>20</b> prolonged REM sleep onset latency (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, bottom right panel) whereas no indications of sleep fragmentation were revealed by examination of the total number of transitions from sleep states toward waking (data not shown). On the basis of plasma protein binding (data shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), the active dose of 3 mg/kg po corresponded to an approximate free concentration in plasma of 0.14 ng/mL.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of oral administration of <b>20</b> (3 mg/kg) or vehicle (20% CD + 2H2T) on sleep–wake organization in rats during 20 consecutive hours. Mean percentage of occurrence per minute is indicated for each sleep–wake state. Small bar charts indicate amounts of vigilance states in min (plus SEM) during the first 2 h postadministration: ROL, REM sleep onset latency; ∗, <i>p</i> < 0.05; Wilcoxon–Mann–Whitney rank sum tests compared with vehicle values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>20</b> was further evaluated for its effect on phencyclidine-induced hyperlocomotion (PCP-LMA) in mice. The PCP-LMA model is based on the evidence that the noncompetitive NMDA receptor channel blocker phencyclidine (PCP) is capable of evoking schizophrenia-like symptoms in healthy subjects and worsens psychosis in schizophrenic patients,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and hence, PCP is widely used in animal models of psychosis. In rodents, PCP causes an increase in motor activity. As this induced behavior may be linked to increased glutamate release, it is speculated that mGlu2 receptor activation may block these specific PCP-mediated effects. Therefore, this represents a useful model of psychosis and serves as the basis for the “glutamate hypothesis of schizophrenia”. We have administered <b>20</b> in mice pretreated with PCP and evaluated its effect on PCP-induced hyperlocomotion. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, compound <b>20</b> dose-dependently and significantly attenuated the increase in locomotor activity induced by PCP (5 mg/kg sc) with an ED<sub>50</sub> of 5.4 mg/kg sc which corresponded to an approximate free concentration in plasma of 2.6 ng/mL.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>20</b> on PCP-induced locomotor activity in mice. The gray horizontal bar represents the activity level measured in solvent treated control mice not challenged with PCP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, <b>20</b> was extensively characterized for its ADMET and safety profile. Compound <b>20</b> has a low aqueous solubility (<0.004 mg/mL in water) which increases at pH ≈ 4 and in complexation with cyclodextrines (0.995 mg/mL 20% HP-β-CD at pH 4).</div><div class="NLM_p">Compound <b>20</b> showed a rapid rate of absorption from the gastrointestinal tract, reaching the maximal concentration after 0.5 h. Clearance in vivo was moderate to high in both rat and dog (35 and 29 mL min<sup>–1</sup> kg<sup>–1</sup>, respectively). Elimination half-lives are on the shorter side across the species, being 2.7 h in rat and 0.8–1.1 h in dog. Volume of distribution is slightly higher than total body water, indicating distribution outside the plasma, which was confirmed in a rat tissue distribution study (data not shown). In vitro studies (LLC-PK1-MDR1) showed high permeability with no indication for P-glycoprotein (P-gp) efflux. Bioavailability is low to moderate across the species (35% in rat and 18–33% in dog). For a highly permeable compound, the low to moderate bioavailability might be related to an in vivo solubility/dissolution rate limiting factor that could reduce the extent of absorption.</div><div class="NLM_p">Safety characterization of <b>20</b> did not reveal relevant alerts. Thus, compound <b>20</b> showed a low potential to inhibit the metabolism of co-medication (IC<sub>50</sub> for five major CYP450 of >10 μM; Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) and no genotoxic alerts based on both the Ames and the micronucleus tests.</div><div class="NLM_p">Compound <b>20</b> displayed good safety margins in various cardiovascular studies. It did not affect IKr in hERG-transfected HEK293 cells at 0.1 μM and did not induce electrophysiological effects in the isolated rabbit Purkinje fiber at ≤0.075 μM. This was more than 200-fold the estimated free efficacious plasma exposure of 0.14 ng/mL (taking into consideration the high plasma protein binding, i.e., 0.35% free). The no-effect levels (NOEL) in vivo (anesthetized guinea pigs and dogs, 9000 and 6625 ng/mL, respectively) are more than 160-fold the efficacious plasma exposure. On the basis of the currently available preclinical safety and efficacy data, the good safety margins attained support for further studies with compound <b>20</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Overview of Compound <b>20</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0017.gif" alt="" id="GRAPHIC-d885e2171-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">physicochemical properties</td><td class="colsep0 rowsep0" align="left">MW = 440</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">exptl p<i>K</i><sub>a</sub> = 4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">exptl log <i>P</i> = 4.4 at pH 7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vitro</td><td class="colsep0 rowsep0" align="left">mGlu2 PAM EC<sub>50</sub> = 17 nM; <i>E</i><sub>max</sub> = 67%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">mGlu2 Ago EC<sub>50</sub> = 270 nM; <i>E</i><sub>max</sub> = 285%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">mGlu2 PAM binding<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> IC<sub>50</sub> = 15 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">selectivity (mGlu1,3–8) of >100-fold vs mGlu2 PAM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">selectivity (CEREP)<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> of >50-fold vs mGlu2 PAM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ADME profile</td><td class="colsep0 rowsep0" align="left">solubility of <0.004 mg/mL in water and 0.995 mg/mL 20% HP-β-CD at pH 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">plasma protein binding (%) of 99.82 (h), 99.65 (r)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">metabolism (%)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> of 23 (HLM), 25 (RLM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">CYP450 inhibition of 1A2, 2D6, 3A4 (>30 μM), 2C9 (11 μM), 2C19 (20 μM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">permeability (LLC-PK1 cells, ABCB1) AB/BA <i>P</i><sub>app</sub> × 10 cm s<sup>–1</sup> = 12/6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat PK: 2.5 mg/kg iv, 10 mg/kg po</td><td class="colsep0 rowsep0" align="left">Cl = 35 mL min<sup>–1</sup> kg<sup>–1</sup>; Vd<sub>ss</sub> = 1.4 L/kg; <i>T</i><sub>max</sub> = 0.5 h; <i>T</i><sub>1/2</sub> = 2.7 h</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC<sub>0–inf</sub> = 1804 ng·h/mL; <i>C</i><sub>max</sub> = 482 ng/mL; <i>F</i> = 35%; <i>B</i>/<i>P</i> = 1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog PK: 1 mg/kg iv, 2.5 mg/kg po</td><td class="colsep0 rowsep0" align="left">Cl = 29 mL min<sup>–1</sup> kg<sup>–1</sup>; Vd<sub>ss</sub> = 1.3 L/kg; <i>T</i><sub>max</sub> = 0.5 h; <i>T</i><sub>1/2</sub> = 0.8–1.1 h</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC<sub>0–inf</sub> = 531–957 ng·h/mL; <i>C</i><sub>max</sub> = 218–472 ng/mL; <i>F</i> = 18–33%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">swEEG rat po</td><td class="colsep0 rowsep0" align="left">LAD = 3 mg/kg (free plasma concn of 0.14 ng/mL)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PCP-LMA mice sc</td><td class="colsep0 rowsep0" align="left">ED<sub>50</sub> = 5.4 mg/kg (free plasma concn of 2.6 ng/mL)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CV safety</td><td class="colsep0 rowsep0" align="left">hERG PC (% inhat 3 μM)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> = 57%; NOEL = 0.1 μM; margin = 285<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rabbit purkinje fiber; NOEL = 0.075 μM; margin = 214<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">anesthetized guinea pig; NOEL = 9000 ng/mL; margin = 225<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">anesthetized dog; NOEL = 6625 ng/mL; margin = 165<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">genotoxicity</td><td class="colsep0 rowsep0" align="left">Ames TA98:<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> clean up to 125 mg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">in vitro micronucleus:<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a> clean up to 150 μg/mL</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">HLM and RLM data refer to % of compound metabolized after 15 min at 5 μM.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Experiments were performed using HEK293 cells stably transfected with the hERG potassium channel. Whole-cell currents were recorded with an automated patch-clamp system (PatchXpress7000A). Three concentrations of compound were tested (0.1, 0.3, and 3 μM; <i>n</i> = 3) and compared with vehicle (0.1% DMSO; <i>n</i> = 3). Data are presented as percent inhibition at the highest concentration tested (3 μM).</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Study conducted in human lymphoblastoid TK6 cell line in the presence or absence of metabolic activation (rat liver S9).</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Based on efficacy free concentration in sw-EEG model (0.14 ng/mL).</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15201" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15201" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, optimization of the previously reported imidazopyridine series led to the discovery of a novel series of 1,2,4-triazolo[4,3-<i>a</i>]pyridines. Lowering lipophilicity of the central core by the introduction of an additional nitrogen was key to delivering compounds with better metabolic stability while the potency remained comparable. These promising results were followed by sequential optimizations of hERG and PK profiles that led to compound <b>20</b> as the best triazolopyridine derivative identified. <b>20</b> turned out to be among the most potent mGlu2 receptor PAMs prepared so far, displaying very high in vitro potency of 17 nM and good selectivity for the mGlu2 receptor (>50-fold). Compound <b>20</b> showed an acceptable PK profile in rodent and non-rodent species. Likewise, it displayed good in vivo activity in models sensitive to mGlu2 modulation such as sw-EEG and PCP-LMA, both at doses remarkably better compared to leads previously reported in our program. Furthermore, there were no safety concerns identified that would hamper the progression of the compound. Collectively, compound <b>20</b> is considered a very attractive pharmacological agent to advance our knowledge of how mGlu2 receptor modulation may reduce the severity of diseases where disruption of glutamatergic transmission is pronounced and as an excellent candidate to progress toward clinical settings.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry</h3><div class="NLM_p">Unless otherwise noted, all reagents and solvents were obtained from commercial suppliers and used without further purification. Thin layer chromatography (TLC) was carried out on silica gel 60 F254 plates (Merck). Flash column chromatography was performed on silica gel, particle size 60 Å, mesh of 230–400 (Merck) under standard techniques. Microwave assisted reactions were performed in a single-mode reactor, Biotage Initiator Sixty microwave reactor (Biotage), or in a multimode reactor, MicroSYNTH Labstation (Milestone, Inc.). Nuclear magnetic resonance (NMR) spectra were recorded with either a Bruker DPX-400 or a Bruker AV-500 spectrometer (Bruker AG) with standard pulse sequences, operating at 400 and 500 MHz, respectively, using CDCl<sub>3</sub> and DMSO-<i>d</i><sub>6</sub> as solvents. Chemical shifts (δ) are reported in parts per million (ppm) downfield from tetramethylsilane (δ = 0). Coupling constants are reported in hertz. Splitting patterns are defined by s (singlet), d (doublet), dd (double doublet), t (triplet), q (quartet), quin (quintet), sex (sextet), sep (septet), or m (multiplet). Liquid chromatography combined with mass spectrometry (LCMS) was performed on either a HP 1100 HPLC system (Agilent Technologies) or Advanced Chromatography Technologies system composed of a quaternary or binary pump with degasser, an autosampler, a column oven, a diode array detector (DAD), and a column as specified in the respective methods below. Flow from the column was split to a MS spectrometer. The MS detector was configured with either an electrospray ionization source or an ESCI dual ionization source (electrospray combined with atmospheric pressure chemical ionization). Nitrogen was used as the nebulizer gas. Data acquisition was performed with MassLynx-Openlynx software or with Chemsation-Agilent data browser software. More detailed information about the different LCMS methods employed can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Melting point values are peak values and were obtained with experimental uncertainties that are commonly associated with this analytical method. Melting points were determined in open capillary tubes on a Mettler FP62 apparatus with a temperature gradient of 10 °C/min. Maximum temperature was 300 °C.</div><div class="NLM_p last">Purities of all new compounds were determined by analytical RP-HPLC using the area percentage method on the UV trace recorded at a wavelength of 254 nm, and compounds were found to have ≥95% purity unless otherwise specified.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> 3-Ethyl-7-(4-phenylpiperidin-1-yl)[1,2,4]triazolo[4,3-<i>a</i>]pyridine-8-carbonitrile (<b>5</b>)</h3><div class="NLM_p last">A solution of <b>32</b> (0.05 g, 0.17 mmol) and EtC(OEt)<sub>3</sub> (0.46 mL, 2.56 mmol) in xylenes (1 mL) was heated in a sealed tube at 180 °C for 2 h. After the mixture was cooled to room temperature, the volatiles were evaporated in vacuo. The residue thus obtained was precipitated by treatment with Et<sub>2</sub>O. The resulting solid was filtered off and dried in the vacuum oven (50 °C) to give <b>5</b> (0.042 g, 74%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.31 (t, <i>J</i> = 7.5 Hz, 3 H), 1.77 (qd, <i>J</i> = 12.6, 3.8 Hz, 2 H), 1.95 (br d, <i>J</i> = 11.3 Hz, 2 H), 2.86–2.95 (m, 1 H), 3.00 (q, <i>J</i> = 7.5 Hz, 2 H), 3.34–3.42 (m, 2 H), 4.32 (br d, <i>J</i> = 13.3 Hz, 2 H), 6.96 (d, <i>J</i> = 7.8 Hz, 1 H), 7.19–7.25 (m, 1 H), 7.26–7.37 (m, 4 H), 8.34 (d, <i>J</i> = 8.1 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 332 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.46 min.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 7-(4-Phenylpiperidin-1-yl)-3-propyl[1,2,4]triazolo[4,3-<i>a</i>]pyridine-8-carbonitrile (<b>7</b>)</h3><div class="NLM_p last">To a solution of 32 (0.2 g, 0.68 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (2 mL) cooled at 0 °C were added Et<sub>3</sub>N (0.14 mL, 1.02 mmol) and butanoyl chloride (0.087 g, 0.82 mmol). The resulting reaction mixture was allowed to gradually warm to room temperature and then further stirred for 1 h. NaHCO<sub>3</sub> (aqueous saturated solution) was added, and the resulting solution was then extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried over MgSO<sub>4</sub>, and the volatiles were evaporated in vacuo. The residue thus obtained was dissolved in 1,2-dichloroethane (2 mL), and POCl<sub>3</sub> (0.035 mL, 0.371 mmol) was added. The resulting mixture was heated at 150 °C for 5 min under microwave irradiation. After cooling to room temperature, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with NaHCO<sub>3</sub> (aqueous saturated solution). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, EtAcO in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 40/50) to give <b>7</b> (0.039 g, 17%). Mp > 300 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.05 (t, <i>J</i> = 7.4 Hz, 3 H), 1.81–1.98 (m, 4 H), 2.07 (br d, <i>J</i> = 12.0 Hz, 2 H), 2.84 (tt, <i>J</i> = 12.1, 3.5 Hz, 1 H), 2.97 (t, <i>J</i> = 7.5 Hz, 2 H), 3.38 (br t, <i>J</i> = 12.0 Hz, 2 H), 4.30 (br d, <i>J</i> = 13.2 Hz, 2 H), 6.60 (d, <i>J</i> = 7.9 Hz, 1 H), 7.20–7.29 (m, 3 H), 7.30–7.38 (m, 2 H), 7.75 (d, <i>J</i> = 7.9 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 346 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.03 min.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 7-(4-Phenylpiperidin-1-yl)-3-(2,2,2-trifluoroethyl)[1,2,4]triazolo[4,3-<i>a</i>]pyridine-8-carbonitrile (<b>9</b>)</h3><div class="NLM_p last">To a suspension of <b>32</b> (0.3 g, 1.02 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (10 mL) at room temperature were added diisopropylethylamine (0.36 mL, 2.045 mmol), polymer supported PPh<sub>3</sub> (1.43 g, 3.07 mmol, loading 2.15 mmol/g), CF<sub>3</sub>CO<sub>2</sub>H (0.09 mL, 1.02 mmol), and trichloroacetonitrile (0.21 mL, 2.04 mmol) in 1,2-dichloroethane (10 mL). The resulting reaction mixture was heated at 150 °C under microwave irradiation for 18 min. After cooling to room temperature, the reaction mixture was filtered through a Celite pad and solids were washed thoroughly with CH<sub>2</sub>Cl<sub>2</sub> and MeOH. The combined filtrates were concentrated in vacuo and the residue thus obtained was purified by column chromatography (silica gel, MeOH in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 5/100) to give <b>9</b> (100 mg, 25%). Mp > 300 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.92 (qd, <i>J</i> = 12.7, 3.8 Hz, 2 H), 2.09 (br d, <i>J</i> = 12.4 Hz, 2 H), 2.87 (tt, <i>J</i> = 12.1, 3.5 Hz, 1 H), 3.42 (br t, <i>J</i> = 12.7, 12.7 Hz, 2 H), 3.98 (q, <i>J</i> = 9.8 Hz, 2 H), 4.36 (br d, <i>J</i> = 13.3 Hz, 2 H), 6.70 (d, <i>J</i> = 7.8 Hz, 1 H), 7.21–7.26 (m, 3 H), 7.31–7.38 (m, 2 H), 7.86 (d, <i>J</i> = 7.8 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 386 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.82 min.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 3-Cyclopropylmethyl-7-(4-phenyl-1-piperidin-1-yl)-1,2,4-triazolo[4,3-<i>a</i>]pyridine-8-carbonitrile (<b>10</b>)</h3><div class="NLM_p last">To a solution of <b>32</b> (0.8 g, 2.73 mmol) in dry CHCl<sub>3</sub> (14 mL) cooled at 0 °C were added Et<sub>3</sub>N (0.61 mL, 4.36 mmol) and cyclopropylacetyl chloride (0.48 g, 4.09 mmol). The resulting reaction mixture was gradually warmed to room temperature and further stirred for 1 h. Then NaHCO<sub>3</sub> (aqueous saturated solution) was added, and the resulting solution was then extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The resulting residue was dissolved in 1,2-dichloroethane (10 mL), and POCl<sub>3</sub> (0.4 mL, 4.26 mmol) was added. The mixture was heated at 150 °C for 5 min under microwave irradiation. After cooling to room temperature, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with NaHCO<sub>3</sub> (aqueous saturated solution). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, MeOH–NH<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 3/97) to give 10 (0.14 g, 15%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.27–0.37 (m, 2 H), 0.56–0.69 (m, 2 H), 1.08–1.18 (m, 1 H), 1.85–1.98 (m, 2 H), 2.07 (br d, <i>J</i> = 11.6 Hz, 2 H), 2.85 (tt, <i>J</i> = 12.1, 3.5 Hz, 1 H), 3.00 (d, <i>J</i> = 6.6 Hz, 2 H), 3.39 (td, <i>J</i> = 12.8, 1.9 Hz, 2 H), 4.31 (br d, <i>J</i> = 13.3 Hz, 2 H), 6.61 (d, <i>J</i> = 7.8 Hz, 1 H), 7.22–7.27 (m, 3 H), 7.30–7.38 (m, 2 H), 7.85 (d, <i>J</i> = 7.8 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 358 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.88 min.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 3-<i>tert</i>-Butyl-7-(4-phenyl-1-piperidin-1-yl)-1,2,4-triazolo[4,3-<i>a</i>]pyridine-8-carbonitrile (<b>11</b>)</h3><div class="NLM_p last">To a solution of <b>32</b> (0.3 g, 1.02 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (2 mL) cooled at 0 °C were added Et<sub>3</sub>N (0.14 mL, 1.02 mmol) and 2,2-dimethylpropionyl chloride (0.15 g, 1.23 mmol). The resulting reaction mixture was gradually warmed to room temperature and further stirred for 16 h. NaHCO<sub>3</sub> (aqueous saturated solution) was added, and the resulting solution was then extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residue thus obtained was dissolved in 1,2-dichloroethane (2 mL), and POCl<sub>3</sub> (0.094 mL, 1.01 mmol) was added. The resulting mixture was heated at 150 °C for 5 min under microwave irradiation. After cooling to room temperature, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with NaHCO<sub>3</sub> (aqueous saturated solution). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, EtAcO in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 20/80) to give 11 (0.11 g, 31%) as a solid. Mp > 300 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.55 (s, 9 H), 1.90 (qd, <i>J</i> = 12.3, 3.5 Hz, 2 H), 2.06 (dd, <i>J</i> = 12.7, 1.8 Hz, 2 H), 2.84 (tt, <i>J</i> = 12.1, 3.7 Hz, 1 H), 3.37 (td, <i>J</i> = 12.8, 2.3 Hz, 2 H), 4.31 (dt, <i>J</i> = 13.6, 2.1 Hz, 2 H), 6.57 (d, <i>J</i> = 7.9 Hz, 1 H), 7.20–7.28 (m, 3 H), 7.29–7.38 (m, 2 H), 8.05 (d, <i>J</i> = 8.1 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 360 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.18 min.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 3-Methoxymethyl-7-(4-phenyl-1-piperidin-1-yl)-1,2,4-triazolo[4,3-<i>a</i>]pyridine-8-carbonitrile (<b>12</b>)</h3><div class="NLM_p last">To a solution of <b>32</b> (0.2 g, 0.68 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (2 mL) cooled at 0 °C were added Et<sub>3</sub>N (0.19 mL, 1.36 mmol) and methoxyacetyl chloride (0.074 g, 0.68 mmol). The resulting reaction mixture was gradually warmed to room temperature and further stirred for 1 h. NaHCO<sub>3</sub> (aqueous saturated solution) was added, and the resulting solution was then extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residue thus obtained was dissolved in 1,2-dichloroethane (2 mL), and POCl<sub>3</sub> (0.035 mL, 0.37 mmol) was added. The resulting mixture was heated at 150 °C for 5 min under microwave irradiation. After cooling to room temperature, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with NaHCO<sub>3</sub> (aqueous saturated solution). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, MeOH–NH<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub> 0/100 to 10/90) to give <b>12</b> (0.075 g, 32%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.78 (qd, <i>J</i> = 12.6, 3.6 Hz, 2 H), 1.95 (br d, <i>J</i> = 11.0 Hz, 2 H), 2.92 (tt, <i>J</i> = 12.0, 3.5 Hz, 1 H), 3.29 (s, 3 H), 3.39–3.47 (m, 2 H), 4.35 (br d, <i>J</i> = 13.3 Hz, 2 H), 4.86 (s, 2 H), 7.03 (d, <i>J</i> = 7.8 Hz, 1 H), 7.19–7.25 (m, 1 H), 7.26–7.36 (m, 4 H), 8.33 (d, <i>J</i> = 8.1 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 348 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.62 min.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 7-(4-Phenylpiperidin-1-yl)-3-pyrrolidin-1-ylmethyl[1,2,4]triazolo[4,3-<i>a</i>]pyridine-8-carbonitrile (<b>13</b>)</h3><div class="NLM_p last">To a solution of <b>33</b> (0.15 g, 0.49 mmol) in acetic acid (2 mL) were added pyrrolidine (0.63 g, 0.89 mmol) and paraformaldehyde (0.46 mL, 2.03 mmol). The resulting mixture was stirred at 80 °C for 16 h. After the mixture was cooled to room temperature, water was added. The resulting aqueous solution was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried over MgSO<sub>4</sub>, and the volatiles were evaporated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, MeOH in CH<sub>2</sub>Cl<sub>2</sub> 0/100 to 3/97) to give <b>13</b> as a white solid (0.084 g, 44%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.68 (quin, <i>J</i> = 3.1 Hz, 4 H), 1.77 (qd, <i>J</i> = 12.6, 3.8 Hz, 2 H), 1.94 (dd, <i>J</i> = 12.5, 1.8 Hz, 2 H), 2.46 (br s, 4 H), 2.91 (tt, <i>J</i> = 12.0, 3.6 Hz, 1 H), 3.37–3.46 (m, 2 H), 4.04 (s, 2 H), 4.32 (br d, <i>J</i> = 13.4 Hz, 2 H), 6.98 (d, <i>J</i> = 7.9 Hz, 1 H), 7.19–7.24 (m, 1 H), 7.25–7.36 (m, 4 H), 8.36 (d, <i>J</i> = 8.1 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 387 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.09 min.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 8-Chloro-7-(4-phenylpiperidin-1-yl)-3-(2,2,2-trifluoroethyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>14</b>)</h3><div class="NLM_p last">To a solution of <b>37a</b> (0.45 g, 1.47 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (2 mL) were added Et<sub>3</sub>N (0.31 mL, 2.23 mmol), 3,3,3-trifluoropropionyl chloride (0.22 mL, 1.78 mmol), and the resulting mixture was stirred at room temperature for 1 h. Then the volatiles were evaporated in vacuo. The residue thus obtained was dissolved in 1,2-dichloroethane (5 mL), and POCl<sub>3</sub> (0.13 mL, 1.45 mmol) was added at room temperature. The resulting mixture was heated at 150 °C for 5 min under microwave irradiation. After cooling to room temperature, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with NaHCO<sub>3</sub> (aqueous saturated solution). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue thus obtained was purified by column chromatography (silica gel EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 10/90) to give <b>14</b> as a white solid (0.15 g, 26%). Mp 228.6 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.94–2.06 (m, 4 H), 2.66–2.78 (m, 1 H), 3.00–3.11 (m, 2 H), 3.77 (br d, <i>J</i> = 12.1 Hz, 2 H), 4.02 (q, <i>J</i> = 9.8 Hz, 2 H), 6.85 (d, <i>J</i> = 7.2 Hz, 1 H), 7.21–7.31 (m, 3 H), 7.31–7.38 (m, 2 H), 7.86 (d, <i>J</i> = 7.5 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 395 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.66 min.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 8-Chloro-3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>15</b>)</h3><div class="NLM_p last">To a solution of <b>37a</b> (0.15 g, 0.49 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (4 mL) were added Et<sub>3</sub>N (0.12 mL, 0.89 mmol) and cyclopropylacetyl chloride (0.059 mL, 0.49 mmol). The resulting mixture was stirred at room temperature for 1 h. Then the volatiles were evaporated in vacuo. The residue thus obtained was dissolved in 1,2-dichloroethane (5 mL), and POCl<sub>3</sub> (0.13 mL, 1.45 mmol) was added. The reaction mixture was heated at 150 °C for 5 min under microwave irradiation. After cooling to room temperature, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with NaHCO<sub>3</sub> (aqueous saturated solution). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>) to give <b>15</b> as a white solid (0.069 g, 36%). Mp 194.1 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.26–0.39 (m, 2 H), 0.55–0.68 (m, 2 H), 1.10–1.23 (m, 1 H), 1.93–2.07 (m, 4 H), 2.65–2.77 (m, 1 H), 2.95–3.04 (m, 2 H), 3.05 (d, <i>J</i> = 6.7 Hz, 2 H), 3.72 (br d, <i>J</i> = 12.0 Hz, 2 H), 6.77 (d, <i>J</i> = 7.4 Hz, 1 H), 7.20–7.32 (m, 3 H), 7.32–7.39 (m, 2 H), 7.84 (d, <i>J</i> = 7.4 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 367 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.69 min.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 8-Chloro-3-ethyl-7-(4-phenylpiperidin-1-yl)[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>16</b>)</h3><div class="NLM_p last">A solution of <b>37a</b> (0.1 g, 0.33 mmol) and EtC(OEt)<sub>3</sub> (0.058 mL, 0.33 mmol) in xylene (2 mL) was heated in a sealed tube at 180 °C for 2 h. After the mixture was cooled to room temperature, the volatiles were evaporated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, MeOH–NH<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 3/97) to give <b>16</b> as a white solid (0.056 g, 50%). Mp 227.7 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.34 (t, <i>J</i> = 7.5 Hz, 3 H), 1.84 (qd, <i>J</i> = 12.1, 3.8 Hz, 2 H), 1.91 (br d, <i>J</i> = 10.4 Hz, 2 H), 2.73 (tt, <i>J</i> = 11.9, 3.8 Hz, 1 H), 2.98–3.09 (m, 4 H), 3.62 (br d, <i>J</i> = 12.1 Hz, 2 H), 6.98 (d, <i>J</i> = 7.5 Hz, 1 H), 7.19–7.26 (m, 1 H), 7.28–7.37 (m, 4 H), 8.32 (d, <i>J</i> = 7.2 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 341 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.34 min.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 8-Chloro-7-(4-fluoro-4-phenylpiperidin-1-yl)-3-(2,2,2-trifluoroethyl)-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>17</b>)</h3><div class="NLM_p last">To a solution of <b>37b</b> (6 g, 18.7 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (30 mL) cooled at 0 °C were added Et<sub>3</sub>N (4.69 mL, 33.67 mmol) and 3,3,3-trifluoropropionyl chloride (3.08 mL, 29.93 mmol). The reaction mixture was allowed to warm to room temperature and then further stirred for 1 h. Then NaHCO<sub>3</sub> (aqueous saturated solution) was added, and the resulting solution was then extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residue thus obtained was dissolved in 1,2-dichloroethane (180 mL), and polymer supported diisopropylethylamine (13.87 g, 54.09 mmol, loading 3.9 mmol/g), polymer supported PPh<sub>3</sub> (25.04 g, 45.07 mmol, loading 1.8 mmol/g) and trichloroacetonitrile (2.17 mL 21.64 mmol) were added. The resulting mixture was heated at 150 °C for 10 min under microwave irradiation. After cooling to room temperature, the mixture was filtered through a Celite pad and the solids were washed thoroughly with CH<sub>2</sub>Cl<sub>2</sub> and MeOH. The combined filtrates were concentrated in vacuo, and the residue thus obtained was purified by column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 40/60). The desired fractions were collected, and the volatiles were evaporated in vacuo. The resulting residue was purified by preparative supercritical fluid purification (pyridine 20 mm; mobile phase, isocratic 83% CO<sub>2</sub>, 17% MeOH) to give <b>17</b> as a white solid (2.36 g, 31%). Mp > 300 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.11–2.22 (m, 2 H), 2.30 (td, <i>J</i> = 13.2, 4.8 Hz, 1 H), 2.41 (td, <i>J</i> = 13.3, 4.9 Hz, 1 H), 3.39 (td, <i>J</i> = 12.2, 2.0 Hz, 2 H), 3.53–3.64 (m, 2 H), 4.04 (q, <i>J</i> = 9.9 Hz, 2 H), 6.90 (d, <i>J</i> = 7.3 Hz, 1 H), 7.31–7.38 (m, 1 H), 7.38–7.50 (m, 4 H), 7.91 (d, <i>J</i> = 7.7 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 413 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.05 min.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 8-Chloro-3-cyclopropylmethyl-7-(4-phenyl-4-trifluoromethylpiperidin-1-yl)[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>18</b>)</h3><div class="NLM_p last">To a stirred solution of <b>40</b> (1 g, 3 mmol) in toluene (10 mL) were added 4-trifluoromethyl-4-phenylpiperidine 41 (0.962 mL, 4.2 mmol), Pd(OAc)<sub>2</sub> (0.034 g, 0.15 mmol), Cs<sub>2</sub>CO<sub>3</sub> (1.46 g, 4.5 mmol), and BINAP (0.14 g, 0.225 mmol), and the reaction mixture was heated at 95 °C for 16 h in a sealed tube. After cooling to room temperature, the mixture was concentrated in vacuo and the resulting residue was suspended in water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated in vacuo, and purified by column chromatography (silica gel, MeOH in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 10/90) to give <b>18</b> as a solid (0.5 g, 39%). Mp 276.7 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.24–0.34 (m, 2 H), 0.53–0.64 (m, 2 H), 1.07–1.19 (m, 1 H), 2.38–2.48 (m, 2 H), 2.64 (d, <i>J</i> = 12.7 Hz, 2 H), 2.91 (t, <i>J</i> = 11.8 Hz, 2 H), 3.02 (d, <i>J</i> = 6.6 Hz, 2 H), 3.51 (br d, <i>J</i> = 12.1 Hz, 2 H), 6.57 (d, <i>J</i> = 7.5 Hz, 1 H), 7.36–7.42 (m, 1 H), 7.46 (t, <i>J</i> = 7.7 Hz, 2 H), 7.49–7.53 (m, 2 H), 7.76 (d, <i>J</i> = 7.2 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 435 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.43 min.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 8-Chloro-3-cyclopropylmethyl-7-(4-phenylpiperazin-1-yl)-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>19</b>)</h3><div class="NLM_p last">To a stirred solution of <b>40</b> (0.3 g, 0.9 mmol) in toluene (4 mL) were added 4-phenylpiperazine <b>42</b> (0.18 mL, 1.69 mmol), Pd(OAc)<sub>2</sub> (0.010 g, 0.045 mmol), Cs<sub>2</sub>CO<sub>3</sub> (0.73 g, 2.24 mmol), and BINAP (0.042 g, 0.068 mmol), and the reaction mixture was heated at 95 °C for 16 h in a sealed tube. After cooling to room temperature, the mixture was concentrated in vacuo and the resulting residue was suspended in water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), concentrated in vacuo, and purified by column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 40/60). The desired fractions were collected, and the volatiles were evaporated in vacuo. The residue thus obtained was precipitated by treatment with diisopropyl ether to give compound <b>19</b> as a solid (0.2 g, 60%). Mp > 300 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.27–0.39 (m, 2 H), 0.55–0.69 (m, 2 H), 1.12–1.22 (m, 1 H), 3.06 (d, <i>J</i> = 6.7 Hz, 2 H), 3.33–3.48 (m, 8 H), 6.77 (d, <i>J</i> = 7.4 Hz, 1 H), 6.92 (t, <i>J</i> = 7.3 Hz, 1 H), 7.00 (d, <i>J</i> = 8.1 Hz, 2 H), 7.31 (t, <i>J</i> = 8.1 Hz, 2 H), 7.88 (d, <i>J</i> = 7.4 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 368 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.79 min.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 3-Cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>20</b>)</h3><div class="NLM_p last">A mixture of <b>46</b> (4 g, 14.51 mmol), 4-phenylpiperidine <b>30</b> (3.3 g, 17.41 mmol), and diisopropyethylamine (5.05 mL, 29.02 mmol) in CH<sub>3</sub>CN (8.5 mL) was heated at 180 °C for 20 min under microwave irradiation. After cooling to room temperature, the mixture was concentrated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, MeOH–NH<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 10/90) to give <b>20</b> as a solid (2.8 g, 48%). Mp 211.3 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.28–0.39 (m, 2 H), 0.57–0.72 (m, 2 H), 1.06–1.22 (m, 1 H), 1.78–2.11 (m, 4 H), 2.72 (tt, <i>J</i> = 11.5, 4.4 Hz, 1 H), 3.04 (d, <i>J</i> = 6.6 Hz, 2 H), 3.18 (td, <i>J</i> = 12.1, 2.0 Hz, 2 H), 3.62 (br d, <i>J</i> = 12.4 Hz, 2 H), 6.76 (d, <i>J</i> = 7.5 Hz, 1 H), 7.21–7.28 (m, 3 H), 7.34 (t, <i>J</i> = 7.7 Hz, 2 H), 7.92 (d, <i>J</i> = 7.8 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 401 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.78 min.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 3-Ethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>21</b>)</h3><div class="NLM_p last">To a solution of <b>50a</b> (2.6 g, 7.73 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (70 mL) at 0 °C were added Et<sub>3</sub>N (1.9 mL, 13.91 mmol) and propanoyl chloride (0.83 mL, 9.28 mmol). The resulting reaction mixture was stirred at room temperature for 10 min. The mixture was then concentrated in vacuo. The residue thus obtained was dissolved in 1,2-dichloroethane (5 mL), and POCl<sub>3</sub> (0.7 mL, 1.15 mmol) was added. The resulting mixture was heated at 150 °C for 5 min under microwave irradiation. After cooling to room temperature, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with NaHCO<sub>3</sub> (aqueous saturated solution). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude product was purified by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>) to give <b>21</b> (0.14 g, 50%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.46 (t, <i>J</i> = 7.5 Hz, 3 H), 1.87–2.01 (m, 4 H), 2.72 (tt, <i>J</i> = 11.5, 4.3 Hz, 1 H), 3.06 (q, <i>J</i> = 7.5 Hz, 2 H), 3.18 (td, <i>J</i> = 12.4, 2.3 Hz, 2 H), 3.62 (br d, <i>J</i> = 12.7 Hz, 2 H), 6.77 (d, <i>J</i> = 7.5 Hz, 1 H), 7.21–7.28 (m, 3 H), 7.31–7.37 (m, 2 H), 7.81 (d, <i>J</i> = 7.5 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 375 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.4 min.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3-Butyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>22</b>)</h3><div class="NLM_p last">To a solution of <b>50a</b> (0.35 g, 1.04 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added Et<sub>3</sub>N (0.25 mL, 1.87 mmol) and pentanoyl chloride (0.13 mL, 1.04 mmol). The resulting reaction mixture was stirred at room temperature for 10 min. The mixture was then concentrated in vacuo. The residue thus obtained was dissolved in 1,2-dichloroethane (5 mL), and POCl<sub>3</sub> (0.15 mL, 1.57 mmol) was added. The resulting mixture was heated at 150 °C for 5 min under microwave irradiation. After cooling to room temperature, the mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with NaHCO<sub>3</sub> (aqueous saturated solution). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, MeOH–NH<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 3/97) to give <b>22</b> as a solid (0.16 g, 38%). Mp 221.7 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.97 (t, <i>J</i> = 7.3 Hz, 3 H), 1.42–1.53 (m, 2 H), 1.78–1.87 (m, 2 H), 1.87–2.02 (m, 4 H), 2.65–2.78 (m, 1 H), 2.99–3.08 (m, 2 H), 3.12–3.24 (m, 2 H), 3.61 (br d, <i>J</i> = 12.5 Hz, 2 H), 6.76 (d, <i>J</i> = 7.6 Hz, 1 H), 7.20–7.30 (m, 3 H), 7.30–7.39 (m, 2 H), 7.81 (d, <i>J</i> = 7.9 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 403 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.96 min.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3-Cyclopropylmethyl-7-(4-fluoro-4-phenylpiperidin-1-yl)-8-trifluoromethyl-1,2,4-triazolo[4,3-<i>a</i>]pyridine (<b>23</b>)</h3><div class="NLM_p last">To a solution of <b>50b</b> (0.29 g, 0.82 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (10 mL) were added Et<sub>3</sub>N (0.2 mL, 1.47 mmol) and cyclopropylacetyl chloride (0.12 g, 0.98 mmol). The resulting reaction mixture was stirred at room temperature for 10 min. The mixture was then concentrated in vacuo. The residue was dissolved in 1,2-dichloroethane (10 mL), and polymer supported diisopropylethylamine (0.65 g, 2.54 mmol, loading 3.9 mmol/g), polymer supported PPh<sub>3</sub> (1.77 g, 2.12 mmol, loading 1.8 mmol/g), and trichloroacetonitrile (0.1 mL, 1.02 mmol) were added. The resulting mixture was heated at 150 °C for 10 min under microwave irradiation. After cooling to room temperature, the mixture was filtered through a Celite pad and the solids were washed thoroughly with CH<sub>2</sub>Cl<sub>2</sub> and MeOH. The combined filtrates were concentrated in vacuo and the residue thus obtained was purified by column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 40/60) to give a residue that was purified by supercritical fluid purification (pyridine 20 mm; mobile phase, isocratic 85% CO<sub>2</sub>, 15% MeOH) to give <b>23</b> as a solid (0.1 g, 29%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.27–0.41 (m, 2 H), 0.57–0.70 (m, 2 H), 1.11–1.22 (m, 1 H), 2.08–2.19 (m, 2 H), 2.20–2.31 (m, 1 H), 2.36 (td, <i>J</i> = 13.2, 5.1 Hz, 1 H), 3.06 (d, <i>J</i> = 6.5 Hz, 2 H), 3.33–3.43 (m, 2 H), 3.43–3.55 (m, 2 H), 6.83 (d, <i>J</i> = 7.6 Hz, 1 H), 7.31–7.37 (m, 1 H), 7.38–7.48 (m, 4 H), 7.98 (d, <i>J</i> = 7.6 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 419 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.09 min.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-(3-Cyclopropylmethyl-8-trifluoromethyl[1,2,4]triazolo[4,3-<i>a</i>]pyridin-7-yl)-1,2,3,4-tetrahydroisoquinoline (<b>24</b>)</h3><div class="NLM_p last">A mixture of <b>46</b> (0.25 g, 0.91 mmol), 1,2,3,4-tetrahydroisoquinoline (0.14 mL, 1.09 mmol), and diisopropylethylamine (0.31 mL, 1.81 mmol) in CH<sub>3</sub>CN (5 mL) was heated at 180 °C for 20 min under microwave irradiation. After cooling to room temperature, the mixture was concentrated in vacuo. The crude product was purified by column chromatography (silica gel, MeOH–NH<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 1/99) to give <b>24</b> as a solid (0.12 g, 36%). Mp > 300 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.26–0.38 (m, 2 H), 0.54–0.67 (m, 2 H), 1.07–1.17 (m, 1 H), 2.99–3.05 (m, 2 H), 3.03 (d, <i>J</i> = 6.7 Hz, 2 H), 3.68 (t, <i>J</i> = 5.9 Hz, 2 H), 4.52 (s, 2 H), 6.79 (d, <i>J</i> = 7.9 Hz, 1 H), 7.08–7.14 (m, 1 H), 7.14–7.25 (m, 3 H), 7.89 (d, <i>J</i> = 7.6 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 373 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.2 min.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-Cyclopropylmethyl-7-(1,3-dihydroisoindol-2-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>25</b>)</h3><div class="NLM_p last">A mixture of <b>46</b> (0.2 g, 0.73 mmol), isoindoline (0.17 g, 1.45 mmol), and diisopropylethylamine (0.76 mL, 4.35 mmol) in CH<sub>3</sub>CN (10 mL) was heated at 180 °C for 20 min under microwave irradiation. After cooling to room temperature, the mixture was concentrated in vacuo. The crude product was purified by column chromatography (silica gel, MeOH–NH<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 1/99) to give <b>25</b> as a solid (0.13 g, 50%). Mp > 300 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.28–0.37 (m, 2 H), 0.56–0.66 (m, 2 H), 1.10–1.18 (m, 1 H), 3.02 (d, <i>J</i> = 6.6 Hz, 2 H), 5.00 (s, 4 H), 6.80 (d, <i>J</i> = 7.8 Hz, 1 H), 7.30–7.37 (m, 4 H), 7.85 (d, <i>J</i> = 7.8 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 359 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.66 min.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>rac</i>-3-Cyclopropylmethyl-7-(3-phenylpyrrolidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>26</b>)</h3><div class="NLM_p last">A mixture of <b>46</b> (0.2 g, 0.73 mmol), <i>rac</i>-3-phenylpyrrolidine (0.21 g, 1.45 mmol), and diisopropylethylamine (0.76 mL, 4.35 mmol) in CH<sub>3</sub>CN (10 mL) was heated at 180 °C for 20 min under microwave irradiation. After cooling, the mixture was concentrated in vacuo. The crude product was purified by column chromatography (silica gel, MeOH–NH<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 1/99) to give <b>26</b> as a solid (0.092 g, 32%). Mp 178.3 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.26–0.37 (m, 2 H), 0.56–0.64 (m, 2 H), 1.08–1.18 (m, 1 H), 2.10–2.21 (m, 1 H), 2.36–2.45 (m, 1 H), 2.94–3.06 (m, 2 H), 3.44–3.53 (m, 1 H), 3.65–3.73 (m, 2 H), 3.76–3.84 (m, 1 H), 3.84–3.91 (m, 1 H), 6.68 (d, <i>J</i> = 7.8 Hz, 1 H), 7.23–7.32 (m, 3 H), 7.33–7.39 (m, 2 H), 7.79 (d, <i>J</i> = 7.8 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 387 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.18 min.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-Cyclopropylmethyl-7-[4-(2,4-difluorophenyl)piperidin-1-yl]-8-trifluoromethyl[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>27</b>)</h3><div class="NLM_p last">A mixture of <b>46</b> (0.06 g, 0.22 mmol), 4-(2,4-difluorophenyl)piperidine <b>27</b> (0.061 g, 0.261 mmol), and diisopropylethylamine (0.076 mL, 0.43 mmol) in CH<sub>3</sub>CN (2 mL) was heated at 180 °C for 15 min under microwave irradiation. After the mixture was cooled to room temperature, the volatiles were evaporated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 30/70) to give <b>27</b> as a solid (0.041 g, 43%). Mp > 300 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.28–0.39 (m, 2 H), 0.57–0.68 (m, 2 H), 1.11–1.19 (m, 1 H), 1.86–1.97 (m, 4 H), 2.97–3.08 (m, 1 H), 3.05 (d, <i>J</i> = 6.6 Hz, 2 H), 3.13–3.24 (m, 2 H), 3.60 (d, <i>J</i> = 12.1 Hz, 2 H), 6.77 (d, <i>J</i> = 7.5 Hz, 1 H), 6.81 (ddd, <i>J</i> = 10.7, 8.7, 2.6 Hz, 1 H), 6.87 (td, <i>J</i> = 8.3, 2.2 Hz, 1 H), 7.22 (td, <i>J</i> = 8.5, 6.6 Hz, 1 H), 7.94 (d, <i>J</i> = 7.5 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 437 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.55 min.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1′-(3-Cyclopropylmethyl-8-trifluoromethyl[1,2,4]triazolo[4,3-<i>a</i>]pyridin-7-yl)-1′,2′,3′,4′,5′,6′-hexahydro[3,4′]bipyridinyl (<b>28</b>)</h3><div class="NLM_p last">A mixture of <b>46</b> (0.22 g, 0.8 mmol), 4-(3-pyridyl)piperidine (0.14 g, 0.84 mmol), and diisopropylethylamine (0.17 mL, 0.96 mmol) in CH<sub>3</sub>CN (5 mL) was heated at 90 °C for 1 day. After the mixture was cooled to room temperature, the volatiles were evaporated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, EtOAc in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 30/70) to give <b>28</b> as a solid (0.11 g, 35%). Mp 201.9 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.27–0.40 (m, 2 H), 0.55–0.69 (m, 2 H), 1.09–1.22 (m, 1 H), 1.86–2.03 (m, 4 H), 2.70–2.81 (m, 1 H), 3.05 (d, <i>J</i> = 6.7 Hz, 2 H), 3.12–3.24 (m, 2 H), 3.61 (br d, <i>J</i> = 12.5 Hz, 2 H), 6.77 (d, <i>J</i> = 7.6 Hz, 1 H), 7.28 (dd, <i>J</i> = 8.1, 4.9 Hz, 1 H), 7.58 (dt, <i>J</i> = 8.0, 1.9 Hz, 1 H), 7.95 (d, <i>J</i> = 7.6 Hz, 1 H), 8.50 (dd, <i>J</i> = 4.7, 1.5 Hz, 1 H), 8.54 (d, <i>J</i> = 2.1 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 402 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.58 min.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-Bromo-3-cyano-4-(4-phenylpiperidin-1-yl)pyridine (<b>31</b>)</h3><div class="NLM_p last">To a suspension of NaH (0.15 g, 3.82 mmol, 60% in mineral oil) in DMF (20 mL) at 0 °C was added portionwise 4-phenylpiperidine <b>30</b> (0.62 g, 3.82 mmol). The resulting mixture was stirred at 0 °C for 5 min, and then 2,4-dibromo-3-cyanopyridine <b>29</b> (1 g, 3.016 mmol) was added. The resulting reaction mixture was stirred for 1 h. The reaction mixture was then quenched with NH<sub>4</sub>Cl (aqueous saturated solution) and extracted with Et<sub>2</sub>O. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and the volatiles were evaporated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, MeOH–NH<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 1/99) to give <b>31</b> (0.98 g, 75%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.91 (qd, <i>J</i> = 12.7, 3.6 Hz, 2 H), 2.03 (br d, <i>J</i> = 12.4 Hz, 2 H), 2.80 (tt, <i>J</i> = 12.1, 3.6 Hz, 1 H), 3.19 (br t, <i>J</i> = 12.1 Hz, 2 H), 4.15 (br d, <i>J</i> = 13.0 Hz, 2 H), 6.76 (d, <i>J</i> = 6.1 Hz, 1 H), 7.21–7.28 (m, 3 H), 7.30–7.37 (m, 2 H), 8.10 (d, <i>J</i> = 6.1 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 342 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.48 min.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> [3-Cyano-4-(4-phenylpiperidin-1-yl)pyridin-2-yl]hydrazine (<b>32</b>)</h3><div class="NLM_p last">To a solution of <b>31</b> (0.5 g, 1.46 mmol) in THF (4 mL) at room temperature was added hydrazine monohydrate (0.37 g, 7.30 mmol), and the mixture was heated at 160 °C for 15 min under microwave irradiation. The reaction mixture was then cooled to room temperature, and the volatiles were evaporated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, MeOH–NH<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 1/99) to give <b>32</b> as a white solid (0.38 g, 89%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.71 (qd, <i>J</i> = 12.6, 3.7 Hz, 2 H), 1.88 (dd, <i>J</i> = 12.0, 1.4 Hz, 2 H), 2.78 (tt, <i>J</i> = 12.0, 3.7 Hz, 1 H), 3.07 (td, <i>J</i> = 12.5, 2.1 Hz, 2 H), 3.97 (br d, <i>J</i> = 12.9 Hz, 2 H), 4.28 (s, 2 H), 6.34 (d, <i>J</i> = 6.2 Hz, 1 H), 7.17–7.24 (m, 1 H), 7.24–7.35 (m, 4 H), 7.77 (s, 1 H), 7.96 (d, <i>J</i> = 6.0 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 294 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.62 min.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 7-(4-Phenylpiperidin-1-yl)[1,2,4]triazolo[4,3-<i>a</i>]pyridine-8-carbonitrile (<b>33</b>)</h3><div class="NLM_p last">A mixture of <b>32</b> (1 g, 3.41 mmol) and HC(OEt)<sub>3</sub> (7.58 g, 51.13 mmol) in xylenes (25 mL) was heated in a sealed tube at 180 °C for 2 h. The reaction mixture was cooled to room temperature and then concentrated in vacuo. The residue thus obtained was treated with Et<sub>2</sub>O and the resulting solid was filtered off and dried in the vacuum oven (50 °C) to give <b>33</b> (0.93 g, 90%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.77 (qd, <i>J</i> = 12.6, 3.6 Hz, 2 H), 1.89–1.99 (m, 2 H), 2.91 (tt, <i>J</i> = 12.1, 3.7 Hz, 1 H), 3.25–3.45 (m, 2 H), 4.32 (br d, <i>J</i> = 13.4 Hz, 2 H), 7.00 (d, <i>J</i> = 7.9 Hz, 1 H), 7.19–7.25 (m, 1 H), 7.25–7.36 (m, 4 H), 8.45 (d, <i>J</i> = 7.9 Hz, 1 H), 8.98 (s, 1 H). LCMS: <i>m</i>/<i>z</i> 304 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.11 min.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2′,3′-Dichloro-4-phenyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,4′]bipyridinyl (<b>36a</b>)</h3><div class="NLM_p last">A mixture of 2,3-dichloro-4-iodopyridine <b>34</b> (4 g, 14.61 mmol), 4-phenylpiperidine <b>30</b> (3.53 g, 21.91 mmol), and diisopropylethylamine (5.09 mL, 29.21 mmol) in CH<sub>3</sub>CN (150 mL) was heated in a sealed tube at 110 °C for 16 h. The mixture was then cooled to room temperature, and then NaHCO<sub>3</sub> (aqueous saturated solution) was added. The resulting mixture was extracted with EtOAc. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and the volatiles were evaporated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, MeOH–NH<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 1/99). The desired fractions were collected and concentrated in vacuo to give <b>36a</b> as a white solid (2.32 g, 52%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.80 (qd, <i>J</i> = 12.3, 3.7 Hz, 2 H), 1.90 (dd, <i>J</i> = 12.3, 2.3 Hz, 2 H), 2.75 (tt, <i>J</i> = 12.0, 3.8 Hz, 1 H), 2.93 (td, <i>J</i> = 12.1, 2.1 Hz, 2 H), 3.68 (br d, <i>J</i> = 12.5 Hz, 2 H), 7.14 (d, <i>J</i> = 5.5 Hz, 1 H), 7.18–7.24 (m, 1 H), 7.26–7.35 (m, 4 H), 8.16 (d, <i>J</i> = 5.5 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 307 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.46 min.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2′,3′-Dichloro-4-fluoro-4-phenyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,4′]bipyridinyl (<b>36b</b>)</h3><div class="NLM_p last">A mixture of 2,3-dichloro-4-iodopyridine <b>34</b> (2 g, 7.30 mmol), 4-fluoro-4-phenylpiperidine hydrochloride <b>35</b> (2.05 g, 9.49 mmol), and diisopropylethylamine (5.05 mL, 29.21 mmol) in CH<sub>3</sub>CN (10 mL) was heated in a sealed tube at 110 °C for 16 h. The mixture was cooled to room temperature, and then NaHCO<sub>3</sub> (aqueous saturated solution) was added. The resulting mixture was extracted with EtOAc. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and the volatiles were evaporated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub> in heptane 25/75 to 75/25) to give <b>36b</b> as a white solid (0.88 g, 37%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.08–2.20 (m, 2 H), 2.27 (ddd, <i>J</i> = 13.6, 13.0, 4.6 Hz, 1 H), 2.35 (td, <i>J</i> = 13.3, 4.9 Hz, 1 H), 3.25 (td, <i>J</i> = 12.3, 2.0 Hz, 2 H), 3.53–3.63 (m, 2 H), 6.90 (d, <i>J</i> = 5.5 Hz, 1 H), 7.31–7.37 (m, 1 H), 7.38–7.49 (m, 4 H), 8.14 (d, <i>J</i> = 5.5 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 325 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.32 min.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (3′-Chloro-4-phenyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,4′]bipyridinyl-2′-yl)hydrazine (<b>37a</b>)</h3><div class="NLM_p last">To a suspension of <b>36a</b> (0.25 g, 0.81 mmol) in 1,4-dioxane (3 mL) at room temperature was added hydrazine monohydrate (0.79 mL, 16.27 mmol). The reaction mixture was heated at 160 °C for 20 min under microwave irradiation. After the mixture was cooled to room temperature, the solvent was evaporated in vacuo, and the residue thus obtained was taken up in CH<sub>2</sub>Cl<sub>2</sub>. The resulting solution was washed with NaHCO<sub>3</sub> (aqueous saturated solution). The organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated in vacuo to give <b>37a</b> (0.24 g, 99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.79 (qd, <i>J</i> = 12.3, 3.7 Hz, 2 H), 1.84–1.91 (m, 2 H), 2.63–2.75 (m, 1 H), 2.81 (td, <i>J</i> = 11.8, 2.1 Hz, 2 H), 3.54 (br d, <i>J</i> = 12.0 Hz, 2 H), 4.16 (s, 2 H), 6.48 (d, <i>J</i> = 5.5 Hz, 1 H), 7.18–7.24 (m, 1 H), 7.26–7.36 (m, 5 H), 7.93 (d, <i>J</i> = 5.5 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 303 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 4.13 min.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (3′-Chloro-4-fluoro-4-phenyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,4′]bipyridinyl-2′-yl)hydrazine (<b>37b</b>)</h3><div class="NLM_p last">To a suspension of compound <b>36b</b> (0.97 g, 2.97 mmol) in EtOH (6 mL) was added hydrazine monohydrate (2.88 mL, 59.41 mmol). The reaction mixture was heated under microwave irradiation at 160 °C for 20 min. After the mixture was cooled to room temperature, the volatiles were evaporated in vacuo and the residue thus obtained was taken up in CH<sub>2</sub>Cl<sub>2</sub>. The resulting solution was washed with NaHCO<sub>3</sub> (aqueous saturated solution). The organic layer was separated, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The residue thus obtained was precipitated by treatment with Et<sub>2</sub>O. The resulting solid was filtered off and dried in the vacuum oven (50 °C) to give <b>37b</b> as a white solid (0.8 g, 84%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 2.04 (dd, <i>J</i> = 12.3, 11.3 Hz, 2 H), 2.19 (td, <i>J</i> = 13.2, 4.6 Hz, 1 H), 2.29 (td, <i>J</i> = 13.4, 4.0 Hz, 1 H), 3.07 (t, <i>J</i> = 11.4 Hz, 2 H), 3.37–3.49 (m, 2 H), 4.17 (s, 2 H), 6.53 (d, <i>J</i> = 5.8 Hz, 1 H), 7.31–7.39 (m, 2 H), 7.42 (t, <i>J</i> = 7.5 Hz, 2 H), 7.46–7.53 (m, 2 H), 7.95 (d, <i>J</i> = 5.5 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 321 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.37 min.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (3-Chloro-4-iodopyridin-2-yl)hydrazine (<b>38</b>)</h3><div class="NLM_p last">To a solution of 2,3-dichloro-4-iodopyridine <b>34</b> (8 g, 29.21 mmol) in 1,4-dioxane (450 mL) was added hydrazine monohydrate (14.17 mL, 175.25 mmol). The reaction mixture was heated in a sealed tube at 70 °C for 16 h. After the mixture was cooled to room temperature, NH<sub>4</sub>OH (32% aqueous solution) was added and the resulting mixture was concentrated in vacuo. The resulting residue was taken up in EtOH, and the suspension thus obtained was heated to reflux. The remaining solid was filtered off while hot, and the filtrate was cooled to room temperature. The precipitate newly formed was filtered off and then the filtrate concentrated in vacuo to give <b>38</b> as a white solid (2.67 g, 52%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.90 (br s, 3 H), 7.10 (d, <i>J</i> = 5.1 Hz, 1 H), 7.70 (d, <i>J</i> = 5.1 Hz, 1 H), 7.84 (br s, 1 H). LCMS: <i>m</i>/<i>z</i> 270 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.13 min.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Cyclopropylacetic Acid <i>N</i>′-(3-Chloro-4-iodopyridin-2-yl)hydrazide (<b>39</b>)</h3><div class="NLM_p last">To a solution of <b>38</b> (0.73 g, 2.71 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (8 mL), cooled at 0 °C, were added Et<sub>3</sub>N (0.56 mL, 4.06 mmol) and cyclopropylacetyl chloride (0.38 g, 3.25 mmol). The reaction mixture was stirred at room temperature for 16 h, and then NaHCO<sub>3</sub> (aqueous saturated solution) was added. The resulting solution was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give <b>39</b> (0.94 g, 99%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.27–0.40 (m, 2 H), 0.56–0.70 (m, 2 H), 1.11–1.23 (m, 1 H), 1.68 (s, 2 H), 3.07 (d, <i>J</i> = 6.7 Hz, 2 H), 7.17 (d, <i>J</i> = 7.2 Hz, 1 H), 7.69 (d, <i>J</i> = 7.2 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 352 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.82 min.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 8-Chloro-3-cyclopropylmethyl-7-iodo[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>40</b>)</h3><div class="NLM_p last">Compound <b>39</b> (0.74 g, 2.39 mmol) was heated at 160 °C for 3 h. After the mixture was cooled to room temperature, the brown gum thus obtained was triturated with diisopropyl ether to give a solid that was filtered off and dried in the vacuum oven (50 °C), yielding <b>40</b> (0.74 g, 93%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.26–0.41 (m, 2 H), 0.56–0.70 (m, 2 H), 1.12–1.24 (m, 1 H), 3.07 (d, <i>J</i> = 6.7 Hz, 2 H), 7.18 (d, <i>J</i> = 7.2 Hz, 1 H), 7.69 (d, <i>J</i> = 7.2 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 334 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.5 min.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-Benzyloxy-2-chloro-3-trifluoromethylpyridine (<b>44</b>)</h3><div class="NLM_p last">To a suspension of NaH (0.49 g, 12.73 mmol, 60% in mineral oil) in DMF (50 mL) cooled at 0 °C was added benzyl alcohol (1.26 mL 12.2 mmol). The resulting mixture was stirred for 2 min, and then <b>43</b> (2.5 g, 11.57 mmol) was added. The mixture was gradually warmed to room temperature and further stirred for 1 h. The reaction mixture was quenched with water and extracted with Et<sub>2</sub>O. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, heptane in CH<sub>2</sub>Cl<sub>2</sub>0/100 to 50/50) to give <b>44</b> (1.1 g, 33%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.25 (s, 2 H), 6.93 (d, <i>J</i> = 5.8 Hz, 1 H), 7.33–7.39 (m, 2 H), 7.38–7.44 (m, 3 H), 8.33 (d, <i>J</i> = 5.8 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 288 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.57 min.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (4-Benzyloxy-3-trifluoromethylpyridin-2-yl)hydrazine (<b>45</b>)</h3><div class="NLM_p last">To a suspension of <b>44</b> (1.09 g, 3.79 mmol) in 1,4-dioxane (9 mL), was added hydrazine monohydrate (3.68 mL, 75.78 mmol). The reaction mixture was heated at 160 °C for 30 min under microwave irradiation. After the mixture was cooled to room temperature, the volatiles were evaporated in vacuo. The residue thus obtained was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed with NaHCO<sub>3</sub> (aqueous saturated solution). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to give <b>45</b> as a white solid (0.89 g, 83%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 4.01 (br s, 2 H), 5.18 (s, 2 H), 6.39 (d, <i>J</i> = 5.8 Hz, 1 H), 6.53 (br s, 1 H), 7.31–7.41 (m, 3 H), 7.39 (d, <i>J</i> = 4.6 Hz, 2 H), 8.15 (d, <i>J</i> = 5.8 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 284 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.88 min.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 7-Chloro-3-cyclopropylmethyl-8-trifluoromethyl[1,2,4]triazolo[4,3-<i>a</i>]pyridine (<b>46</b>)</h3><div class="NLM_p last">A mixture of <b>45</b> (1.14 g, 1.87 mmol) and POCl<sub>3</sub> (0.35 mL, 3.74 mmol) in 1,2-dichloroethane (10 mL) was heated at 150 °C under microwave irradiation for 10 min. After cooling to room temperature, the resulting reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with NaHCO<sub>3</sub> (aqueous saturated solution). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and the volatiles were evaporated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, MeOH–NH<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 20/80) to give <b>46</b> as a white solid (0.26 g, 51%). Mp 184.5 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.28–0.40 (m, 2 H), 0.58–0.71 (m, 2 H), 1.11–1.24 (m, 1 H), 3.10 (d, <i>J</i> = 6.7 Hz, 2 H), 6.92 (d, <i>J</i> = 7.4 Hz, 1 H), 8.05 (d, <i>J</i> = 7.4 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 276 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 1.79 min.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2′-Chloro-4-phenyl-3′-trifluoromethyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,4′]bipyridinyl (<b>49a</b>)</h3><div class="NLM_p last">To a suspension of NaH (0.19 g, 4.83 mmol, 60% in mineral oil) in DMF (20 mL) cooled at 0 °C was added 4-phenylpiperidine <b>30</b> (0.84 g, 5.24 mmol). The resulting reaction mixture was stirred at 0 °C for 10 min, and then <b>43</b> (0.87 g, 4.03 mmol) was added. The reaction mixture was allowed to warm to room temperature and further stirred for 1 h. The mixture was then quenched with water and extracted with Et<sub>2</sub>O. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and the volatiles were evaporated in vacuo. The residue thus obtained was purified by column chromatography (silica gel, MeOH–NH<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub>, 0/100 to 2/98) to give <b>49a</b> as a solid (0.73 g, 53%). Mp 111.4 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.84–2.00 (m, 4 H), 2.63–2.75 (m, 1 H), 3.05 (td, <i>J</i> = 12.0, 3.0 Hz, 2 H), 3.58 (br d, <i>J</i> = 12.7 Hz, 2 H), 6.88 (d, <i>J</i> = 5.8 Hz, 1 H), 7.19–7.29 (m, 3 H), 7.29–7.37 (m, 2 H), 8.17 (d, <i>J</i> = 5.8 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 341 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.13 min.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2′-Chloro-4-fluoro-4-phenyl-3′-trifluoromethyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,4′]bipyridinyl (<b>49b</b>)</h3><div class="NLM_p last">A mixture of <b>43</b> (0.4 g, 1.85 mmol), 4-fluoro-4-phenylpiperidine hydrochloride <b>35</b> (0.4 g, 1.85 mmol), and diisopropyletylamine (0.645 mL, 3.70 mmol) in CH<sub>3</sub>CN (4 mL) was heated in a sealed tube at 110 °C for 4 h. The mixture was cooled to room temperature, diluted with EtOAc, and washed with NaHCO<sub>3</sub> (aqueous saturated solution). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and the volatiles were evaporated in vacuo to give a residue that was purified by column chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>) to give <b>49b</b> (0.53 g, 62%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.08–2.17 (m, 2 H), 2.23 (dt, <i>J</i> = 14.3, 8.8 Hz, 1 H), 2.31 (dt, <i>J</i> = 13.9, 8.8 Hz, 1 H), 3.40 (br d, <i>J</i> = 8.1 Hz, 4 H), 6.94 (d, <i>J</i> = 5.8 Hz, 1 H), 7.32–7.38 (m, 1 H), 7.38–7.45 (m, 4 H), 8.23 (d, <i>J</i> = 5.5 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 359 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 3.98 min.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (4-Phenyl-3′-trifluoromethyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,4′]bipyridinyl-2′-yl)hydrazine (<b>50a</b>)</h3><div class="NLM_p last">To a suspension of compound <b>49a</b> (0.35 g, 1.03 mmol) in THF (6 mL) at room temperature was added hydrazine monohydrate (0.2 mL, 4.11 mmol). The reaction mixture was heated at 160 °C for 45 min under microwave irradiation. Addition of hydrazine monohydrate (0.2 and 0.25 mL) to the reaction mixture followed by heating at 160 °C under microwave irradiation for 45 min was repeated twice. After cooling to room temperature, the resulting solution was concentrated in vacuo and the residue thus obtained was precipitated by treatment with Et<sub>2</sub>O to give <b>50a</b> as a white solid (0.32 g, 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.82–1.92 (m, 2 H), 1.99 (qd, <i>J</i> = 12.5, 3.9 Hz, 2 H), 2.65–2.76 (m, 1 H), 2.86 (br t, <i>J</i> = 11.2, 2 H), 3.84 (br d, <i>J</i> = 12.3 Hz, 2 H), 4.90 (s, 2 H), 6.38 (d, <i>J</i> = 5.3 Hz, 1 H), 7.16–7.25 (m, 1 H), 7.25–7.38 (m, 5 H), 8.08 (d, <i>J</i> = 5.1 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 337 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.94 min.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (4-Fluoro-4-phenyl-3′-trifluoromethyl-3,4,5,6-tetrahydro-2<i>H</i>-[1,4′]bipyridinyl-2′-yl)hydrazine (<b>50b</b>)</h3><div class="NLM_p last">To a suspension of compound <b>49b</b> (0.53 g, 1.15 mmol) in THF (10 mL) was added hydrazine monohydrate (0.224 mL, 4.61 mmol). The reaction mixture was heated at 160 °C for 45 min under microwave irradiation. After the mixture was cooled to room temperature, the volatiles were evaporated in vacuo. The residue thus obtained was precipitated by treatment with Et<sub>2</sub>O to give <b>50b</b> as a white solid (0.28 g, 69%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 2.03–2.12 (m, 2 H), 2.16–2.25 (m, 1 H), 2.25–2.34 (m, 1 H), 3.22–3.32 (m, 4 H), 4.04 (br s, 2 H), 6.26 (br s, 1 H), 6.49 (d, <i>J</i> = 5.8 Hz, 1 H), 7.30–7.38 (m, 1 H), 7.38–7.46 (m, 4 H), 8.12 (d, <i>J</i> = 5.5 Hz, 1 H). LCMS: <i>m</i>/<i>z</i> 355 [M + H]<sup>+</sup>, <i>t</i><sub>R</sub> = 2.50 min.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Biology. Membrane Preparation</h3><div class="NLM_p last">CHO cells expressing the human mGlu2 receptor were grown until 80% confluence, washed in ice-cold phosphate buffered saline, and stored at −20 °C until membrane preparation. After thawing, cells were suspended in 50 mM Tris-HCl, pH 7.4, and collected through centrifugation for 10 min at 23500<i>g</i> at 4 °C. Cells were lysed in 5 mM hypotonic Tris-HCl, pH 7.4, and after recentrifugation for 20 min at 30000<i>g</i> at 4 °C, the pellet was homogenized with an Ultra Turrax homogenizer in 50 mM Tris-HCl, pH 7.4. Protein concentrations were measured by the Bio-Rad protein assay using bovine serum albumin as standard.</div></div><div id="sec5_41_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> [<sup>35</sup>S]GTPγS Binding Assay</h3><div class="NLM_p last">For [<sup>35</sup>S]GTPγS measurements, compound and glutamate were diluted in buffer containing 10 mM HEPES acid, 10 mM HEPES salt, pH 7.4, containing 100 mM NaCl, 3 mM MgCl<sub>2</sub>, and 10 μM GDP. Membranes were thawed on ice and diluted in the same buffer, supplemented with 14 μg/mL saponin (final assay concentration of 2 μg/mL saponin). Final assay mixtures contained 7 μg of membrane protein and were preincubated with compound alone (determination of agonist effects) or together with an EC<sub>20</sub> concentration (4 μM) of glutamate (determination of PAM effects) for 30 min at 30 °C. [<sup>35</sup>S]GTPγS was added at a final concentration of 0.1 nM and incubated for another 30 min at 30 °C. Reactions were terminated by rapid filtration through Unifilter-96 GF/B filter plates (PerkinElmer) using a Unifilter-96 Harvester (PerkinElmer). Filters were washed 3 times with ice-cold 10 mM NaH<sub>2</sub>PO<sub>4</sub>/10 mM Na<sub>2</sub>HPO<sub>4</sub>, pH 7.4, and filter-bound radioactivity was counted in a Topcount microplate scintillation and luminescence counter from PerkinElmer.</div></div><div id="sec5_41_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Data Analysis</h3><div class="NLM_p last">The concentration–response curves in the presence of added EC<sub>25</sub> of mGlu2 agonist glutamate to determine positive allosteric modulation (PAM) were generated using the Prism GraphPad software (Graph Pad Inc., San Diego, CA, U.S.). The curves were fitted to a four-parameter logistic equation <i>Y</i> = Bottom + (Top – Bottom)/(1 + 10<sup>(log EC<sub>50</sub>–<i>X</i>)Hill slope</sup>) allowing determination of EC<sub>50</sub> values. The EC<sub>50</sub> is the concentration of a compound that causes a half-maximal potentiation of the glutamate response. This is calculated by subtracting the maximal responses of glutamate in the presence of a fully saturating concentration of a positive allosteric modulator from the response of glutamate in the absence of a positive allosteric modulator. The concentration producing the half-maximal effect is then calculated as EC<sub>50</sub>. The pEC<sub>50</sub> values are calculated as the −log EC<sub>50</sub> (wherein EC<sub>50</sub> is expressed in mol L<sup>–1</sup>).</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Patch Clamp Assay</h3><div class="NLM_p last">Experiments were performed using HEK293 cells stably expressing the HERG potassium channel. Cells were grown at 37 °C and 5% CO<sub>2</sub> in culture flasks in MEM medium supplemented with 10% heat-inactivated fetal bovine serum, 1% <span class="smallcaps smallerCapital">l</span>-glutamine–penicillin–streptomycin solution, 1% nonessential amino acids (100×), 1% sodium pyruvate (100 mM), and 0.8% Geneticin (50 mg/mL). Before use the cells were subcultured in MEM medium in the absence of 5 mL of <span class="smallcaps smallerCapital">l</span>-glutamine–penicillin–streptomycin. For use in the automated patch-clamp system PatchXpress 7000A (Axon Instruments) cells were harvested to obtain cell suspension of single cells. Extracellular solution contained the following (mM): 150 NaCl, 4 KCl, 1 MgCl<sub>2</sub>, 1.8 CaCl<sub>2</sub>, 10 HEPES, 5 glucose (pH 7.4 with NaOH). Pipette solution contained the following (mM): 120 KCl, 10 HEPES, 5 EGTA, 4 ATP-Mg<sub>2</sub>, 2 MgCl<sub>2</sub>, 0.5 CaCl<sub>2</sub> (pH 7.2 with KOH). Patch-clamp experiments were performed in the voltage-clamp mode, and whole-cell currents were recorded with an automated patch-clamp assay utilizing the PatchXpress 7000A system (Axon Instruments). Current signals were amplified and digitized by a Multiclamp amplifier, stored, and analyzed by using the PatchXpress and DataXpress software and Igor 5.0 (Wavemetrics). The holding potential was −80 mV. The HERG current (K<sup>+</sup>-selective outward current) was determined as the maximal tail current at −40 mV after a 2 s depolarization to +60 mV. Pulse cycling rate was 15 s. Before each test pulse a short pulse (0.5 s) from the holding potential to −60 mV was given to determine (linear) leak current. After establishment of whole-cell configuration and a stability period, the vehicle was applied for 5 min followed by the test substance at increasing concentrations of 10<sup>–7</sup>, 3 × 10<sup>–7</sup>, and 3 × 10<sup>–6</sup> M. Each concentration of the test substance was applied twice. The effect of each concentration was determined after 5 min as an average current of three sequential voltage pulses. To determine the extent of block, the residual current was compared with vehicle pretreatment.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Method for Identification of Main Metabolites</h3><div class="NLM_p last">The test compounds were incubated with human and rat liver microsomes at 0.4% final solvent concentration (0.16% DMSO and 0.24% CH<sub>3</sub>CN). The study was conducted to identify the main metabolites formed after 0 min (control) and 60 min of incubation time in the presence of NADPH generating system at 37 °C. Test concentration of the compound was 5 μM. Samples were compared to the control incubations in which compound was added at termination. Data were acquired on a Waters UPLC/QToF Premier mass spectrometer using a 10 min generic UPLC method and a generic MSe method. Complementary MS/MS experiments were performed when necessary. An Acquity UPLC C18 (2.1 mm × 100 mm, 1.8 μm) column was used. Interpretation of data was performed with Waters Metabolynx software.</div></div><div id="sec5_44_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Sleep–Wake EEG. Animals, Drug Treatment, and Experimental Procedure</h3><div class="NLM_p">All in vivo experimental procedures were performed according to the applicable European Communities Council Directive of November 24, 1986 (86/609/EEC) and approved by the Animal Care and Use Committee of Janssen Pharmaceutical Companies of Johnson & Johnson and by the local ethical committee.</div><div class="NLM_p">Male Sprague–Dawley rats (Charles River, France) weighing 250–300 g were used. Animals were chronically implanted with electrodes for recording the cortical electroencephalogram (EEG), electrical neck muscle activity (EMG), and ocular movements (EOG). All animals were housed in individually ventilated cages under environmentally controlled conditions (ambient temperature, 22 °C; humidity, 60%) on a 12 h light/dark cycle (lights on from 12:00 a.m. to 12:00 p.m., illumination intensity of ∼100 lx). The animals had free access to food and tap water.</div><div class="NLM_p">The effects of the tested molecule and vehicle on sleep–wake distribution during the lights-on period were investigated in 16 rats (<i>n</i> = 8 each group). Two EEG recording sessions were performed: the first recording session started at 13:30 h and lasted 20 h following oral administration of saline. The second recording session was performed during the same consecutive circadian time and for the same duration following administration of either vehicle (20% CD + 2H2T) or tested compound.</div><div class="NLM_p last">Sleep polysomnographic variables were determined offline as described elsewhere using a sleep stages analyzer, scoring each 2 s epoch before averaging stages over 30 min periods. Sleep–wake state classifications were assigned based upon combination of dynamics of five EEG frequency domains, integrated EMG, EOG, and body activity level: active wake (AW); passive wake (PW); intermediate stage (pre-REM transients); rapid eye movement sleep (REM); light non-REM sleep (lSWS); deep non-REM sleep (dSWS). Different sleep–wake parameters were investigated over 20 h postadministration, and time spent in each vigilance state, sleep parameters, latencies for first REM sleep period and the number of transitions between states were determined.</div></div><div id="sec5_44_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Statistical Analysis</h3><div class="NLM_p last">Time spent in each vigilance state (AW, PW, lSWS, dSWS, IS, and REMS) was expressed as a percentage of the recording period. A statistical analysis of the obtained data was carried out by a nonparametric analysis of variance of each 30 min period, followed by a Wilcoxon–Mann–Whitney rank sum test of comparisons with the control group.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Phencyclidine (PCP) Induced Hyperlocomotion in Mice</h3><div class="NLM_p last">Male NMRI mice (Charles River, France or Germany) were housed 5 per cage and kept under a 12 h light/dark cycle under constant temperature and humidity conditions. All experimental procedures were performed in full compliance with the European legislation governing the protection of animals used in scientific research. Phencyclidine (PCP) was purchased from Sigma-Aldrich (France). Nonhabituated animals were treated with the vehicle, or <b>20</b>, and immediately challenged with either PCP (5.0 mg/kg, sc) or vehicle and individually placed into open-fields for a 30 min period. The distance traveled by animals was measured using video tracking and computerized analysis systems (Ethovision XT video tracking system, version 3.1; Noldus, Wageningen, The Netherlands). Averaged activity in solvent-treated control mice was 11096 ± 3612 counts (mean ± SD; <i>n</i> = 2334). The criterion for drug-induced inhibition of hyperlocomotion was the following: total distance of < 5500 counts (4.9% false positives). ED<sub>50</sub> values (the dose inducing 50% responders to this criterion) and corresponding 95% confidence limits were determined according to the modified Spearman–Kaerber estimate, using theoretical probabilities instead of empirical ones.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> This modification allows the determination of the ED<sub>50</sub> and its confidence interval as a function of the slope of the log dose–response curve.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59"><a href="/doi/suppl/10.1021/jm3010724">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">LCMS methods for the characterization of intermediate and final compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3010724/suppl_file/jm3010724_si_001.pdf">jm3010724_si_001.pdf (148.41 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3010724" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72758" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72758" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jose María Cid</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#afc5ccc6cbefc6dbdc81c5c1c581ccc0c2"><span class="__cf_email__" data-cfemail="e9838a808da9809d9ac7838783c78a8684">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Tresadern</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juan Antonio Vega</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Isabel de Lucas</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Encarnación Matesanz</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Iturrino</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Lourdes Linares</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aránzazu Garcia</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Ignacio Andrés</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregor J. Macdonald</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Oehlrich</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hilde Lavreysen</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anton Megens</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Abdellah Ahnaou</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wilhelmus Drinkenburg</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claire Mackie</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Pype</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Gallacher</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrés A. Trabanco</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Medicinal Chemistry and ‡Molecular Sciences, Janssen Research & Development, Janssen-Cilag
S.A., Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Medicinal
Chemistry, ∥Neuroscience Biology, ⊥Discovery ADME/Tox, #Project Management Office, and ∞Center of Excellence for Cardiovascular
Safety Research & Mechanistic Pharmacology, Janssen Research & Development, Turnhoutseweg 30,
B-2340, Beerse, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d885e5663-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank collaborators from Addex Therapeutics and the members of the purification and analysis group and the biology and in vitro metabolism team from Janssen R&D.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i61" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i61"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i62" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i62"> Abbreviations Used</h2><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">AMPA</td><td class="NLM_def"><p class="first last">α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">AW</td><td class="NLM_def"><p class="first last">active wake</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CyPr</td><td class="NLM_def"><p class="first last">cyclopropyl</p></td></tr><tr><td class="NLM_term">DMS-IV</td><td class="NLM_def"><p class="first last">diagnostic statistical manual of mental disorders volume IV</p></td></tr><tr><td class="NLM_term">dSWS</td><td class="NLM_def"><p class="first last">deep non-REM sleep</p></td></tr><tr><td class="NLM_term">EEG</td><td class="NLM_def"><p class="first last">electroencephalogram</p></td></tr><tr><td class="NLM_term">EMG</td><td class="NLM_def"><p class="first last">electrical neck muscle activity</p></td></tr><tr><td class="NLM_term">EOG</td><td class="NLM_def"><p class="first last">ocular movement</p></td></tr><tr><td class="NLM_term">GABA</td><td class="NLM_def"><p class="first last">γ-aminobutyric acid, GPCR, G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HP-β-CD</td><td class="NLM_def"><p class="first last">2-hydroxylpropyl-β-cyclodextrin</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high throughput screening</p></td></tr><tr><td class="NLM_term">imidazopyridine</td><td class="NLM_def"><p class="first last">imidazo[1,2-<i>a</i>]pyridine</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">LAD</td><td class="NLM_def"><p class="first last">lowest active dose</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">LELP</td><td class="NLM_def"><p class="first last">lipophilicity-corrected ligand efficiency</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">LMA</td><td class="NLM_def"><p class="first last">locomotor activity</p></td></tr><tr><td class="NLM_term">mGlu2</td><td class="NLM_def"><p class="first last">metabotropic glutamate 2</p></td></tr><tr><td class="NLM_term">lSWS</td><td class="NLM_def"><p class="first last">light non-REM sleep</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">ND</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">nm</td><td class="NLM_def"><p class="first last">not measurable</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">NOEL</td><td class="NLM_def"><p class="first last">no effect level</p></td></tr><tr><td class="NLM_term">nt</td><td class="NLM_def"><p class="first last">not tested</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">PCP</td><td class="NLM_def"><p class="first last">phencyclidine</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PW</td><td class="NLM_def"><p class="first last">passive wake</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of mean</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">oral</p></td></tr><tr><td class="NLM_term">REM</td><td class="NLM_def"><p class="first last">rapid eye movement</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">ROL</td><td class="NLM_def"><p class="first last">REM sleep onset latency</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">sw-EEG</td><td class="NLM_def"><p class="first last">sleep–wake electroencephalogram</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">total polar surface area</p></td></tr><tr><td class="NLM_term">triazolopyridine</td><td class="NLM_def"><p class="first last">1,2,4-triazolo[4,3-<i>a</i>]pyridine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 60 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, J. P.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors: physiology, pharmacology, and disease</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1146%2Fannurev.pharmtox.011008.145533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=20055706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVelurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=295-322&author=C.+M.+Niswenderauthor=J.+P.+Conn&title=Metabotropic+glutamate+receptors%3A+physiology%2C+pharmacology%2C+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptors: physiology, pharmacology, and disease</span></div><div class="casAuthors">Niswender, Colleen M.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">295-322</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The metabotropic glutamate receptors (mGluRs) are family C G-protein-coupled receptors that participate in the modulation of synaptic transmission and neuronal excitability throughout the central nervous system.  The mGluRs bind glutamate within a large extracellular domain and transmit signals through the receptor protein to intracellular signaling partners.  A great deal of progress was made in detg. the mechanisms by which mGluRs are activated, proteins with which they interact, and orthosteric and allosteric ligands that can modulate receptor activity.  The widespread expression of mGluRs makes these receptors particularly attractive drug targets, and recent studies continue to validate the therapeutic utility of mGluR ligands in neurol. and psychiatric disorders such as Alzheimer's disease, Parkinson's disease, anxiety, depression, and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9idcZk-YH9LVg90H21EOLACvtfcHk0ljx8ydIywcBmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVelurg%253D&md5=4e7c2fa7dec6b3e3227e32fb7653423b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.011008.145533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.011008.145533%26sid%3Dliteratum%253Aachs%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DJ.%2BP.%26atitle%3DMetabotropic%2520glutamate%2520receptors%253A%2520physiology%252C%2520pharmacology%252C%2520and%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2010%26volume%3D50%26spage%3D295%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Pilc, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span> </span><span class="NLM_article-title">Mood disorders: regulation by metabotropic glutamate receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=997-1006&author=A.+Pilcauthor=S.+Chakiauthor=G.+Nowakauthor=J.+M.+Witkin&title=Mood+disorders%3A+regulation+by+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPilc%26aufirst%3DA.%26aulast%3DChaki%26aufirst%3DS.%26aulast%3DNowak%26aufirst%3DG.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26atitle%3DMood%2520disorders%253A%2520regulation%2520by%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D997%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Lüscher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K. M.</span><span> </span><span class="NLM_article-title">Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2010&pages=445-459&author=C.+L%C3%BCscherauthor=K.+M.+Huber&title=Group+1+mGluR-dependent+synaptic+long-term+depression%3A+mechanisms+and+implications+for+circuitry+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25BCscher%26aufirst%3DC.%26aulast%3DHuber%26aufirst%3DK.%2BM.%26atitle%3DGroup%25201%2520mGluR-dependent%2520synaptic%2520long-term%2520depression%253A%2520mechanisms%2520and%2520implications%2520for%2520circuitry%2520and%2520disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D65%26spage%3D445%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors as therapeutic targets for schizophrenia</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=1461-1472&author=P.+N.+Vinsonauthor=P.+J.+Conn&title=Metabotropic+glutamate+receptors+as+therapeutic+targets+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520as%2520therapeutic%2520targets%2520for%2520schizophrenia%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D1461%26epage%3D1472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Chiechio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors and the control of chronic pain</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1016%2Fj.coph.2011.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=22040745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=28-34&author=S.+Chiechioauthor=F.+Nicoletti&title=Metabotropic+glutamate+receptors+and+the+control+of+chronic+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptors and the control of chronic pain</span></div><div class="casAuthors">Chiechio, Santina; Nicoletti, Ferdinando</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-34</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past two decades metabotropic glutamate (mGlu) receptor ligands have been investigated for their potential therapeutic effects in different disorders of the central nervous system (CNS), including anxiety, depression, schizophrenia, and neurodegenerative diseases.  In addn., it has been widely demonstrated that mGlu receptors are able to modulate pain transmission both in inflammatory and neuropathic pain models.  A large no. of preclin. studies combining the use of selective ligands with the knockout strategy have revealed more details about the role of the different mGlu receptor subtypes in the modulation of pain information.  This review will address the role of mGlu receptors in pain sensitivity focusing on different strategies to achieve pain control by targeting specific mGlu receptor subtypes.  Specifically, pharmacol. interventions aimed at inhibiting group I mGlu receptor-mediated signaling and/or potentiating groups II and III mGlu receptor signaling together with an epigenetic approach leading to an increased expression of mGlu2 receptors will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbB81DKFAZW7Vg90H21EOLACvtfcHk0li7jlM6cXlf0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSntbk%253D&md5=7c5a28309126537e2cda089e75aa017b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2011.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2011.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DChiechio%26aufirst%3DS.%26aulast%3DNicoletti%26aufirst%3DF.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520and%2520the%2520control%2520of%2520chronic%2520pain%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2012%26volume%3D12%26spage%3D28%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Foster, O. M.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor ligands as potential therapeutics for addiction</span> <span class="citation_source-journal">Curr. Drug Abuse Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.2174%2F1874473710902010083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=19630739" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=83-98&author=O.+M.+Foster&title=Metabotropic+glutamate+receptor+ligands+as+potential+therapeutics+for+addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1874473710902010083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1874473710902010083%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DO.%2BM.%26atitle%3DMetabotropic%2520glutamate%2520receptor%2520ligands%2520as%2520potential%2520therapeutics%2520for%2520addiction%26jtitle%3DCurr.%2520Drug%2520Abuse%2520Rev.%26date%3D2009%26volume%3D2%26spage%3D83%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Johnson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span> </span><span class="NLM_article-title">Glutamate receptors as therapeutic targets for Parkinson’s disease</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.2174%2F187152709789824606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=19702565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGqt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=475-491&author=K.+A.+Johnsonauthor=P.+J.+Connauthor=C.+M.+Niswender&title=Glutamate+receptors+as+therapeutic+targets+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptors as therapeutic targets for Parkinson's disease</span></div><div class="casAuthors">Johnson, Kari A.; Conn, P. Jeffrey; Niswender, Colleen M.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">475-491</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor symptoms including tremor and bradykinesia.  The primary pathophysiol. underlying PD is the degeneration of dopaminergic neurons of the substantia nigra pars compacta.  Loss of these neurons causes pathol. changes in neurotransmission in the basal ganglia motor circuit.  The ability of ionotropic and metabotropic glutamate receptors to modulate neurotransmission throughout the basal ganglia suggests that these receptors may be targets for reversing the effects of altered neurotransmission in PD.  Studies in animal models suggest that modulating the activity of these receptors may alleviate the primary motor symptoms of PD as well as side effects induced by dopamine replacement therapy.  Moreover, glutamate receptor ligands may slow disease progression by delaying progressive dopamine neuron degeneration.  Antagonists of NMDA receptors have shown promise in reversing motor symptoms, levodopa-induced dyskinesias, and neurodegeneration in preclin. PD models.  The effects of drugs targeting AMPA receptors are more complex; while antagonists of these receptors exhibit utility in the treatment of levodopa-induced dyskinesias, AMPA receptor potentiators show promise for neuroprotection.  Pharmacol. modulation of metabotropic glutamate receptors (mGluRs) may hold even more promise for PD treatment due to the ability of mGluRs to fine-tune neurotransmission.  Antagonists of mGluR5, as well as activators of group II mGluRs and mGluR4, have shown promise in several animal models of PD.  These drugs reverse motor deficits in addn. to providing protection against neurodegeneration.  Glutamate receptors therefore represent exciting targets for the development of novel pharmacol. therapies for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTN40JchWl97Vg90H21EOLACvtfcHk0li7jlM6cXlf0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGqt7fM&md5=112813ce19be89395c36a72276105d07</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F187152709789824606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152709789824606%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26atitle%3DGlutamate%2520receptors%2520as%2520therapeutic%2520targets%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2009%26volume%3D8%26spage%3D475%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Watkins, J. C.</span><span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">l</span>-Glutamate as a central neurotransmitter: looking back</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1042%2F0300-5127%3A0280297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=10961913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVeitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=297-310&author=J.+C.+Watkins&title=l-Glutamate+as+a+central+neurotransmitter%3A+looking+back"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">L-Glutamate as a central neurotransmitter: looking back</span></div><div class="casAuthors">Watkins, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-310</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review, with 114 refs.  The high concn. in brain of unbound L-glutamic acid (in its anionic form, L-glutamate) fueled considerable speculation as to its role in central nervous function more than 50 yr ago.  Claims in the 1940s that it could improve cognitive acuity in patients with mental impairment were particularly intriguing, though later refuted.  In the early 1950s Hayashi found that L-glutamate could cause convulsions and proposed that it might be a central synaptic transmitter.  Soon thereafter, Curtis and colleagues showed that L-glutamate depolarized and excited central neurons, as expected for an excitatory transmitter; however, various aspects of the action of L-glutamate seemed to argue strongly against a transmitter function.  This neg. view prevailed for some 20 yr, before compelling evidence for such a role was adduced.  Over the last two decades, extensive research has revealed a host of glutamate receptor subtypes, subserving several different functions in excitatory synaptic transmission.  This paper gives a very brief and personal over-view of the development of the field over the last 50 yr from a mainly pharmacol. stand-point.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTJ2Xbf1GO6rVg90H21EOLACvtfcHk0li7jlM6cXlf0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVeitLk%253D&md5=feb7517645ed59e3eaa0179c4ac6bd60</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1042%2F0300-5127%3A0280297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252F0300-5127%253A0280297%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DJ.%2BC.%26atitle%3Dl-Glutamate%2520as%2520a%2520central%2520neurotransmitter%253A%2520looking%2520back%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2000%26volume%3D28%26spage%3D297%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kew, J. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. A.</span><span> </span><span class="NLM_article-title">Ionotropic and metabotropic glutamate receptor structure and pharmacology</span> <span class="citation_source-journal">Psyhopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1007%2Fs00213-005-2200-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=15731895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtV2itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=4-29&author=J.+N.+C.+Kewauthor=J.+A.+Kemp&title=Ionotropic+and+metabotropic+glutamate+receptor+structure+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Ionotropic and metabotropic glutamate receptor structure and pharmacology</span></div><div class="casAuthors">Kew, James N. C.; Kemp, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-29</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Rationale: L-Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS) and mediates its actions via activation of both ionotropic and metabotropic receptor families.  The development of selective ligands, including competitive agonists and antagonists and pos. and neg. allosteric modulators, has enabled investigation of the functional roles of glutamate receptor family members.  Objective: In this review we describe the subunit structure and compn. of the ionotropic and metabotropic glutamate receptors and discuss their pharmacol., particularly with respect to selective tools useful for investigation of their function in the CNS.  Results: A large no. of ligands are now available that are selective either for glutamate receptor subfamilies or for particular receptor subtypes.  Such ligands have enabled considerable advances in the elucidation of the physiol. and pathophysiol. roles of receptor family members.  Furthermore, efficacy in animal models of neurol. and psychiatric disorders has supported the progression of several glutamatergic ligands into clin. studies.  These include ionotropic glutamate receptor antagonists, which have entered clin. trials for disorders including epilepsy and ischemic stroke, α-amino-3-hydroxy-5-methyl-4-isoazolepropionic acid (AMPA) receptor pos. allosteric modulators which are under evaluation as cognitive enhancers, and metabotropic glutamate receptor 2 (mGluR2) agonists which are undergoing clin. evaluation as anxiolytics.  Furthermore, preclin. studies have illustrated therapeutic potential for ligands selective for other receptor subtypes in various disorders.  These include mGluR1 antagonists in pain, mGluR5 antagonists in anxiety, pain and drug abuse and mGluR5 pos. allosteric modulators in schizophrenia.  Conclusions: Selective pharmacol. tools have enabled the study of glutamate receptors.  However, pharmacol. coverage of the family is incomplete and considerable scope remains for the development of novel ligands, particularly those with in vivo utility, and for the their use together with existing tools for the further investigation of the roles of receptor family members in CNS function and as potentially novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEJ0YO_TO0PbVg90H21EOLACvtfcHk0lgPYOb3e8vluw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtV2itbY%253D&md5=e9ac822d32082f7779cc202c59db4247</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00213-005-2200-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-005-2200-z%26sid%3Dliteratum%253Aachs%26aulast%3DKew%26aufirst%3DJ.%2BN.%2BC.%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26atitle%3DIonotropic%2520and%2520metabotropic%2520glutamate%2520receptor%2520structure%2520and%2520pharmacology%26jtitle%3DPsyhopharmacology%26date%3D2005%26volume%3D179%26spage%3D4%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labesse, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondard, P.</span><span> </span><span class="NLM_article-title">Interdomain movements in metabotropic glutamate receptor activation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">15480</span><span class="NLM_x">–</span> <span class="NLM_lpage">15485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=15480-15485&author=S.+Huangauthor=J.+Caoauthor=M.+Jiangauthor=G.+Labesseauthor=J.+Liuauthor=J.-P.+Pinauthor=P.+Rondard&title=Interdomain+movements+in+metabotropic+glutamate+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DLabesse%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DRondard%26aufirst%3DP.%26atitle%3DInterdomain%2520movements%2520in%2520metabotropic%2520glutamate%2520receptor%2520activation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D15480%26epage%3D15485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Pin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezeau, L.</span><span> </span><span class="NLM_article-title">Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1016%2FS0163-7258%2803%2900038-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=12782243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktVOqsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2003&pages=325-354&author=J.+P.+Pinauthor=T.+Galvezauthor=L.+Prezeau&title=Evolution%2C+structure%2C+and+activation+mechanism+of+family+3%2FC+G-protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors</span></div><div class="casAuthors">Pin, Jean-Philippe; Galvez, Thierry; Prezeau, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-354</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  G-protein-coupled receptors (GPCRs) represent one of the largest gene families in the animal genome.  These receptors can be classified into several groups based on the sequence similarity of their common heptahelical domain.  The family 3 (or C) GPCRs are receptors for the main neurotransmitters glutamate and γ-aminobutyric acid, for Ca2+, for sweet and amino acid taste compds., and for some pheromone mols., as well as for odorants in fish.  Although none of these family 3 receptors have been found in plants, members have been identified in ancient organisms, such as slime molds (Dictyostelium) and sponges.  Like any other GPCRs, family 3 receptors possess a transmembrane heptahelical domain responsible for G-protein activation.  However, most of these identified receptors also possess a large extracellular domain that is responsible for ligand recognition, is structurally similar to bacterial periplasmic proteins involved in the transport of small mols., and is called a Venus Flytrap module.  The recent resoln. of the structure of this binding domain in one of these receptors, the metabotropic glutamate 1 receptor, together with the recent demonstration that these receptors are dimers, revealed a unique mechanism of activation for these GPCRs.  Such data open new possibilities in the development of drugs aimed at modulating these receptors, and raise a no. of interesting questions on the activation mechanism of the other GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqNRDDmZSLFrVg90H21EOLACvtfcHk0lgPYOb3e8vluw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktVOqsb8%253D&md5=33ed658debc421c5dbd63a8b6dbf56b1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2803%2900038-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252803%252900038-X%26sid%3Dliteratum%253Aachs%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DGalvez%26aufirst%3DT.%26aulast%3DPrezeau%26aufirst%3DL.%26atitle%3DEvolution%252C%2520structure%252C%2520and%2520activation%2520mechanism%2520of%2520family%25203%252FC%2520G-protein-coupled%2520receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2003%26volume%3D98%26spage%3D325%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Brauner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellendorph, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span> </span><span class="NLM_article-title">Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.2174%2F138945007779315614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=17266540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FmtF2kuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=169-184&author=H.+Brauner-Osborneauthor=P.+Wellendorphauthor=A.+A.+Jensen&title=Structure%2C+pharmacology+and+therapeutic+prospects+of+family+C+G-protein+coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors</span></div><div class="casAuthors">Brauner-Osborne Hans; Wellendorph Petrine; Jensen Anders A</div><div class="citationInfo"><span class="NLM_cas:title">Current drug targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Family C of G-protein coupled receptors (GPCRs) from humans is constituted by eight metabotropic glutamate (mGlu(1-8)) receptors, two heterodimeric gamma-aminobutyric acid(B) (GABA(B)) receptors, a calcium-sensing receptor (CaR), three taste (T1R) receptors, a promiscuous L-alpha-amino acid receptor (GPRC6A), and five orphan receptors.  Aside from the orphan receptors, the family C GPCRs are characterised by a large amino-terminal domain, which bind the endogenous orthosteric agonists.  Recently, a number of allosteric modulators binding to the seven transmembrane domains of the receptors have also been reported.  Family C GPCRs regulate a number of important physiological functions and are thus intensively pursued as drug targets.  So far, two drugs acting at family C receptors (the GABA(B) agonist baclofen and the positive allosteric CaR modulator cinacalcet) have been marketed.  Cinacalcet is the first allosteric GPCR modulator to enter the market, which demonstrates that the therapeutic principle of allosteric modulation can also be extended to this important drug target class.  In this review we outline the structure and function of family C GPCRs with particular focus on the ligand binding sites, and we present the most important pharmacological agents and the therapeutic prospects of the receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMO1HRaArq6WxpATR2EQURfW6udTcc2eYB3VbENl24NLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FmtF2kuw%253D%253D&md5=242ec346ee4fd59c033b5574983fd164</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F138945007779315614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945007779315614%26sid%3Dliteratum%253Aachs%26aulast%3DBrauner-Osborne%26aufirst%3DH.%26aulast%3DWellendorph%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26atitle%3DStructure%252C%2520pharmacology%2520and%2520therapeutic%2520prospects%2520of%2520family%2520C%2520G-protein%2520coupled%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2007%26volume%3D8%26spage%3D169%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Cartmell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Regulation of neurotransmitter release by metabotropic glutamate receptors</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1046%2Fj.1471-4159.2000.0750889.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=10936169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2000&pages=889-907&author=J.+Cartmellauthor=D.+D.+Schoepp&title=Regulation+of+neurotransmitter+release+by+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of neurotransmitter release by metabotropic glutamate receptors</span></div><div class="casAuthors">Cartmell, Jayne; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">889-907</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review, with ∼145 refs.  The G protein-coupled metabotropic glutamate (mGlu) receptors are differentially localized at various synapses throughout the brain.  Depending on the receptor subtype, they appear to be localized at presynaptic and/or postsynaptic sites, including glial as well as neuronal elements.  The heterogeneous distribution of these receptors on glutamate and nonglutamate neurons/cells thus allows modulation of synaptic transmission by a no. of different mechanisms.  Electrophysiol. studies have demonstrated that the activation of mGlu receptors can modulate the activity of Ca2+ or K+ channels, or interfere with release processes downstream of Ca2+ entry, and consequently regulate neuronal synaptic activity.  Such changes evoked by mGlu receptors can ultimately regulate transmitter release at both glutamatergic and nonglutamatergic synapses.  Increasing neurochem. evidence has emerged, obtained from in vitro and in vivo studies, showing modulation of the release of a variety of transmitters by mGlu receptors.  This review addresses the neurochem. evidence for mGlu receptor-mediated regulation of neurotransmitters, such as excitatory and inhibitory amino acids, monoamines, and neuropeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrRIHmsUn6YbVg90H21EOLACvtfcHk0ljPh9uWOoiX-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D&md5=15379bf75d0949789eeaeaf4f9485460</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0750889.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0750889.x%26sid%3Dliteratum%253Aachs%26aulast%3DCartmell%26aufirst%3DJ.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DRegulation%2520of%2520neurotransmitter%2520release%2520by%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D75%26spage%3D889%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ohishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigemoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, N.</span><span> </span><span class="NLM_article-title">Distribution of the messenger RNA for metabotropic glutamate receptor, mGlu2, in the central nervous system of the rat</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=1009-1018&author=H.+Ohishiauthor=R.+Shigemotoauthor=S.+Nakanishiauthor=N.+Mizuno&title=Distribution+of+the+messenger+RNA+for+metabotropic+glutamate+receptor%2C+mGlu2%2C+in+the+central+nervous+system+of+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhishi%26aufirst%3DH.%26aulast%3DShigemoto%26aufirst%3DR.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DMizuno%26aufirst%3DN.%26atitle%3DDistribution%2520of%2520the%2520messenger%2520RNA%2520for%2520metabotropic%2520glutamate%2520receptor%252C%2520mGlu2%252C%2520in%2520the%2520central%2520nervous%2520system%2520of%2520the%2520rat%26jtitle%3DNeuroscience%26date%3D1993%26volume%3D53%26spage%3D1009%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Richards, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockhaus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span> </span><span class="NLM_article-title">Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [<sup>3</sup>H]LY354740 binding in vitro and quantitative radioautography: correlation with the sites of synthesis, expression, and agonist stimulation of [<sup>35</sup>S]GTPγS binding</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1002%2Fcne.20538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=15861463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVGhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2005&pages=15-27&author=G.+Richardsauthor=J.+Messerauthor=P.+Malherbeauthor=R.+Pinkauthor=M.+Brockhausauthor=H.+Stadlerauthor=J.+Wichmannauthor=H.+J.+Schaffhauserauthor=V.+Mutel&title=Distribution+and+abundance+of+metabotropic+glutamate+receptor+subtype+2+in+rat+brain+revealed+by+%5B3H%5DLY354740+binding+in+vitro+and+quantitative+radioautography%3A+correlation+with+the+sites+of+synthesis%2C+expression%2C+and+agonist+stimulation+of+%5B35S%5DGTP%CE%B3S+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [3H]LY354740 binding in vitro and quantitative radioautography: Correlation with the sites of synthesis, expression, and agonist stimulation of [35S]GTPγS binding</span></div><div class="casAuthors">Richards, Grayson; Messer, Juerg; Malherbe, Pari; Pink, Richard; Brockhaus, Manfred; Stadler, Heinz; Wichmann, Juergen; Schaffhauser, Herve; Mutel, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-27</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Until recently, there was a lack of selective radioligands for the subtypes of metabotropic glutamate (mGlu) receptors.  [3H]LY 354740 ((+)-2-aminobicyclo[3,1,0]hexane-2,6-dicarboxylic acid), a selective agonist for group II receptors (mGlu2 and -3, which are neg. coupled to cAMP prodn.), has now been used to map their brain distribution and abundance by in vitro binding and quant. radioautog.  The selective cation dependence of its binding allowed the discrimination between mGlu2 and mGlu3 receptor labeling.  Thus, in the presence of Ca2+ and Mg2+ ions, the agonist bound selectively to mGlu2 receptors as evidenced by: (1) the correlative distribution and abundance of binding sites (highest in the lacunosum moleculare of the hippocampus and lowest in white matter) with mGlu2 receptor mRNA and protein revealed by in situ hybridization histochem. and immunohistochem., resp.; (2) its selective pharmacol.; and (3) the distribution of LY 354740-stimulated [35S]GTPγS binding (25-97% above basal, according to the brain region), revealing G protein-coupled receptor coupling to Gi proteins.  Nonspecific binding (in the presence of 10 μM DCG-IV, a group II-selective, mGlu2-preferring, receptor agonist) was <10% of total.  In adjacent sections, the distribution of binding sites for [3H]DCG-IV was very similar.  This extensive study paves the way for investigations of the regional expression and regulation of mGlu2 receptors in human CNS diseases, such as Alzheimer's disease, which may reveal their functional roles and identify potential therapeutic drug targets.  Indeed, it has recently been demonstrated (Higgins et al. [2004]) that pharmacol. manipulation of mGlu2 receptors influences cognitive performance in the rodent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV2ub35EbJUbVg90H21EOLACvtfcHk0ljPh9uWOoiX-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVGhs7k%253D&md5=711b9b109da0ea76161bbe8a629b1336</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcne.20538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.20538%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DG.%26aulast%3DMesser%26aufirst%3DJ.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DPink%26aufirst%3DR.%26aulast%3DBrockhaus%26aufirst%3DM.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DSchaffhauser%26aufirst%3DH.%2BJ.%26aulast%3DMutel%26aufirst%3DV.%26atitle%3DDistribution%2520and%2520abundance%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25202%2520in%2520rat%2520brain%2520revealed%2520by%2520%255B3H%255DLY354740%2520binding%2520in%2520vitro%2520and%2520quantitative%2520radioautography%253A%2520correlation%2520with%2520the%2520sites%2520of%2520synthesis%252C%2520expression%252C%2520and%2520agonist%2520stimulation%2520of%2520%255B35S%255DGTP%25CE%25B3S%2520binding%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2005%26volume%3D487%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span> </span><span class="NLM_article-title">Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: implication in emotional responses and central disinhibition</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1197</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1016%2Fj.brainres.2007.12.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=18242587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVaqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1197&publication_year=2008&pages=47-62&author=G.+Guauthor=D.+S.+Lorrainauthor=H.+Weiauthor=R.+L.+Coleauthor=X.+Zhangauthor=L.+P.+Daggettauthor=H.+J.+Schaffhauserauthor=L.+J.+Bristowauthor=S.+M.+Lechner&title=Distribution+of+metabotropic+glutamate+2+and+3+receptors+in+the+rat+forebrain%3A+implication+in+emotional+responses+and+central+disinhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition</span></div><div class="casAuthors">Gu, Guibao; Lorrain, Daniel S.; Wei, Hongbing; Cole, Rebecca L.; Zhang, Xin; Daggett, Lorrie P.; Schaffhauser, Herve J.; Bristow, Linda J.; Lechner, Sandra M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-62</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The receptor localization of metabotropic glutamate receptors (mGlu) 2 and 3 was examd. by using in situ hybridization and a well-characterized mGlu2-selective antibody in the rat forebrain.  The mGlu2 was highly and discretely expressed in cell bodies in almost all of the key regions of the limbic system in the forebrain, including the midline and intralaminar structures of the thalamus, the assocn. cortices, the dentate gyrus of the hippocampus, the medial mammillary nucleus, and the lateral and basolateral nuclei of the amygdala.  Moreover, presynaptic mGlu2 terminals were found in most of the forebrain structures, esp. in the lateral part of the central nucleus of the amygdala, and the CA1 region of the hippocampus.  Although some overlaps exist, such as in the hippocampus and the amygdala, the expression of mGlu3 mRNA, however, appeared to be more disperse, compared with that of mGlu2 mRNA.  These distribution results support previous behavioral studies that the mGlu2 and 3 receptors may play important roles in emotional responses.  In addn. to its expression in glia, mGlu3 was distinctively expressed in cells in the GABAergic reticular nucleus of the thalamus.  Local infusion of a non-selective mGlu2/3 agonist, LY 379268, in the reticular nucleus of the thalamus, significantly reduced GABA release, suggesting that mGlu3 may also play a role in central disinhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5fnpYDrcWc7Vg90H21EOLACvtfcHk0ljORZZJedyyzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVaqsrs%253D&md5=48befca37fcd63a7a5b86562a5672826</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2007.12.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2007.12.057%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DG.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DCole%26aufirst%3DR.%2BL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DSchaffhauser%26aufirst%3DH.%2BJ.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26atitle%3DDistribution%2520of%2520metabotropic%2520glutamate%25202%2520and%25203%2520receptors%2520in%2520the%2520rat%2520forebrain%253A%2520implication%2520in%2520emotional%2520responses%2520and%2520central%2520disinhibition%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1197%26spage%3D47%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ghose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis-Amezcua, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamminga, C. A.</span><span> </span><span class="NLM_article-title">Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1176%2Fappi.ajp.2009.08091445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=19487395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A280%3ADC%252BD1MvlvVWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2009&pages=812-820&author=S.+Ghoseauthor=K.+A.+Gleasonauthor=B.+W.+Pottsauthor=K.+Lewis-Amezcuaauthor=C.+A.+Tamminga&title=Differential+expression+of+metabotropic+glutamate+receptors+2+and+3+in+schizophrenia%3A+a+mechanism+for+antipsychotic+drug+action%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?</span></div><div class="casAuthors">Ghose Subroto; Gleason Kelly A; Potts Bryan W; Lewis-Amezcua Kelly; Tamminga Carol A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">812-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Preclinical and clinical data implicate the group II metabotropic glutamate receptors mGluR2 and mGluR3 in the pathophysiology of schizophrenia.  Moreover, a recent phase II clinical trial demonstrated the antipsychotic efficacy of a mGluR2/mGluR3 agonist.  The purpose of the present study was to distinguish the expression of mGluR2 and mGluR3 receptor proteins in schizophrenia and to quantify glutamate carboxypeptidase II (GCP II) in order to explore a role for the metabotropic receptors in schizophrenia therapeutics.  GCP II is an enzyme that metabolizes N-acetyl-aspartyl-glutamate (NAAG), which is the only known specific endogenous agonist of mGluR3 in the mammalian brain.  METHOD:  The normal expression levels of mGluR2, mGluR3, and GCP II were determined for 10 regions of the postmortem human brain using specific antibodies.  Differences in expression levels of each protein were examined in the dorsolateral prefrontal cortex, temporal cortex, and motor cortex in 15 postmortem schizophrenia subjects and 15 postmortem matched normal comparison subjects.  Chronic antipsychotic treatment in rodents was conducted to examine the potential effect of antipsychotic drugs on expression of the three proteins.  RESULTS:  Findings revealed a significant increase in GCP II protein and a reduction in mGluR3 protein in the dorsolateral prefrontal cortex in schizophrenia subjects, with mGluR2 protein levels unchanged.  Chronic antipsychotic treatment in rodents did not influence GCP II or mGluR3 levels.  CONCLUSIONS:  Increased GCP II expression and low mGluR3 expression in the dorsolateral prefrontal cortex suggest that NAAG-mediated signaling is impaired in this brain region in schizophrenia.  Further, these data implicate the mGluR3 receptor in the antipsychotic action of mGluR2/mGluR3 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRH7FPLGZ5fKrHHuJhbyicZfW6udTcc2eZnbLdRC7Tgzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvlvVWltg%253D%253D&md5=b2f45d5fc6ff54baa76c335b0fa08c4c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2009.08091445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2009.08091445%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DS.%26aulast%3DGleason%26aufirst%3DK.%2BA.%26aulast%3DPotts%26aufirst%3DB.%2BW.%26aulast%3DLewis-Amezcua%26aufirst%3DK.%26aulast%3DTamminga%26aufirst%3DC.%2BA.%26atitle%3DDifferential%2520expression%2520of%2520metabotropic%2520glutamate%2520receptors%25202%2520and%25203%2520in%2520schizophrenia%253A%2520a%2520mechanism%2520for%2520antipsychotic%2520drug%2520action%253F%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2009%26volume%3D166%26spage%3D812%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Shigeyuki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirohiko, H.</span><span> </span><span class="NLM_article-title">Targeting of metabotropic glutamate receptors for the treatment of schizophrenia</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.2174%2F138161211795049570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=21355835" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=94-102&author=C.+Shigeyukiauthor=H.+Hirohiko&title=Targeting+of+metabotropic+glutamate+receptors+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F138161211795049570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211795049570%26sid%3Dliteratum%253Aachs%26aulast%3DShigeyuki%26aufirst%3DC.%26aulast%3DHirohiko%26aufirst%3DH.%26atitle%3DTargeting%2520of%2520metabotropic%2520glutamate%2520receptors%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D94%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valli, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salhoff, C .R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffey, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic roperties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9606756" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=528-537&author=J.+A.+Monnauthor=M.+J.+Valliauthor=S.+M.+Masseyauthor=R.+A.+Wrightauthor=C+.R.+Salhoffauthor=B.+G.+Johnsonauthor=T.+Howeauthor=C.+A.+Altauthor=G.+A.+Rhodesauthor=R.+L.+Robeyauthor=K.+R.+Griffeyauthor=J.+P.+Tizzanoauthor=M.+J.+Kallmanauthor=D.+R.+Heltonauthor=D.+D.+Schoepp&title=Design%2C+synthesis%2C+and+pharmacological+characterization+of+%28%2B%29-2-aminobicyclo%5B3.1.0%5Dhexane-2%2C6-dicarboxylic+acid+%28LY354740%29%3A+a+potent%2C+selective%2C+and+orally+active+group+2+metabotropic+glutamate+receptor+agonist+possessing+anticonvulsant+and+anxiolytic+roperties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm9606756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9606756%26sid%3Dliteratum%253Aachs%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DValli%26aufirst%3DM.%2BJ.%26aulast%3DMassey%26aufirst%3DS.%2BM.%26aulast%3DWright%26aufirst%3DR.%2BA.%26aulast%3DSalhoff%26aufirst%3DC%2B.R.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DAlt%26aufirst%3DC.%2BA.%26aulast%3DRhodes%26aufirst%3DG.%2BA.%26aulast%3DRobey%26aufirst%3DR.%2BL.%26aulast%3DGriffey%26aufirst%3DK.%2BR.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DKallman%26aufirst%3DM.%2BJ.%26aulast%3DHelton%26aufirst%3DD.%2BR.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520characterization%2520of%2520%2528%252B%2529-2-aminobicyclo%255B3.1.0%255Dhexane-2%252C6-dicarboxylic%2520acid%2520%2528LY354740%2529%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520group%25202%2520metabotropic%2520glutamate%2520receptor%2520agonist%2520possessing%2520anticonvulsant%2520and%2520anxiolytic%2520roperties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D528%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Swanson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bures, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Glutamate receptors as novel targets for anxiety and stress disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=131-144&author=C.+J.+Swansonauthor=M.+Buresauthor=M.+P.+Johnsonauthor=A.+M.+Lindenauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Glutamate+receptors+as+novel+targets+for+anxiety+and+stress+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DC.%2BJ.%26aulast%3DBures%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DLinden%26aufirst%3DA.%2BM.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DGlutamate%2520receptors%2520as%2520novel%2520targets%2520for%2520anxiety%2520and%2520stress%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D131%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span> </span><span class="NLM_article-title">Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1473</span><span class="NLM_x">–</span> <span class="NLM_lpage">1483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=1473-1483&author=M.+J.+Fellauthor=D.+L.+McKinzieauthor=J.+A.+Monnauthor=K.+A.+Svensson&title=Group+II+metabotropic+glutamate+receptor+agonists+and+positive+allosteric+modulators+as+novel+treatments+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DMcKinzie%26aufirst%3DD.%2BL.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26atitle%3DGroup%2520II%2520metabotropic%2520glutamate%2520receptor%2520agonists%2520and%2520positive%2520allosteric%2520modulators%2520as%2520novel%2520treatments%2520for%2520schizophrenia%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D1473%26epage%3D1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Patil, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreev, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avedisova, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardenstein, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurovich, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morozova, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosolov, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neznanov, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reznik, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smulevich, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tochilov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1038%2Fnm1632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=17767166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSgtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1102-1107&author=S.+T.+Patilauthor=L.+Zhangauthor=F.+Martenyiauthor=S.+L.+Loweauthor=K.+A.+Jacksonauthor=B.+V.+Andreevauthor=A.+S.+Avedisovaauthor=L.+M.+Bardensteinauthor=I.+Y.+Gurovichauthor=M.+A.+Morozovaauthor=S.+N.+Mosolovauthor=N.+G.+Neznanovauthor=A.+M.+Reznikauthor=A.+B.+Smulevichauthor=V.+A.+Tochilovauthor=B.+G.+Johnsonauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Activation+of+mGlu2%2F3+receptors+as+a+new+approach+to+treat+schizophrenia%3A+a+randomized+phase+2+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial</span></div><div class="casAuthors">Patil, Sandeep T.; Zhang, Lu; Martenyi, Ferenc; Lowe, Stephen L.; Jackson, Kimberley A.; Andreev, Boris V.; Avedisova, Alla S.; Bardenstein, Leonid M.; Gurovich, Issak Y.; Morozova, Margarita A.; Mosolov, Sergey N.; Neznanov, Nikolai G.; Reznik, Alexander M.; Smulevich, Anatoly B.; Tochilov, Vladimir A.; Johnson, Bryan G.; Monn, James A.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1102-1107</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Schizophrenia is a chronic, complex and heterogeneous mental disorder, with pathol. features of disrupted neuronal excitability and plasticity within limbic structures of the brain.  These pathol. features manifest behaviorally as pos. symptoms (including hallucinations, delusions and thought disorder), neg. symptoms (such as social withdrawal, apathy and emotional blunting) and other psychopathol. symptoms (such as psychomotor retardation, lack of insight, poor attention and impulse control).  Altered glutamate neurotransmission has for decades been linked to schizophrenia, but all commonly prescribed antipsychotics act on dopamine receptors.  LY404039 is a selective agonist for metabotropic glutamate 2/3 (mGlu2/3) receptors and has shown antipsychotic potential in animal studies.  With data from rodents, we provide new evidence that mGlu2/3 receptor agonists work by a distinct mechanism different from that of olanzapine.  To clin. test this mechanism, an oral prodrug of LY404039 (LY2140023) was evaluated in schizophrenic patients with olanzapine as an active control in a randomized, three-armed, double-blind, placebo-controlled study.  Treatment with LY2140023, like treatment with olanzapine, was safe and well-tolerated; treated patients showed statistically significant improvements in both pos. and neg. symptoms of schizophrenia compared to placebo (P < 0.001 at week 4).  Notably, patients treated with LY2140023 did not differ from placebo-treated patients with respect to prolactin elevation, extrapyramidal symptoms or wt. gain.  These data suggest that mGlu2/3 receptor agonists have antipsychotic properties and may provide a new alternative for the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYtB0jdSzAQrVg90H21EOLACvtfcHk0lg54Jgw6V8uBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSgtrvF&md5=afab88e888cba7e72e14c4e949f894d7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnm1632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1632%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DK.%2BA.%26aulast%3DAndreev%26aufirst%3DB.%2BV.%26aulast%3DAvedisova%26aufirst%3DA.%2BS.%26aulast%3DBardenstein%26aufirst%3DL.%2BM.%26aulast%3DGurovich%26aufirst%3DI.%2BY.%26aulast%3DMorozova%26aufirst%3DM.%2BA.%26aulast%3DMosolov%26aufirst%3DS.%2BN.%26aulast%3DNeznanov%26aufirst%3DN.%2BG.%26aulast%3DReznik%26aufirst%3DA.%2BM.%26aulast%3DSmulevich%26aufirst%3DA.%2BB.%26aulast%3DTochilov%26aufirst%3DV.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DActivation%2520of%2520mGlu2%252F3%2520receptors%2520as%2520a%2520new%2520approach%2520to%2520treat%2520schizophrenia%253A%2520a%2520randomized%2520phase%25202%2520clinical%2520trial%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D1102%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span>During the preparation of this manuscript Eli Lilly and Company announced in a press release (August 29, 2012) the decision to stop the clinical studies investigating LY2140023 for the treatment of patients suffering from schizophrenia. The press release mentioned that the decision was made after a recently conducted independent futility analysis concluded that HBBN, the second of Lilly’s two pivotal studies, was unlikely to be positive in its primary efficacy endpoint if enrolled to completion. The decision was not based on any safety signals. <a href="https://investor.lilly.com/releaseDetail.cfm?ReleaseID=703018" class="extLink">https://investor.lilly.com/releaseDetail.cfm?ReleaseID=703018</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=During+the+preparation+of+this+manuscript+Eli+Lilly+and+Company+announced+in+a+press+release+%28August+29%2C+2012%29+the+decision+to+stop+the+clinical+studies+investigating+LY2140023+for+the+treatment+of+patients+suffering+from+schizophrenia.+The+press+release+mentioned+that+the+decision+was+made+after+a+recently+conducted+independent+futility+analysis+concluded+that+HBBN%2C+the+second+of+Lilly%E2%80%99s+two+pivotal+studies%2C+was+unlikely+to+be+positive+in+its+primary+efficacy+endpoint+if+enrolled+to+completion.+The+decision+was+not+based+on+any+safety+signals.+https%3A%2F%2Finvestor.lilly.com%2FreleaseDetail.cfm%3FReleaseID%3D703018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Pin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezeau, L.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators for γ-aminobutyric acid<sub>B</sub> receptors open new routes for the development of drugs targeting family 3 G-protein-coupled receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=881-884&author=J.+P.+Pinauthor=M.-L.+Parmentierauthor=L.+Prezeau&title=Positive+allosteric+modulators+for+%CE%B3-aminobutyric+acidB+receptors+open+new+routes+for+the+development+of+drugs+targeting+family+3+G-protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DParmentier%26aufirst%3DM.-L.%26aulast%3DPrezeau%26aufirst%3DL.%26atitle%3DPositive%2520allosteric%2520modulators%2520for%2520%25CE%25B3-aminobutyric%2520acidB%2520receptors%2520open%2520new%2520routes%2520for%2520the%2520development%2520of%2520drugs%2520targeting%2520family%25203%2520G-protein-coupled%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D881%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Gjoni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, S.</span><span> </span><span class="NLM_article-title">Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABA<sub>B</sub> receptor desensitization</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=1293-1299&author=T.+Gjoniauthor=S.+Urwyler&title=Receptor+activation+involving+positive+allosteric+modulation%2C+unlike+full+agonism%2C+does+not+result+in+GABAB+receptor+desensitization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGjoni%26aufirst%3DT.%26aulast%3DUrwyler%26aufirst%3DS.%26atitle%3DReceptor%2520activation%2520involving%2520positive%2520allosteric%2520modulation%252C%2520unlike%2520full%2520agonism%252C%2520does%2520not%2520result%2520in%2520GABAB%2520receptor%2520desensitization%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D1293%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Urwyler, S.</span><span> </span><span class="NLM_article-title">Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=59-126&author=S.+Urwyler&title=Allosteric+modulation+of+family+C+G-protein-coupled+receptors%3A+from+molecular+insights+to+therapeutic+perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrwyler%26aufirst%3DS.%26atitle%3DAllosteric%2520modulation%2520of%2520family%2520C%2520G-protein-coupled%2520receptors%253A%2520from%2520molecular%2520insights%2520to%2520therapeutic%2520perspectives%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D59%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span> </span><span class="NLM_article-title">Progress in the development of positive allosteric modulators of the metabotropic glutamate receptor 2</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.2174%2F092986711793979706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=21110815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=47-68&author=A.+A.+Trabancoauthor=J.+M.+Cidauthor=H.+Lavreysenauthor=G.+J.+Macdonaldauthor=G.+Tresadern&title=Progress+in+the+development+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of positive allosteric modulators of the metabotropic glutamate receptor 2</span></div><div class="casAuthors">Trabanco, A. A.; Cid, J. M.; Lavreysen, H.; MacDonald, G. J.; Tresadern, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-68</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The metabotropic glutamate type 2 (mGlu2) receptor is a G-protein coupled receptor (GPCR) expressed on presynaptic nerve terminals where it neg. modulates glutamate and GABA release.  Mixed mGlu2/mGlu3 orthosteric agonists such as LY354740 have shown activity in a range of preclin. animal models of anxiety and schizophrenia.  Clin. work with LY354740 demonstrated activity in a CO2 inhalation study suggesting application in the treatment of anxiety related disorders.  Subsequently, a related prodrug LY2140023 demonstrated improvements in pos. and neg. symptoms in patients suffering from schizophrenia.  These mols. exhibit combined mGlu2/mGlu3 activity although there is evidence from knock-out studies that preclin. anti-psychotic effects may be mediated via the mGlu2 receptor.  An alternative avenue for modulating GPCRs is to act via allosteric mechanisms, binding at a different site from the orthosteric agonist.  Since the first discovery of mGlu2 pos. allosteric modulators (PAMs) such as 2,2,2-TEMPS and BINA, multiple families of mGlu2 modulators have been reported and several have entered into clin. development.  This review focuses on recent advances in the development of novel mGlu2 PAMs by anal. of compds. disclosed in research articles and patent literature between 2007 and 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkHtOXKWJY9rVg90H21EOLACvtfcHk0li-u-waEbH5sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahs7g%253D&md5=b4059bdfb0001b97cde8ec0e30032a48</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F092986711793979706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711793979706%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DTresadern%26aufirst%3DG.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D47%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furnari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behaj, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thollon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Addona, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of <i>N</i>-propyl-8-chloro-6-substituted isoquinolones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">976</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=971-976&author=A.+A.+Trabancoauthor=G.+Duveyauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=P.+Cluzeauauthor=V.+Nhemauthor=R.+Furnariauthor=N.+Behajauthor=G.+Poulainauthor=T.+Finnauthor=H.+Lavreysenauthor=S.+Poliauthor=A.+Rauxauthor=Y.+Thollonauthor=N.+Poirierauthor=D.+D%E2%80%99Addonaauthor=J.+I.+Andresauthor=R.+Lutjensauthor=E.+Le+Poulauthor=H.+Imogaiauthor=J.-P.+Rocher&title=New+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2+%28mGluR2%29%3A+identification+and+synthesis+of+N-propyl-8-chloro-6-substituted+isoquinolones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFurnari%26aufirst%3DR.%26aulast%3DBehaj%26aufirst%3DN.%26aulast%3DPoulain%26aufirst%3DG.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DThollon%26aufirst%3DY.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DD%25E2%2580%2599Addona%26aufirst%3DD.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DNew%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGluR2%2529%253A%2520identification%2520and%2520synthesis%2520of%2520N-propyl-8-chloro-6-substituted%2520isoquinolones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D971%26epage%3D976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furnari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behaj, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thollon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Addona, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of <i>N</i>-propyl-5-substituted isoquinolones</span> <span class="citation_source-journal">Med. Chem. Commum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1039%2Fc0md00200c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1yktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=132-139&author=A.+A.+Trabancoauthor=G.+Duveyauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=P.+Cluzeauauthor=V.+Nhemauthor=R.+Furnariauthor=N.+Behajauthor=G.+Poulainauthor=T.+Finnauthor=S.+Poliauthor=H.+Lavreysenauthor=A.+Rauxauthor=Y.+Thollonauthor=N.+Poirierauthor=D.+D%E2%80%99Addonaauthor=J.+I.+Andr%C3%A9sauthor=R.+Lutjensauthor=E.+Le+Poulauthor=H.+Imogaiauthor=J.-P.+Rocher&title=New+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2+%28mGluR2%29%3A+identification+and+synthesis+of+N-propyl-5-substituted+isoquinolones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2). Identification and synthesis of N-propyl-5-substituted isoquinolones</span></div><div class="casAuthors">Trabanco, Andres A.; Duvey, Guillaume; Cid, Jose Maria; Macdonald, Gregor J.; Cluzeau, Philippe; Nhem, Vanthea; Furnari, Rocco; Behaj, Nadia; Poulain, Geraldine; Finn, Terry; Poli, Sonia; Lavreysen, Hilde; Raux, Alexandre; Thollon, Yves; Poirier, Nicolas; D'Addona, David; Andres, Jose Ignacio; Lutjens, Robert; Le Poul, Emmanuel; Imogai, Hassan; Rocher, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-139</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of N-propyl-5-substituted isoquinolones was identified as pos. allosteric modulators (PAM) of metabotropic glutamate receptor 2 (mGluR2) via high-throughput screening (HTS).  The subsequent synthesis and preliminary SAR exploration that led to the identification of compd. 20 are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2w5fK6sXL07Vg90H21EOLACvtfcHk0ljH9BF3Eb3v6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1yktbg%253D&md5=f729cbf8bcdeb592859e3e921c089be1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2Fc0md00200c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0md00200c%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFurnari%26aufirst%3DR.%26aulast%3DBehaj%26aufirst%3DN.%26aulast%3DPoulain%26aufirst%3DG.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DThollon%26aufirst%3DY.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DD%25E2%2580%2599Addona%26aufirst%3DD.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DNew%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGluR2%2529%253A%2520identification%2520and%2520synthesis%2520of%2520N-propyl-5-substituted%2520isoquinolones%26jtitle%3DMed.%2520Chem.%2520Commum.%26date%3D2011%26volume%3D2%26spage%3D132%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macary, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urios, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epping-Jordan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamelot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derouet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzábal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">Discovery of 1,5-disubstituted pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn1000638" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgsbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=788-795&author=J.+M.+Cidauthor=G.+Duveyauthor=P.+Cluzeauauthor=V.+Nhemauthor=K.+Macaryauthor=A.+Rauxauthor=N.+Poirierauthor=J.+Mullerauthor=C.+Boleaauthor=T.+Finnauthor=I.+Uriosauthor=M.+Epping-Jordanauthor=E.+Chamelotauthor=F.+Derouetauthor=F.+Girardauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=E.+Matesanzauthor=H.+Lavreysenauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=J.+Oyarz%C3%A1balauthor=G.+Tresadernauthor=A.+A.+Trabancoauthor=J.+I.+Andr%C3%A9sauthor=E.+Le+Poulauthor=H.+Imogaiauthor=R.+Lutjensauthor=J.-P.+Rocher&title=Discovery+of+1%2C5-disubstituted+pyridones%3A+a+new+class+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,5-Disubstituted Pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor</span></div><div class="casAuthors">Cid, Jose Maria; Duvey, Guillaume; Cluzeau, Philippe; Nhem, Vanthea; Macary, Karim; Raux, Alexandre; Poirier, Nicolas; Muller, Jessica; Bolea, Christelle; Finn, Terry; Urios, Isabelle; Epping-Jordan, Mark; Chamelot, Emilie; Derouet, Francis; Girard, Francoise; MacDonald, Gregor J.; Vega, Juan Antonio; de Lucas, Ana Isabel; Matesanz, Encarnacion; Lavreysen, Hilde; Linares, Maria Lourdes; Oehlrich, Daniel; Oyarzabal, Julen; Tresadern, Gary; Trabanco, Andres A.; Andres, Jose Ignacio; Le Poul, Emmanuel; Imogai, Hassan; Lutjens, Robert; Rocher, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">788-795</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 1,5-disubstituted pyridones was identified as pos. allosteric modulators (PAMs) of the metabotropic glutamate receptor 2 (mGluR2) via high throughput screening (HTS).  Subsequent SAR exploration led to the identification of several compds. with improved in vitro activity.  Lead compd. 8 (I) was further profiled and found to attenuate the increase in PCP induced locomotor activity in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-saUfhQDgzLVg90H21EOLACvtfcHk0ljH9BF3Eb3v6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgsbzO&md5=85204e53809a7efcbd7d9fb5f04a3601</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcn1000638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn1000638%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DMacary%26aufirst%3DK.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DBolea%26aufirst%3DC.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DUrios%26aufirst%3DI.%26aulast%3DEpping-Jordan%26aufirst%3DM.%26aulast%3DChamelot%26aufirst%3DE.%26aulast%3DDerouet%26aufirst%3DF.%26aulast%3DGirard%26aufirst%3DF.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DOyarz%25C3%25A1bal%26aufirst%3DJ.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DDiscovery%2520of%25201%252C5-disubstituted%2520pyridones%253A%2520a%2520new%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D788%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Imogai, H. J.; Cid-Nuñez, J. M.; Duvey, G. A. J.; Bolea, C. M.; Nhem, V.; Finn, T. P.; Le Poul, E. C.; Rocher, J.-P. F. C.; Lutjens, R. J.</span><span> </span><span class="NLM_article-title">Novel Pyridinone Derivatives and Their Preparation, Pharmaceutical Compositions, and Use as Positive Allosteric Modulators of mGluR2-Receptors for Treatment of Various Neurological and Psychiatric Disorders</span>. WO2006030032 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=H.+J.+Imogai&author=J.+M.+Cid-Nu%C3%B1ez&author=G.+A.+J.+Duvey&author=C.+M.+Bolea&author=V.+Nhem&author=T.+P.+Finn&author=E.+C.+Le+Poul&author=J.-P.+F.+C.+Rocher&author=R.+J.+Lutjens&title=Novel+Pyridinone+Derivatives+and+Their+Preparation%2C+Pharmaceutical+Compositions%2C+and+Use+as+Positive+Allosteric+Modulators+of+mGluR2-Receptors+for+Treatment+of+Various+Neurological+and+Psychiatric+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DImogai%26aufirst%3DH.%2BJ.%26atitle%3DNovel%2520Pyridinone%2520Derivatives%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%252C%2520and%2520Use%2520as%2520Positive%2520Allosteric%2520Modulators%2520of%2520mGluR2-Receptors%2520for%2520Treatment%2520of%2520Various%2520Neurological%2520and%2520Psychiatric%2520Disorders%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funary, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Discovery of 1,4-disubstituted 3-cyano-2-pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2405</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2016864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2388-2405&author=J.+M.+Cidauthor=G.+Duveyauthor=G.+Tresadernauthor=V.+Nhemauthor=R.+Funaryauthor=P.+Cluzeauauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=E.+Matesanzauthor=J.+M.+Alonsoauthor=M.+L.+Linaresauthor=J.+I.+Andr%C3%A9sauthor=S.+Poliauthor=R.+Lutjensauthor=H.+Imogaiauthor=J.-P.+Rocherauthor=G.+J.+Macdonaldauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=A.+Ahnaouauthor=W.+Drinkenburgauthor=C.+Mackieauthor=A.+A.+Trabanco&title=Discovery+of+1%2C4-disubstituted+3-cyano-2-pyridones%3A+a+new+class+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm2016864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016864%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFunary%26aufirst%3DR.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DDiscovery%2520of%25201%252C4-disubstituted%25203-cyano-2-pyridones%253A%2520a%2520new%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2388%26epage%3D2405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; Trabanco-Suárez, A. A.; Macdonald, G. J.; Duvey, G. A. J.; Lutjens, R. J.</span><span> </span><span class="NLM_article-title">Preparation of 3-Cyano-4-(4-tetrahydropyran-phenyl)pyridin-2-one Derivatives as Positive mGluR2 Receptor Modulators</span>. WO 2008107481 A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+M.+Cid-Nu%C3%B1ez&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Macdonald&author=G.+A.+J.+Duvey&author=R.+J.+Lutjens&title=Preparation+of+3-Cyano-4-%284-tetrahydropyran-phenyl%29pyridin-2-one+Derivatives+as+Positive+mGluR2+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26atitle%3DPreparation%2520of%25203-Cyano-4-%25284-tetrahydropyran-phenyl%2529pyridin-2-one%2520Derivatives%2520as%2520Positive%2520mGluR2%2520Receptor%2520Modulators%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Imogai, H. I.; Cid-Nuñez, J. M.; Andrés-Gil, J. I.; Trabanco-Suárez, A. A.; Oyarzábal-Santamarina, J.; Dautzenberg, F. M.; Macdonald, G. J.; Pullan, S. E.; Lutjens, R. J.; Duvey, G. A. J.; Nhem, V.; Finn, T. P.; Melikyan, G.</span><span> </span><span class="NLM_article-title">1,4-Disubstituted 3-Cyanopyridone Derivatives and Their Use as Positive Allosteric Modulators of mGlu2-Receptors and Their Preparation</span>. WO2007104783 A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=H.+I.+Imogai&author=J.+M.+Cid-Nu%C3%B1ez&author=J.+I.+Andr%C3%A9s-Gil&author=A.+A.+Trabanco-Su%C3%A1rez&author=J.+Oyarz%C3%A1bal-Santamarina&author=F.+M.+Dautzenberg&author=G.+J.+Macdonald&author=S.+E.+Pullan&author=R.+J.+Lutjens&author=G.+A.+J.+Duvey&author=V.+Nhem&author=T.+P.+Finn&author=G.+Melikyan&title=1%2C4-Disubstituted+3-Cyanopyridone+Derivatives+and+Their+Use+as+Positive+Allosteric+Modulators+of+mGlu2-Receptors+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DImogai%26aufirst%3DH.%2BI.%26atitle%3D1%252C4-Disubstituted%25203-Cyanopyridone%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Positive%2520Allosteric%2520Modulators%2520of%2520mGlu2-Receptors%2520and%2520Their%2520Preparation%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesmans, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Scaffold hopping from pyridones to imidazo[1,2-<i>a</i>]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=175-179&author=G.+Tresadernauthor=J.+M+Cidauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=A.+Garc%C3%ADaauthor=E.+Matesanzauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=I.+Biesmansauthor=A.+A.+Trabanco&title=Scaffold+hopping+from+pyridones+to+imidazo%5B1%2C2-a%5Dpyridines.+New+positive+allosteric+modulators+of+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DBiesmans%26aufirst%3DI.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DScaffold%2520hopping%2520from%2520pyridones%2520to%2520imidazo%255B1%252C2-a%255Dpyridines.%2520New%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D175%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Trabanco, A. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso de Diego, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span> </span><span class="NLM_article-title">Imidazo[1,2-<i>a</i>]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2688</span><span class="NLM_x">–</span> <span class="NLM_lpage">2701</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201561r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2688-2701&author=A.+A+Trabancoauthor=G.+Tresadernauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=E.+Matesanzauthor=A.+Garciaauthor=M.+L.+Linaresauthor=S.+A.+Alonso+de+Diegoauthor=J.+M.+Alonsoauthor=D.+Oehlrichauthor=A.+Ahnaouauthor=W.+Drinkenburgauthor=C.+Mackieauthor=J.+I.+Andresauthor=H.+Lavreysenauthor=J.+M.+Cid&title=Imidazo%5B1%2C2-a%5Dpyridines%3A+orally+active+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm201561r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201561r%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26atitle%3DImidazo%255B1%252C2-a%255Dpyridines%253A%2520orally%2520active%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2688%26epage%3D2701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; Trabanco-Suárez, A. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">Preparation of Indole and Benzoxazine Derivatives as Modulators of Metabotropic Glutamate Receptors for Treating Neurological and Psychiatric Disorders</span>. WO 2010060589 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nu%C3%B1ez&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Macdonald&title=Preparation+of+Indole+and+Benzoxazine+Derivatives+as+Modulators+of+Metabotropic+Glutamate+Receptors+for+Treating+Neurological+and+Psychiatric+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26atitle%3DPreparation%2520of%2520Indole%2520and%2520Benzoxazine%2520Derivatives%2520as%2520Modulators%2520of%2520Metabotropic%2520Glutamate%2520Receptors%2520for%2520Treating%2520Neurological%2520and%2520Psychiatric%2520Disorders%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Trabanco-Suárez, A. A.; Tresadern, G. J.; Vega-Ramiro, J. A.; Cid-Nuñez, J. M..</span><span> </span><span class="NLM_article-title">Preparation of Imidazopyridine Derivatives for Use as mGluR2 Receptor Modulators</span>. WO2009062676 A2,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Tresadern&author=J.+A.+Vega-Ramiro&author=J.+M..+Cid-Nu%C3%B1ez&title=Preparation+of+Imidazopyridine+Derivatives+for+Use+as+mGluR2+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco-Su%25C3%25A1rez%26aufirst%3DA.%2BA.%26atitle%3DPreparation%2520of%2520Imidazopyridine%2520Derivatives%2520for%2520Use%2520as%2520mGluR2%2520Receptor%2520Modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; Oehlrich, D.; Trabanco-Suárez, A. A.; Tresadern, G. J.; Vega-Ramiro, J. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">1,2,4-Triazolo[4,3-<i>a</i>]pyridine Derivatives and Their Use for the Treatment or Prevention of Neurological Disorders</span>. WO2010130424 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nu%C3%B1ez&author=D.+Oehlrich&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Tresadern&author=J.+A.+Vega-Ramiro&author=G.+J.+Macdonald&title=1%2C2%2C4-Triazolo%5B4%2C3-a%5Dpyridine+Derivatives+and+Their+Use+for+the+Treatment+or+Prevention+of+Neurological+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26atitle%3D1%252C2%252C4-Triazolo%255B4%252C3-a%255Dpyridine%2520Derivatives%2520and%2520Their%2520Use%2520for%2520the%2520Treatment%2520or%2520Prevention%2520of%2520Neurological%2520Disorders%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; De Lucas-Olivares, A. I.; Trabanco-Suárez, A. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">7-Aryl-1,2,4-triazolo[4,3-<i>a</i>]pyridine Derivatives and Their Use as Positive Allosteric Modulators of mGluR2 Receptors</span>. WO2010130423 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nu%C3%B1ez&author=A.+I.+De+Lucas-Olivares&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Macdonald&title=7-Aryl-1%2C2%2C4-triazolo%5B4%2C3-a%5Dpyridine+Derivatives+and+Their+Use+as+Positive+Allosteric+Modulators+of+mGluR2+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26atitle%3D7-Aryl-1%252C2%252C4-triazolo%255B4%252C3-a%255Dpyridine%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Positive%2520Allosteric%2520Modulators%2520of%2520mGluR2%2520Receptors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; De Lucas-Olivares, A. I.; Trabanco-Suárez, A. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">1,2,4-Triazolo[4,3-<i>a</i>]pyridine Derivatives and Their Use as Positive Allosteric Modulators of mGluR2 Receptors</span>. WO2010130422 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nu%C3%B1ez&author=A.+I.+De+Lucas-Olivares&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Macdonald&title=1%2C2%2C4-Triazolo%5B4%2C3-a%5Dpyridine+Derivatives+and+Their+Use+as+Positive+Allosteric+Modulators+of+mGluR2+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26atitle%3D1%252C2%252C4-Triazolo%255B4%252C3-a%255Dpyridine%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Positive%2520Allosteric%2520Modulators%2520of%2520mGluR2%2520Receptors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="note"><p class="first last">The in vitro [<sup>35</sup>S]GTPγS assay provides two measures of compound activity: pEC<sub>50</sub>, which is defined as the negative logarithm of the concentration at which half-maximal potentiation of glutamate is reached, and the maximal increase in observed glutamate response, the % <i>E</i><sub>MAX</sub>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="note"><p class="first last">Compound <b>20</b> shifts the concentration–response curve of glutamate to the left, increasing the potency of glutamate up to ∼25-fold.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0liWEoFo6hxvJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0liWEoFo6hxvJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Keseru, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1038%2Fnrd2796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=19247303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keseruauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lead discovery strategies on the properties of drug candidates</span></div><div class="casAuthors">Keseru Gyorgy M; Makara Gergely M</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Drug discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite the widespread acceptance of guidelines related to desirable physicochemical properties of potential small-molecule drugs, key properties - such as lipophilicity - of recently developed clinical candidates and advanced lead compounds have been shown to differ significantly from those of historical leads and drugs.  By analysing the physicochemical properties of a large database of hits and corresponding leads identified in the past decade, we show that this undesirable phenomenon can be traced back to the nature of high-throughput screening hits and hit-to-lead optimization practices.  Conceptual and organizational adjustments may be required to enable a smooth lead-evolution process that reduces the chance of high compound-related attrition in clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCjUjH8uzRfyM8MEzWGjS9fW6udTcc2eavwMmvVqNy87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D&md5=57f8228cf7f46bd4f3c3ff48f34da32c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnrd2796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2796%26sid%3Dliteratum%253Aachs%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Tarcsay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyiri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span> </span><span class="NLM_article-title">Impact of lipophilic efficiency on compound quality</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1252</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201388p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1252-1260&author=A.+Tarcsayauthor=K.+Nyiriauthor=G.+M.+Keseru&title=Impact+of+lipophilic+efficiency+on+compound+quality"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Lipophilic Efficiency on Compound Quality</span></div><div class="casAuthors">Tarcsay, Akos; Nyiri, Kinga; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1252-1260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipophilic efficiency indexes such as LLE and LELP were suggested to support balanced optimization of potency and ADMET profile.  Here we investigated the performance of LLE and LELP on multiple data sets representing different stages of drug discovery including fragment and HTS hits and leads, development candidates, phase II compds., and launched drugs.  Analyzing their impact on ADME and safety properties and binding thermodn., we found that both LLE and LELP help identifying better quality compds.  LLE is sensible for the development stages but does not prefer fragment-type hits, while LELP has an advantage for this class of compds. and discriminates preferred starting points effectively.  Both LLE and LELP have significant impact on ADME and safety profiles; however, LELP outperforms LLE in risk assessment at least on the present data set.  On the basis of the results reported here, monitoring lipophilic efficiency metrics could contribute significantly to compd. quality and might improve the output of medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxB8xs6-5DL7Vg90H21EOLACvtfcHk0liEawriLkXM8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D&md5=2536abef781f52806013016971c78bcb</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm201388p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201388p%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3DA.%26aulast%3DNyiri%26aufirst%3DK.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DImpact%2520of%2520lipophilic%2520efficiency%2520on%2520compound%2520quality%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1252%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="note"><p class="first last">Molecule <b>20</b> had a calculated (ACD, version 12.0) log <i>D</i> at pH 7.4 of 2.65, subtracted from the in vitro potency of 15 nM (pEC<sub>50</sub> of 7.82), and yielded an LLE of 5.2. However, some caution may be needed, as the experimental log <i>P</i> was 4.4 (pH 7.0, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), suggesting a discrepancy between experiment and theory in this case.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="note"><p class="first last">The CEREP selectivity screen was performed on the following targets: 5HT<sub>1A</sub>, 5HT<sub>2A</sub>, 5HT<sub>3</sub>, 5HT<sub>5A</sub>, 5HT<sub>6</sub>, 5HT<sub>7</sub>, A<sub>1</sub>, A<sub>2A</sub>, A<sub>3</sub>, AT<sub>1</sub>, β<sub>1</sub>, BK<sub>2</sub>, CCKA, CCR<sub>1</sub>, D<sub>1</sub>, D<sub>2</sub>, DAT, ETA, GAL<sub>2</sub>, H<sub>1</sub>, H<sub>2</sub>, IL<sub>8B</sub>, CXCR<sub>2</sub>, M<sub>1</sub>, M<sub>2</sub>, M<sub>3</sub>, MC<sub>4</sub>, NET, NK<sub>2</sub>, NK<sub>3</sub>, NPY<sub>1</sub>, NPY<sub>2</sub>, NT<sub>1</sub>, OP<sub>1</sub>, OP<sub>3</sub>, ORL<sub>1</sub>, V<sub>1</sub>A, VIP, SST, 5HT<sub>1B</sub>, α<sub>1</sub>, α<sub>2</sub>, BZD, CaCH, CICH, GABA, KCH, NaCH, SKCaCH.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Lopez-Rodriguez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina-Ceja, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales-Villagram, A.</span><span> </span><span class="NLM_article-title">Changes in extracellular glutamate levels in rat orbitofrontal cortex during sleep and wakefulness</span> <span class="citation_source-journal">Arch. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1016%2Fj.arcmed.2006.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=17174723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlaktLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2007&pages=52-55&author=F.+Lopez-Rodriguezauthor=L.+Medina-Cejaauthor=C.+L.+Wilsonauthor=D.+Jhungauthor=A.+Morales-Villagram&title=Changes+in+extracellular+glutamate+levels+in+rat+orbitofrontal+cortex+during+sleep+and+wakefulness"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in Extracellular Glutamate Levels in Rat Orbitofrontal Cortex During Sleep and Wakefulness</span></div><div class="casAuthors">Lopez-Rodriguez, Faustino; Medina-Ceja, Laura; Wilson, Charles L.; Jhung, Donald; Morales-Villagran, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Medical Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-55</span>CODEN:
                <span class="NLM_cas:coden">AEDEER</span>;
        ISSN:<span class="NLM_cas:issn">0188-4409</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: Functional neuroimaging studies have shown that limbic and paralimbic areas display increased activity during REM sleep when compared to wakefulness.  This increase in limbic activity is specific to the REM period of sleep.  PET scanners do not provide a neurochem. explanation for this increased activity during REM sleep.  In order to better understand the neurochem. basis of this increase, extracellular glutamate levels were measured in the rat orbitofrontal cortex during the stages of sleep and wakefulness.  Methods: EEG and EMG activity were registered to score the behavioral state in epochs of 15 s into three stages: wakefulness, non-REM sleep and rapid eye movement (REM) sleep.  To correlate the glutamate concn. of the orbitofrontal cortex with sleep-wake states, 1-min dialyzate samples were taken and classified as wakefulness, non-REM or REM sleep if all four of the 15-s epochs occurring during the collection of that sample and after correction for dead time corresponded to the resp. state.  High-performance liq. chromatog. (HPLC) with electrochem. detection was used to measure glutamate levels.  Results: Glutamate levels of the orbitofrontal cortex were increased during REM sleep, diminished during wakefulness, and the lowest levels were found during non-REM sleep.  Conclusions: These findings demonstrate an increase in the concn. of the excitatory neurotransmitter glutamate in the orbitofrontal cortex during REM sleep, which could be related to the increased activity in paralimbic structures obsd. in humans using functional neuroimaging, as well as to the proposed role of REM sleep on retention of emotional memories.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC9ZgyRujy3bVg90H21EOLACvtfcHk0liEawriLkXM8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlaktLnJ&md5=254195f095ab0cf0ff9b71c26c4589c4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2006.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2006.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Rodriguez%26aufirst%3DF.%26aulast%3DMedina-Ceja%26aufirst%3DL.%26aulast%3DWilson%26aufirst%3DC.%2BL.%26aulast%3DJhung%26aufirst%3DD.%26aulast%3DMorales-Villagram%26aufirst%3DA.%26atitle%3DChanges%2520in%2520extracellular%2520glutamate%2520levels%2520in%2520rat%2520orbitofrontal%2520cortex%2520during%2520sleep%2520and%2520wakefulness%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2007%26volume%3D38%26spage%3D52%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibelin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steckler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W. H. I. M.</span><span> </span><span class="NLM_article-title">Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep–wake architecture</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">603</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1016%2Fj.ejphar.2008.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=19046965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=603&publication_year=2009&pages=62-72&author=A.+Ahnaouauthor=F.+M.+Dautzenbergauthor=H.+Geysauthor=H.+Imogaiauthor=A.+Gibelinauthor=D.+Moecharsauthor=T.+Stecklerauthor=W.+H.+I.+M.+Drinkenburg&title=Modulation+of+group+II+metabotropic+glutamate+receptor+%28mGlu2%29+elicits+common+changes+in+rat+and+mice+sleep%E2%80%93wake+architecture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture</span></div><div class="casAuthors">Ahnaou, Abdellah; Dautzenberg, Frank M.; Geys, Helena; Imogai, Hassan; Gibelin, Antoine; Moechars, Dieder; Steckler, Thomas; Drinkenburg, Wilhelmus H. I. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">603</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">62-72</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Compiling pharmacol. evidence implicates metabotropic glutamate mGlu2 receptors in the regulation of emotional states and suggests pos. modulators as a novel therapeutic approach of Anxiety/Depression and Schizophrenia.  Here, we investigated s.c. effects of the metabotropic glutamate mGlu2/3 agonist (LY354740) on sleep-wake architecture in rat.  To confirm the specific effects on rapid eye movement (REM) sleep were mediated via metabotropic glutamate mGlu2 receptors, we characterized the sleep-wake cycles in metabotropic glutamate mGlu2 receptor deficient mice (mGlu2R-/-) and their arousal response to LY354740.  We furthermore examd. effects on sleep behavior in rats of the pos. allosteric modulator, biphenyl-indanone A (BINA) alone and in combination with LY354740 at sub-EDs.  LY354740 (1, 3 and 10 mg/kg) dose-dependently suppressed REM sleep and prolonged its onset latency.  Metabotropic glutamate mGlu2R-/- and their wild type (WT) littermates exhibited similar spontaneous sleep-wake phenotype, while LY354740 (10 mg/kg) significantly affected REM sleep variables in WT but not in the mutant.  In rats, BINA (1, 3, 10, 20, 40 mg/kg) dose-dependently suppressed REM sleep, lengthened its onset latency and slightly enhanced passive waking.  Addnl., combined treatment elicited a synergistic action on REM sleep variables.  Our findings show common changes of REM sleep variables following modulation of metabotropic glutamate mGlu2 receptor and support an active role of this receptor in the regulation of REM sleep.  The synergistic action of BINA on LY354740's effects on sleep pattern implies that pos. modulators would tune the endogenous glutamate tone suggesting potential benefit in the treatment of psychiatric disorders, in which REM sleep overdrive is manifested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlUXqoXCoqp7Vg90H21EOLACvtfcHk0lg_zjU90OFhuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsbg%253D&md5=eb1e676deebb6b39aad64cf14a281bf2</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26aulast%3DGeys%26aufirst%3DH.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DGibelin%26aufirst%3DA.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DSteckler%26aufirst%3DT.%26aulast%3DDrinkenburg%26aufirst%3DW.%2BH.%2BI.%2BM.%26atitle%3DModulation%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520%2528mGlu2%2529%2520elicits%2520common%2520changes%2520in%2520rat%2520and%2520mice%2520sleep%25E2%2580%2593wake%2520architecture%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D603%26spage%3D62%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Feinberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darchia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, I. G.</span><span> </span><span class="NLM_article-title">The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2<i>S</i>-2-amino-2-(1<i>S</i>,2<i>S</i>-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist LY379268 [(−)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">826</span><span class="NLM_x">–</span> <span class="NLM_lpage">833</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1124%2Fjpet.104.076547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=15383637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVCntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2005&pages=826-833&author=I.+Feinbergauthor=D.+D.+Schoeppauthor=K.-C.+Hsiehauthor=N.+Darchiaauthor=I.+G.+Campbell&title=The+metabotropic+glutamate+%28mGLU%292%2F3+receptor+antagonist+LY341495+%5B2S-2-amino-2-%281S%2C2S-2-carboxycyclopropyl-1-yl%29-3-%28xanth-9-yl%29propanoic+acid%5D+stimulates+waking+and+fast+electroencephalogram+power+and+blocks+the+effects+of+the+mGLU2%2F3+receptor+agonist+LY379268+%5B%28%E2%88%92%29-2-oxa-4-aminobicyclo%5B3.1.0%5Dhexane-4%2C6-dicarboxylate%5D+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist LY379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats</span></div><div class="casAuthors">Feinberg, I.; Schoepp, D. D.; Hsieh, K.-C.; Darchia, N.; Campbell, I. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">826-833</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The highly selective metabotropic glutamate (mGlu)2/3 receptor agonist LY379268 completely suppresses rapid eye movement (REM) sleep and strongly depresses theta (6-10 Hz) and high-frequency (10-60 Hz) power in the waking and nonrapid eye movement (NREM) EEG, effects consistent with depressed brain excitation (arousal).  We hypothesized the selective mGlu2/3 receptor antagonist LY341495 given alone would (1) increase arousal, producing sleep-wake EEG effects opposite those of LY379268, and (2) block/reverse the effects of LY379268 when the drugs are coadministered.  Rats with implanted electrodes were injected with 1, 5, or 10 mg/kg LY341495 at hour 5.5 of the dark period.  In the coadministration study the rats received the same dose of LY341495 followed 30 min later by 1 mg/kg LY379268.  LY341495 alone increased waking by reducing NREM and REM sleep.  LY341495 also depressed low-frequency and stimulated high-frequency EEG power.  It produced a sharp spike in theta power in waking but not NREM sleep, a striking state-dependent difference in pharmacol. response.  These changes indicate that blocking mGlu2/3 receptors increases brain arousal.  Moreover, they show that mGlu2/3 receptors actively support arousal even in the absence of heightened glutamate excitation.  The coadministration expt. demonstrates that LY341495 is selective in vivo since it dose-dependently attenuates or reverses the sleep-wake EEG effects of the highly selective mGlu2/3 receptor agonist LY379268.  The capacity of mGlu2/3 receptor agonists and antagonists to alter the sleep wake balance suggests they could be developed to enhance sleep or sustain arousal.  Their opposing actions on theta EEG could test the putative role of these oscillations in memory consolidation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLNwVF62Xe7rVg90H21EOLACvtfcHk0lg_zjU90OFhuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVCntL0%253D&md5=595e80a40d89c0a600e6226a9026f8ce</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.076547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.076547%26sid%3Dliteratum%253Aachs%26aulast%3DFeinberg%26aufirst%3DI.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26aulast%3DHsieh%26aufirst%3DK.-C.%26aulast%3DDarchia%26aufirst%3DN.%26aulast%3DCampbell%26aufirst%3DI.%2BG.%26atitle%3DThe%2520metabotropic%2520glutamate%2520%2528mGLU%25292%252F3%2520receptor%2520antagonist%2520LY341495%2520%255B2S-2-amino-2-%25281S%252C2S-2-carboxycyclopropyl-1-yl%2529-3-%2528xanth-9-yl%2529propanoic%2520acid%255D%2520stimulates%2520waking%2520and%2520fast%2520electroencephalogram%2520power%2520and%2520blocks%2520the%2520effects%2520of%2520the%2520mGLU2%252F3%2520receptor%2520agonist%2520LY379268%2520%255B%2528%25E2%2588%2592%2529-2-oxa-4-aminobicyclo%255B3.1.0%255Dhexane-4%252C6-dicarboxylate%255D%2520in%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D312%26spage%3D826%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rorick-Kehn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overshiner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaney, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benvenga, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deanna, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlow, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luecke, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wafford, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgar, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quets, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolayev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhugh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khilevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckstein, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catlow, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher-Wisniewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schkeryantz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span> </span><span class="NLM_article-title"><i>N</i>-(4-((2-(Trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1<i>H</i>-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1124%2Fjpet.110.172957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=20947638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1erug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=165-177&author=M.+J.+Fellauthor=J.+M.+Witkinauthor=J.+F.+Falconeauthor=J.+S.+Katnerauthor=K.+W.+Perryauthor=J.+Hartauthor=L.+Rorick-Kehnauthor=C.+D.+Overshinerauthor=K.+Rasmussenauthor=S.+F.+Chaneyauthor=M.+J.+Benvengaauthor=X.+L.+Deannaauthor=L.+Marlowauthor=L.+K.+Thompsonauthor=S.+K.+Lueckeauthor=K.+A.+Waffordauthor=W.+F.+Seidelauthor=D.+M.+Edgarauthor=A.+T.+Quetsauthor=C.+C.+Felderauthor=X.+Wangauthor=B.+A.+Heinzauthor=A.+Nikolayevauthor=M.-S.+Kuoauthor=D.+Mayhughauthor=A.+Khilevichauthor=D.+Zhangauthor=P.+J.+Ebertauthor=J.+A.+Ecksteinauthor=B.+L.+Ackermannauthor=S.+P.+Swansonauthor=J.+T.+Catlowauthor=R.+A.+Deanauthor=K.+Jacksonauthor=S.+Tauscher-Wisniewskiauthor=G.+J.+Marekauthor=J.+M.+Schkeryantzauthor=K.+A.+Svensson&title=N-%284-%28%282-%28Trifluoromethyl%29-3-hydroxy-4-%28isobutyryl%29phenoxy%29methyl%29benzyl%29-1-methyl-1H-imidazole-4-carboxamide+%28THIIC%29%2C+a+novel+metabotropic+glutamate+2+potentiator+with+potential+anxiolytic%2Fantidepressant+properties%3A+in+vivo+profiling+suggests+a+link+between+behavioral+and+central+nervous+system+neurochemical+changes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes</span></div><div class="casAuthors">Fell, Matthew J.; Witkin, Jeffrey M.; Falcone, Julie F.; Katner, Jason S.; Perry, Kenneth W.; Hart, John; Rorick-Kehn, Linda; Overshiner, Carl D.; Rasmussen, Kurt; Chaney, Stephen F.; Benvenga, Mark J.; Li, Xia; Marlow, Deanna L.; Thompson, Linda K.; Luecke, Susan K.; Wafford, Keith A.; Seidel, Wesley F.; Edgar, Dale M.; Quets, Anne T.; Felder, Christian C.; Wang, XuShan; Heinz, Beverly A.; Nikolayev, Alexander; Kuo, Ming-Shang; Mayhugh, Daniel; Khilevich, Albert; Zhang, Deyi; Ebert, Philip J.; Eckstein, James A.; Ackermann, Bradley L.; Swanson, Steven P.; Catlow, John T.; Dean, Robert A.; Jackson, Kimberley; Tauscher-Wisniewski, Sitra; Marek, Gerard J.; Schkeryantz, Jeffrey M.; Svensson, Kjell A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-177</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The normalization of excessive glutamatergic neurotransmission through the activation of metabotropic glutamate 2 (mGlu2) receptors may have therapeutic potential in a variety of psychiatric disorders, including anxiety/depression and schizophrenia.  Here, we characterize the pharmacol. properties of N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a structurally novel, potent, and selective allosteric potentiator of human and rat mGlu2 receptors (EC50 = 23 and 13 nM, resp.).  THIIC produced anxiolytic-like efficacy in the rat stress-induced hyperthermia assay and the mouse stress-induced elevation of cerebellar cGMP and marble-burying assays.  THIIC also produced robust activity in three assays that detect antidepressant-like activity, including the mouse forced-swim test, the rat differential reinforcement of low rate 72-s assay, and the rat dominant-submissive test, with a maximal response similar to that of impiramine.  Effects of THIIC in the forced-swim test and marble burying were deleted in mGlu2 receptor null mice.  Anal. of sleep EEG showed that THIIC had a sleep-promoting profile with increased non-rapid eye movement (REM) and decreased REM sleep.  THIIC also decreased the dark phase increase in extracellular histamine in the medial prefrontal cortex and decreased levels of the histamine metabolite tele-methylhistamine (t-MeHA) in rat cerebrospinal fluid.  Collectively, these results indicate that the novel mGlu2-pos. allosteric modulator THIIC has robust activity in models used to predict anxiolytic/antidepressant efficacy, substantiating, at least with this mol., differentiation in the biol. impact of mGlu2 potentiation vs. mGlu2/3 orthosteric agonism.  In addn., we provide evidence that sleep EEG and CSF t-MeHA might function as viable biomarker approaches to facilitate the translational development of THIIC and other mGlu2 potentiators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocfm6DC8ijJrVg90H21EOLACvtfcHk0ljBovyKwF3khA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1erug%253D%253D&md5=ab138f946460f041067c5330a1b5217a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.172957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.172957%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DKatner%26aufirst%3DJ.%2BS.%26aulast%3DPerry%26aufirst%3DK.%2BW.%26aulast%3DHart%26aufirst%3DJ.%26aulast%3DRorick-Kehn%26aufirst%3DL.%26aulast%3DOvershiner%26aufirst%3DC.%2BD.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DChaney%26aufirst%3DS.%2BF.%26aulast%3DBenvenga%26aufirst%3DM.%2BJ.%26aulast%3DDeanna%26aufirst%3DX.%2BL.%26aulast%3DMarlow%26aufirst%3DL.%26aulast%3DThompson%26aufirst%3DL.%2BK.%26aulast%3DLuecke%26aufirst%3DS.%2BK.%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DSeidel%26aufirst%3DW.%2BF.%26aulast%3DEdgar%26aufirst%3DD.%2BM.%26aulast%3DQuets%26aufirst%3DA.%2BT.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHeinz%26aufirst%3DB.%2BA.%26aulast%3DNikolayev%26aufirst%3DA.%26aulast%3DKuo%26aufirst%3DM.-S.%26aulast%3DMayhugh%26aufirst%3DD.%26aulast%3DKhilevich%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DEbert%26aufirst%3DP.%2BJ.%26aulast%3DEckstein%26aufirst%3DJ.%2BA.%26aulast%3DAckermann%26aufirst%3DB.%2BL.%26aulast%3DSwanson%26aufirst%3DS.%2BP.%26aulast%3DCatlow%26aufirst%3DJ.%2BT.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DJackson%26aufirst%3DK.%26aulast%3DTauscher-Wisniewski%26aufirst%3DS.%26aulast%3DMarek%26aufirst%3DG.%2BJ.%26aulast%3DSchkeryantz%26aufirst%3DJ.%2BM.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26atitle%3DN-%25284-%2528%25282-%2528Trifluoromethyl%2529-3-hydroxy-4-%2528isobutyryl%2529phenoxy%2529methyl%2529benzyl%2529-1-methyl-1H-imidazole-4-carboxamide%2520%2528THIIC%2529%252C%2520a%2520novel%2520metabotropic%2520glutamate%25202%2520potentiator%2520with%2520potential%2520anxiolytic%252Fantidepressant%2520properties%253A%2520in%2520vivo%2520profiling%2520suggests%2520a%2520link%2520between%2520behavioral%2520and%2520central%2520nervous%2520system%2520neurochemical%2520changes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D165%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Siok, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shifflett, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocsis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span> </span><span class="NLM_article-title">Comparative analysis of the neurophysiological profile of group II metabotropic glutamate receptor activators and diazepam: effects on hippocampal and cortical EEG patterns in rats</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=226-236&author=C.+J.+Siokauthor=S.+M.+Coganauthor=L.+B.+Shifflettauthor=A.+C.+Doranauthor=B.+Kocsisauthor=M.+Haj%C3%B3s&title=Comparative+analysis+of+the+neurophysiological+profile+of+group+II+metabotropic+glutamate+receptor+activators+and+diazepam%3A+effects+on+hippocampal+and+cortical+EEG+patterns+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiok%26aufirst%3DC.%2BJ.%26aulast%3DCogan%26aufirst%3DS.%2BM.%26aulast%3DShifflett%26aufirst%3DL.%2BB.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DKocsis%26aufirst%3DB.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26atitle%3DComparative%2520analysis%2520of%2520the%2520neurophysiological%2520profile%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520activators%2520and%2520diazepam%253A%2520effects%2520on%2520hippocampal%2520and%2520cortical%2520EEG%2520patterns%2520in%2520rats%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D226%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="note"><p class="first last">Free plasma concentrations were calculated by multiplying total plasma concentrations with plasma free fraction (plasma protein binding (%) of 0.35).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Gleason, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, H. E.</span><span> </span><span class="NLM_article-title">Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=1997&pages=79-84&author=S.+D.+Gleasonauthor=H.+E.+Shannon&title=Blockade+of+phencyclidine-induced+hyperlocomotion+by+olanzapine%2C+clozapine+and+serotonin+receptor+subtype+selective+antagonists+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGleason%26aufirst%3DS.%2BD.%26aulast%3DShannon%26aufirst%3DH.%2BE.%26atitle%3DBlockade%2520of%2520phencyclidine-induced%2520hyperlocomotion%2520by%2520olanzapine%252C%2520clozapine%2520and%2520serotonin%2520receptor%2520subtype%2520selective%2520antagonists%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D1997%26volume%3D129%26spage%3D79%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="note"><p class="first last">Affinity of JNJ42153605 for the mGlu2 receptor allosteric binding site was evaluated using a radioligand structurally related analogue developed in house. A manuscript describing the synthesis, in vitro and in vivo characterization of this radioligand, and the development of an in vivo assay to measure mGlu2 receptor occupancy is in preparation and will be reported elsewhere.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span>An internal report on the method is available upon request: <span class="NLM_contrib-group">Beerens, D.</span><span> </span><span class="NLM_article-title">In Vitro Bacterial Reverse Mutation (Plate Incorporation) Assay with JNJ42153605-AAA in <i>Salmonella typhimurium </i>TA98</span>; May<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+Beerens&title=In+Vitro+Bacterial+Reverse+Mutation+%28Plate+Incorporation%29+Assay+with+JNJ42153605-AAA+in+Salmonella+typhimurium+TA98"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBeerens%26aufirst%3DD.%26atitle%3DIn%2520Vitro%2520Bacterial%2520Reverse%2520Mutation%2520%2528Plate%2520Incorporation%2529%2520Assay%2520with%2520JNJ42153605-AAA%2520in%2520Salmonella%2520typhimurium%2520TA98%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Tsutakawa, R. K.</span><span> </span><span class="NLM_article-title">Statistical Methods in Bioassay. Estimation of Relative Potency from Quantal Responses</span>. In  <span class="citation_source-book">Encyclopaedia of Statistical Science</span>; <span class="NLM_contrib-group">Kotz, S.; Jonhson, N. L.</span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1982</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1982&author=R.+K.+Tsutakawaauthor=S.+Kotz&author=N.+L.+Jonhson&title=Encyclopaedia+of+Statistical+Science"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTsutakawa%26aufirst%3DR.%2BK.%26atitle%3DStatistical%2520Methods%2520in%2520Bioassay.%2520Estimation%2520of%2520Relative%2520Potency%2520from%2520Quantal%2520Responses%26btitle%3DEncyclopaedia%2520of%2520Statistical%2520Science%26aulast%3DKotz%26aufirst%3DS.%26pub%3DWiley%26date%3D1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span>An internal report on the method is available upon request: <span class="NLM_contrib-group">Lewi, P. J.; Niemegeers, C. J. E.; Gypen, L. M. J.</span><span> </span><span class="NLM_article-title">First Hand Estimation of the Median Effective Dose (ED<sub>50</sub>) and Its Confidence Interval, Assuming a Linear Log Dose-Response Function</span>. Internal Report N123705/1; Department of Global Medical and Scientific Information, Johnson & Johnson Pharmaceutical Research and Development, a Division of Janssen Pharmaceutica, Turnhoutseweg 30, B-2340 Beerse, Belgium,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=P.+J.+Lewi&author=C.+J.+E.+Niemegeers&author=L.+M.+J.+Gypen&title=First+Hand+Estimation+of+the+Median+Effective+Dose+%28ED50%29+and+Its+Confidence+Interval%2C+Assuming+a+Linear+Log+Dose-Response+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26atitle%3DFirst%2520Hand%2520Estimation%2520of%2520the%2520Median%2520Effective%2520Dose%2520%2528ED50%2529%2520and%2520Its%2520Confidence%2520Interval%252C%2520Assuming%2520a%2520Linear%2520Log%2520Dose-Response%2520Function%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':[],'ref43':[],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':[],'ref49':[],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':[],'ref56':['cit56'],'ref57':[],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 56 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Christian B. M. Poulie, Na Liu, Anders A. Jensen, <span class="NLM_string-name hlFld-ContribAuthor">Lennart Bunch</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacological Characterization of Heterobivalent Ligands for the Putative 5-HT2A/mGlu2 Receptor Complex. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9928-9949. <a href="https://doi.org/10.1021/acs.jmedchem.0c01058" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01058%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BCharacterization%252Bof%252BHeterobivalent%252BLigands%252Bfor%252Bthe%252BPutative%252B5-HT2A%25252FmGlu2%252BReceptor%252BComplex%26aulast%3DPoulie%26aufirst%3DChristian%2BB.%2BM.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19062020%26date%3D20082020%26volume%3D63%26issue%3D17%26spage%3D9928%26epage%3D9949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ana Isabel de Lucas, Juan Antonio Vega, Encarnación Matesanz, María Lourdes Linares, Aránzazu García Molina, Gary Tresadern, Hilde Lavreysen, Andrés A. Trabanco, <span class="NLM_string-name hlFld-ContribAuthor">José María Cid</span>. </span><span class="cited-content_cbyCitation_article-title">Spiro-oxindole Piperidines and 3-(Azetidin-3-yl)-1H-benzimidazol-2-ones as mGlu2 Receptor PAMs. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 303-308. <a href="https://doi.org/10.1021/acsmedchemlett.9b00350" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00350</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00350%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSpiro-oxindole%252BPiperidines%252Band%252B3-%252528Azetidin-3-yl%252529-1H-benzimidazol-2-ones%252Bas%252BmGlu2%252BReceptor%252BPAMs%26aulast%3Dde%2BLucas%26aufirst%3DAna%2BIsabel%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D31072019%26date%3D10102019%26date%3D16102019%26date%3D10102019%26volume%3D11%26issue%3D3%26spage%3D303%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maarten
L. J. Doornbos, Xuesong Wang, Sophie C. Vermond, Luc Peeters, Laura Pérez-Benito, Andrés A. Trabanco, Hilde Lavreysen, José María Cid, Laura H. Heitman, Gary Tresadern, <span class="NLM_string-name hlFld-ContribAuthor">Adriaan P. IJzerman</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 223-233. <a href="https://doi.org/10.1021/acs.jmedchem.8b00051" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00051%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCovalent%252BAllosteric%252BProbe%252Bfor%252Bthe%252BMetabotropic%252BGlutamate%252BReceptor%2525C2%2525A02%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BCharacterization%26aulast%3DDoornbos%26aufirst%3DMaarten%2BL.%2BJ.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D12012018%26date%3D07032018%26date%3D01032018%26volume%3D62%26issue%3D1%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maarten L. J.  Doornbos</span>, <span class="hlFld-ContribAuthor ">José María  Cid</span>, <span class="hlFld-ContribAuthor ">Jordi  Haubrich</span>, <span class="hlFld-ContribAuthor ">Alexandro  Nunes</span>, <span class="hlFld-ContribAuthor ">Jasper W.  van de Sande</span>, <span class="hlFld-ContribAuthor ">Sophie C.  Vermond</span>, <span class="hlFld-ContribAuthor ">Thea  Mulder-Krieger</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Abdellah  Ahnaou</span>, <span class="hlFld-ContribAuthor ">Wilhelmus H.  Drinkenburg</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Laura H.  Heitman</span>, <span class="hlFld-ContribAuthor ">Adriaan P.  IJzerman</span>, and <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Kinetic Profiling of 7-Aryl-1,2,4-triazolo[4,3-a]pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (15)
                                     , 6704-6720. <a href="https://doi.org/10.1021/acs.jmedchem.7b00669" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00669</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00669%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BKinetic%252BProfiling%252Bof%252B7-Aryl-1%25252C2%25252C4-triazolo%25255B4%25252C3-a%25255Dpyridines%25253A%252BPositive%252BAllosteric%252BModulators%252Bof%252Bthe%252BMetabotropic%252BGlutamate%252BReceptor%252B2%26aulast%3DDoornbos%26aufirst%3DMaarten%2BL.%2BJ.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10052017%26date%3D01082017%26date%3D10082017%26date%3D13072017%26volume%3D60%26issue%3D15%26spage%3D6704%26epage%3D6720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harold  Moloney</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Magnus</span>, <span class="hlFld-ContribAuthor ">Jonas Y.  Buser</span>, and <span class="hlFld-ContribAuthor ">Matthew C.  Embry</span>  . </span><span class="cited-content_cbyCitation_article-title">Cyclization of Methyl-Coumalate-Derived Methyl 1-Benzamido-6-oxo-1,6-dihydropyridine-3-carboxylates: Assembly of the [1,2,4]Triazolo[1,5-a]pyridine Ring System. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (12)
                                     , 6279-6288. <a href="https://doi.org/10.1021/acs.joc.7b00873" title="DOI URL">https://doi.org/10.1021/acs.joc.7b00873</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b00873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b00873%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCyclization%252Bof%252BMethyl-Coumalate-Derived%252BMethyl%252B1-Benzamido-6-oxo-1%25252C6-dihydropyridine-3-carboxylates%25253A%252BAssembly%252Bof%252Bthe%252B%25255B1%25252C2%25252C4%25255DTriazolo%25255B1%25252C5-a%25255Dpyridine%252BRing%252BSystem%26aulast%3DMoloney%26aufirst%3DHarold%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12042017%26date%3D02062017%26date%3D16062017%26date%3D12052017%26volume%3D82%26issue%3D12%26spage%3D6279%26epage%3D6288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span> and <span class="hlFld-ContribAuthor ">Demetri T.  Moustakas</span>  . </span><span class="cited-content_cbyCitation_article-title">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3552-3579. <a href="https://doi.org/10.1021/acs.jmedchem.6b01807" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BNecessary%252BNitrogen%252BAtom%25253A%252BA%252BVersatile%252BHigh-Impact%252BDesign%252BElement%252Bfor%252BMultiparameter%252BOptimization%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D09122016%26date%3D08022017%26date%3D11052017%26volume%3D60%26issue%3D9%26spage%3D3552%26epage%3D3579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob C.  Timmerman</span>, <span class="hlFld-ContribAuthor ">William W.  Schmitt</span>, and <span class="hlFld-ContribAuthor ">Ross A.  Widenhoefer</span>  . </span><span class="cited-content_cbyCitation_article-title">Gold-Catalyzed Intermolecular, anti-Markovnikov Hydroarylation of Methylenecyclopropanes with Indoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (19)
                                     , 4966-4969. <a href="https://doi.org/10.1021/acs.orglett.6b02431" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b02431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b02431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b02431%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DGold-Catalyzed%252BIntermolecular%25252C%252Banti-Markovnikov%252BHydroarylation%252Bof%252BMethylenecyclopropanes%252Bwith%252BIndoles%26aulast%3DTimmerman%26aufirst%3DJacob%2BC.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14082016%26date%3D15092016%26date%3D07102016%26volume%3D18%26issue%3D19%26spage%3D4966%26epage%3D4969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jose María  Cid</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Vega</span>, <span class="hlFld-ContribAuthor ">Ana Isabel  de Lucas</span>, <span class="hlFld-ContribAuthor ">Alcira  del Cerro</span>, <span class="hlFld-ContribAuthor ">Encarnación  Matesanz</span>, <span class="hlFld-ContribAuthor ">María Lourdes  Linares</span>, <span class="hlFld-ContribAuthor ">Aránzazu  García</span>, <span class="hlFld-ContribAuthor ">Laura  Iturrino</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Gregor J.  Macdonald</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Luc  Peeters</span>, <span class="hlFld-ContribAuthor ">Marc  Ceusters</span>, <span class="hlFld-ContribAuthor ">Abdellah  Ahnaou</span>, <span class="hlFld-ContribAuthor ">Wilhelmus  Drinkenburg</span>, <span class="hlFld-ContribAuthor ">Claire  Mackie</span>, <span class="hlFld-ContribAuthor ">Marijke  Somers</span>, and <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8495-8507. <a href="https://doi.org/10.1021/acs.jmedchem.6b00913" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00913%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B8-Trifluoromethyl-3-cyclopropylmethyl-7-%25255B%2525284-%2525282%25252C4-difluorophenyl%252529-1-piperazinyl%252529methyl%25255D-1%25252C2%25252C4-triazolo%25255B4%25252C3-a%25255Dpyridine%252B%252528JNJ-46356479%252529%25252C%252Ba%252BSelective%252Band%252BOrally%252BBioavailable%252BmGlu2%252BReceptor%252BPositive%252BAllosteric%252BModulator%252B%252528PAM%252529%26aulast%3DCid%26aufirst%3DJose%2BMar%25C3%25ADa%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21062016%26date%3D09092016%26date%3D22092016%26date%3D31082016%26volume%3D59%26issue%3D18%26spage%3D8495%26epage%3D8507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Craig W.  Lindsley</span>, <span class="hlFld-ContribAuthor ">Kyle A.  Emmitte</span>, <span class="hlFld-ContribAuthor ">Corey R.  Hopkins</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Bridges</span>, <span class="hlFld-ContribAuthor ">Karen J.  Gregory</span>, <span class="hlFld-ContribAuthor ">Colleen M.  Niswender</span>, and <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>  . </span><span class="cited-content_cbyCitation_article-title">Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (11)
                                     , 6707-6741. <a href="https://doi.org/10.1021/acs.chemrev.5b00656" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00656%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DPractical%252BStrategies%252Band%252BConcepts%252Bin%252BGPCR%252BAllosteric%252BModulator%252BDiscovery%25253A%252BRecent%252BAdvances%252Bwith%252BMetabotropic%252BGlutamate%252BReceptors%26aulast%3DLindsley%26aufirst%3DCraig%2BW.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D06112015%26date%3D16022016%26date%3D08062016%26volume%3D116%26issue%3D11%26spage%3D6707%26epage%3D6741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José María  Cid</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Guillaume  Duvey</span>, <span class="hlFld-ContribAuthor ">Robert  Lütjens</span>, <span class="hlFld-ContribAuthor ">Terry  Finn</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Rocher</span>, <span class="hlFld-ContribAuthor ">Sonia  Poli</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Vega</span>, <span class="hlFld-ContribAuthor ">Ana Isabel  de Lucas</span>, <span class="hlFld-ContribAuthor ">Encarnación  Matesanz</span>, <span class="hlFld-ContribAuthor ">María Lourdes  Linares</span>, <span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Jesús  Alcazar</span>, <span class="hlFld-ContribAuthor ">José Manuel  Alonso</span>, <span class="hlFld-ContribAuthor ">Gregor J.  Macdonald</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Abdelah  Ahnaou</span>, <span class="hlFld-ContribAuthor ">Wilhelmus  Drinkenburg</span>, <span class="hlFld-ContribAuthor ">Claire  Mackie</span>, <span class="hlFld-ContribAuthor ">Stefan  Pype</span>, <span class="hlFld-ContribAuthor ">David  Gallacher</span>, and <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 1-Butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone (JNJ-40411813): A Novel Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (15)
                                     , 6495-6512. <a href="https://doi.org/10.1021/jm500496m" title="DOI URL">https://doi.org/10.1021/jm500496m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500496m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500496m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B1-Butyl-3-chloro-4-%2525284-phenyl-1-piperidinyl%252529-%2525281H%252529-pyridone%252B%252528JNJ-40411813%252529%25253A%252BA%252BNovel%252BPositive%252BAllosteric%252BModulator%252Bof%252Bthe%252BMetabotropic%252BGlutamate%252B2%252BReceptor%26aulast%3DCid%26aufirst%3DJos%25C3%25A9%2BMar%25C3%25ADa%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D28032014%26date%3D28072014%26date%3D14082014%26date%3D17072014%26volume%3D57%26issue%3D15%26spage%3D6495%26epage%3D6512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Letizia  Barreca</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Manfroni</span>, <span class="hlFld-ContribAuthor ">Pieter  Leyssen</span>, <span class="hlFld-ContribAuthor ">Johan  Winquist</span>, <span class="hlFld-ContribAuthor ">Neerja  Kaushik-Basu</span>, <span class="hlFld-ContribAuthor ">Jan  Paeshuyse</span>, <span class="hlFld-ContribAuthor ">Ramalingam  Krishnan</span>, <span class="hlFld-ContribAuthor ">Nunzio  Iraci</span>, <span class="hlFld-ContribAuthor ">Stefano  Sabatini</span>, <span class="hlFld-ContribAuthor ">Oriana  Tabarrini</span>, <span class="hlFld-ContribAuthor ">Amartya  Basu</span>, <span class="hlFld-ContribAuthor ">U. Helena  Danielson</span>, <span class="hlFld-ContribAuthor ">Johan  Neyts</span>, and <span class="hlFld-ContribAuthor ">Violetta  Cecchetti</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of Pyrazolobenzothiazine Derivatives As Inhibitors of Hepatitis C Virus Replication. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (6)
                                     , 2270-2282. <a href="https://doi.org/10.1021/jm301643a" title="DOI URL">https://doi.org/10.1021/jm301643a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301643a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301643a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDiscovery%252Bof%252BPyrazolobenzothiazine%252BDerivatives%252BAs%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252BReplication%26aulast%3DBarreca%26aufirst%3DMaria%2BLetizia%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D24102012%26date%3D07032013%26date%3D28032013%26date%3D14022013%26volume%3D56%26issue%3D6%26spage%3D2270%26epage%3D2282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Corey R.  Hopkins</span>  . </span><span class="cited-content_cbyCitation_article-title">Is There a Path Forward for mGlu2 Positive Allosteric Modulators for the Treatment of Schizophrenia?. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2013,</strong> <em>4 </em>
                                    (2)
                                     , 211-213. <a href="https://doi.org/10.1021/cn400023y" title="DOI URL">https://doi.org/10.1021/cn400023y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn400023y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn400023y%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIs%252BThere%252Ba%252BPath%252BForward%252Bfor%252BmGlu2%252BPositive%252BAllosteric%252BModulators%252Bfor%252Bthe%252BTreatment%252Bof%252BSchizophrenia%25253F%26aulast%3DHopkins%26aufirst%3DCorey%2BR.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D21012013%26date%3D21012013%26date%3D20022013%26volume%3D4%26issue%3D2%26spage%3D211%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karen J.  Gregory</span>, <span class="hlFld-ContribAuthor ">Cyril  Goudet</span>, . </span><span class="cited-content_cbyCitation_article-title">International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2021,</strong> <em>73 </em>
                                    (1)
                                     , 521-569. <a href="https://doi.org/10.1124/pr.119.019133" title="DOI URL">https://doi.org/10.1124/pr.119.019133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.119.019133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.119.019133%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DInternational%252BUnion%252Bof%252BBasic%252Band%252BClinical%252BPharmacology.%252BCXI.%252BPharmacology%25252C%252BSignaling%25252C%252Band%252BPhysiology%252Bof%252BMetabotropic%252BGlutamate%252BReceptors%26aulast%3DGregory%26aufirst%3DKaren%2BJ.%26date%3D2021%26date%3D2020%26volume%3D73%26issue%3D1%26spage%3D521%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiwen  Xu</span>, <span class="hlFld-ContribAuthor ">Bei  Shen</span>, <span class="hlFld-ContribAuthor ">Lingfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Chunhua  Qiao</span>. </span><span class="cited-content_cbyCitation_article-title">Metal free [4+1] and [5+1] annulation reactions to prepare heterocycles using DMF and its derivatives as one-carbon source. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (19)
                                     , 151844. <a href="https://doi.org/10.1016/j.tetlet.2020.151844" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151844</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151844%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DMetal%252Bfree%252B%25255B4%25252B1%25255D%252Band%252B%25255B5%25252B1%25255D%252Bannulation%252Breactions%252Bto%252Bprepare%252Bheterocycles%252Busing%252BDMF%252Band%252Bits%252Bderivatives%252Bas%252Bone-carbon%252Bsource%26aulast%3DXu%26aufirst%3DYiwen%26date%3D2020%26volume%3D61%26issue%3D19%26spage%3D151844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hamada Mohamed  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Haider  Behbehani</span>, <span class="hlFld-ContribAuthor ">Wael Abdelgayed  Ahmed Arafa</span>. </span><span class="cited-content_cbyCitation_article-title">A facile, practical and metal-free microwave-assisted protocol for mono- and bis-[1,2,4]triazolo[1,5-
              a
              ]pyridines synthesis utilizing 1-amino-2-imino-pyridine derivatives as versatile precursors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (26)
                                     , 15554-15572. <a href="https://doi.org/10.1039/D0RA02256J" title="DOI URL">https://doi.org/10.1039/D0RA02256J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA02256J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA02256J%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bfacile%25252C%252Bpractical%252Band%252Bmetal-free%252Bmicrowave-assisted%252Bprotocol%252Bfor%252Bmono-%252Band%252Bbis-%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-%252Ba%252B%25255Dpyridines%252Bsynthesis%252Butilizing%252B1-amino-2-imino-pyridine%252Bderivatives%252Bas%252Bversatile%252Bprecursors%26aulast%3DIbrahim%26aufirst%3DHamada%2BMohamed%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D26%26spage%3D15554%26epage%3D15572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liqiang  Hao</span>, <span class="hlFld-ContribAuthor ">Guodong  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Sun</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Hongshuang  Li</span>, <span class="hlFld-ContribAuthor ">Guiyun  Duan</span>, <span class="hlFld-ContribAuthor ">Chengcai  Xia</span>, <span class="hlFld-ContribAuthor ">Pengfei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">From Phenylhydrazone to 1
              H
              ‐1,2,4‐Triazoles via Nitrification, Reduction and Cyclization. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (8)
                                     , 1657-1662. <a href="https://doi.org/10.1002/adsc.201901563" title="DOI URL">https://doi.org/10.1002/adsc.201901563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201901563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201901563%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DFrom%252BPhenylhydrazone%252Bto%252B1%252BH%252B%2525E2%252580%2525901%25252C2%25252C4%2525E2%252580%252590Triazoles%252Bvia%252BNitrification%25252C%252BReduction%252Band%252BCyclization%26aulast%3DHao%26aufirst%3DLiqiang%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D8%26spage%3D1657%26epage%3D1662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. I.  Molosh</span>, <span class="hlFld-ContribAuthor ">E. T.  Dustrude</span>, <span class="hlFld-ContribAuthor ">J. L.  Lukkes</span>, <span class="hlFld-ContribAuthor ">S. D.  Fitz</span>, <span class="hlFld-ContribAuthor ">I. F.  Caliman</span>, <span class="hlFld-ContribAuthor ">A. R. R.  Abreu</span>, <span class="hlFld-ContribAuthor ">A. D.  Dietrich</span>, <span class="hlFld-ContribAuthor ">W. A.  Truitt</span>, <span class="hlFld-ContribAuthor ">L.  Ver Donck</span>, <span class="hlFld-ContribAuthor ">M.  Ceusters</span>, <span class="hlFld-ContribAuthor ">J. M.  Kent</span>, <span class="hlFld-ContribAuthor ">P. L.  Johnson</span>, <span class="hlFld-ContribAuthor ">A .  Shekhar</span>. </span><span class="cited-content_cbyCitation_article-title">Panic results in unique molecular and network changes in the amygdala that facilitate fear responses. </span><span class="cited-content_cbyCitation_journal-name">Molecular Psychiatry</span><span> <strong>2020,</strong> <em>25 </em>
                                    (2)
                                     , 442-460. <a href="https://doi.org/10.1038/s41380-018-0119-0" title="DOI URL">https://doi.org/10.1038/s41380-018-0119-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41380-018-0119-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41380-018-0119-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Psychiatry%26atitle%3DPanic%252Bresults%252Bin%252Bunique%252Bmolecular%252Band%252Bnetwork%252Bchanges%252Bin%252Bthe%252Bamygdala%252Bthat%252Bfacilitate%252Bfear%252Bresponses%26aulast%3DMolosh%26aufirst%3DA.%2BI.%26date%3D2020%26date%3D2018%26volume%3D25%26issue%3D2%26spage%3D442%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Phillip R.  Lazzara</span>, <span class="hlFld-ContribAuthor ">Terry W.  Moore</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     , 18-29. <a href="https://doi.org/10.1039/C9MD00396G" title="DOI URL">https://doi.org/10.1039/C9MD00396G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00396G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00396G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DScaffold-hopping%252Bas%252Ba%252Bstrategy%252Bto%252Baddress%252Bmetabolic%252Bliabilities%252Bof%252Baromatic%252Bcompounds%26aulast%3DLazzara%26aufirst%3DPhillip%2BR.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D18%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María L.  López-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Bellinda  Benhamú</span>, <span class="hlFld-ContribAuthor ">Henar  Vázquez-Villa</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric modulators targeting GPCRs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 195-241. <a href="https://doi.org/10.1016/B978-0-12-816228-6.00011-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-816228-6.00011-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816228-6.00011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816228-6.00011-8%26sid%3Dliteratum%253Aachs%26atitle%3DAllosteric%252Bmodulators%252Btargeting%252BGPCRs%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DMar%25C3%25ADa%2BL.%26date%3D2020%26spage%3D195%26epage%3D241%26pub%3DElsevier%26atitle%3DGPCRs%26date%3D2020%26volume%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Claudia  Llinas del Torrent</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pardo</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>. </span><span class="cited-content_cbyCitation_article-title">The computational modeling of allosteric modulation of metabotropic glutamate receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-33. <a href="https://doi.org/10.1016/bs.apha.2020.02.004" title="DOI URL">https://doi.org/10.1016/bs.apha.2020.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apha.2020.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apha.2020.02.004%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bcomputational%252Bmodeling%252Bof%252Ballosteric%252Bmodulation%252Bof%252Bmetabotropic%252Bglutamate%252Breceptors%26aulast%3DP%25C3%25A9rez-Benito%26aufirst%3DLaura%26date%3D2020%26spage%3D1%26epage%3D33%26pub%3DElsevier%26atitle%3DFrom%252BStructure%252Bto%252BClinical%252BDevelopment%25253A%252BAllosteric%252BModulation%252Bof%252BG%252BProtein-Coupled%252BReceptors%26date%3D2020%26volume%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youwen  Xu</span>, <span class="hlFld-ContribAuthor ">Zizhong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging metabotropic glutamate receptor system: Application of positron emission tomography technology in drug development. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (5)
                                     , 1892-1922. <a href="https://doi.org/10.1002/med.21566" title="DOI URL">https://doi.org/10.1002/med.21566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21566%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DImaging%252Bmetabotropic%252Bglutamate%252Breceptor%252Bsystem%25253A%252BApplication%252Bof%252Bpositron%252Bemission%252Btomography%252Btechnology%252Bin%252Bdrug%252Bdevelopment%26aulast%3DXu%26aufirst%3DYouwen%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D5%26spage%3D1892%26epage%3D1922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paulina  Cieślik</span>, <span class="hlFld-ContribAuthor ">Adrianna  Radulska</span>, <span class="hlFld-ContribAuthor ">Iwona  Pelikant-Małecka</span>, <span class="hlFld-ContribAuthor ">Agata  Płoska</span>, <span class="hlFld-ContribAuthor ">Leszek  Kalinowski</span>, <span class="hlFld-ContribAuthor ">Joanna M  Wierońska</span>. </span><span class="cited-content_cbyCitation_article-title">Reversal of MK-801-Induced Disruptions in Social Interactions and Working Memory with Simultaneous Administration of LY487379 and VU152100 in Mice. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (11)
                                     , 2781. <a href="https://doi.org/10.3390/ijms20112781" title="DOI URL">https://doi.org/10.3390/ijms20112781</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20112781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20112781%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DReversal%252Bof%252BMK-801-Induced%252BDisruptions%252Bin%252BSocial%252BInteractions%252Band%252BWorking%252BMemory%252Bwith%252BSimultaneous%252BAdministration%252Bof%252BLY487379%252Band%252BVU152100%252Bin%252BMice%26aulast%3DCie%25C5%259Blik%26aufirst%3DPaulina%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D11%26spage%3D2781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun-Zhi  Hao</span>, <span class="hlFld-ContribAuthor ">Liang-Min  Yu</span>, <span class="hlFld-ContribAuthor ">Shu-Wei  Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Combining bioactivity and affinity to design of positive allosteric modulators of the metabotropic glutamate receptor using 3D-QSAR. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2019,</strong> <em> </em>, 1-6. <a href="https://doi.org/10.1080/07391102.2019.1618733" title="DOI URL">https://doi.org/10.1080/07391102.2019.1618733</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1618733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1618733%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DCombining%252Bbioactivity%252Band%252Baffinity%252Bto%252Bdesign%252Bof%252Bpositive%252Ballosteric%252Bmodulators%252Bof%252Bthe%252Bmetabotropic%252Bglutamate%252Breceptor%252Busing%252B3D-QSAR%26aulast%3DHao%26aufirst%3DChun-Zhi%26date%3D2019%26date%3D2019%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Llinas del Torrent</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Drug Design Applied to the Study of Metabotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (6)
                                     , 1098. <a href="https://doi.org/10.3390/molecules24061098" title="DOI URL">https://doi.org/10.3390/molecules24061098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24061098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24061098%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DComputational%252BDrug%252BDesign%252BApplied%252Bto%252Bthe%252BStudy%252Bof%252BMetabotropic%252BGlutamate%252BReceptors%26aulast%3DLlinas%2Bdel%2BTorrent%26aufirst%3DClaudia%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D6%26spage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingying  Chai</span>, <span class="hlFld-ContribAuthor ">Changfu  Li</span>, <span class="hlFld-ContribAuthor ">Liying  Meng</span>, <span class="hlFld-ContribAuthor ">Xinglong  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhenqiang  Xia</span>, <span class="hlFld-ContribAuthor ">Weimin  Li</span>, <span class="hlFld-ContribAuthor ">Yang  He</span>. </span><span class="cited-content_cbyCitation_article-title">The Diverse supramolecular synthons formed by 2-subsituted 5-morpholinomethylphenyl Triazolo[1,5-a]pyridines in solid state. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1176 </em>, 149-156. <a href="https://doi.org/10.1016/j.molstruc.2018.08.088" title="DOI URL">https://doi.org/10.1016/j.molstruc.2018.08.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2018.08.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2018.08.088%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DThe%252BDiverse%252Bsupramolecular%252Bsynthons%252Bformed%252Bby%252B2-subsituted%252B5-morpholinomethylphenyl%252BTriazolo%25255B1%25252C5-a%25255Dpyridines%252Bin%252Bsolid%252Bstate%26aulast%3DChai%26aufirst%3DYingying%26date%3D2019%26volume%3D1176%26spage%3D149%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L. Madhava  Reddy</span>, <span class="hlFld-ContribAuthor ">V. Veerabadra  Reddy</span>, <span class="hlFld-ContribAuthor ">P. Sai  Prathima</span>, <span class="hlFld-ContribAuthor ">Ch. Krishna  Reddy</span>, <span class="hlFld-ContribAuthor ">B. V. Subba  Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free One-pot Synthesis of 1,2,4-Triazolo[4,3-
              a
              ]pyridines from 2-Hydrazinylpyridines. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (16)
                                     , 3069-3073. <a href="https://doi.org/10.1002/adsc.201800512" title="DOI URL">https://doi.org/10.1002/adsc.201800512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201800512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201800512%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DMetal-free%252BOne-pot%252BSynthesis%252Bof%252B1%25252C2%25252C4-Triazolo%25255B4%25252C3-%252Ba%252B%25255Dpyridines%252Bfrom%252B2-Hydrazinylpyridines%26aulast%3DReddy%26aufirst%3DL.%2BMadhava%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D16%26spage%3D3069%26epage%3D3073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irini  Abdiaj</span>, <span class="hlFld-ContribAuthor ">Alberto  Fontana</span>, <span class="hlFld-ContribAuthor ">M. Victoria  Gomez</span>, <span class="hlFld-ContribAuthor ">Antonio  de la Hoz</span>, <span class="hlFld-ContribAuthor ">Jesús  Alcázar</span>. </span><span class="cited-content_cbyCitation_article-title">Visible‐Light‐Induced Nickel‐Catalyzed Negishi Cross‐Couplings by Exogenous‐Photosensitizer‐Free Photocatalysis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (28)
                                     , 8609-8613. <a href="https://doi.org/10.1002/ange.201802656" title="DOI URL">https://doi.org/10.1002/ange.201802656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201802656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201802656%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DVisible%2525E2%252580%252590Light%2525E2%252580%252590Induced%252BNickel%2525E2%252580%252590Catalyzed%252BNegishi%252BCross%2525E2%252580%252590Couplings%252Bby%252BExogenous%2525E2%252580%252590Photosensitizer%2525E2%252580%252590Free%252BPhotocatalysis%26aulast%3DAbdiaj%26aufirst%3DIrini%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D28%26spage%3D8609%26epage%3D8613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irini  Abdiaj</span>, <span class="hlFld-ContribAuthor ">Alberto  Fontana</span>, <span class="hlFld-ContribAuthor ">M. Victoria  Gomez</span>, <span class="hlFld-ContribAuthor ">Antonio  de la Hoz</span>, <span class="hlFld-ContribAuthor ">Jesús  Alcázar</span>. </span><span class="cited-content_cbyCitation_article-title">Visible‐Light‐Induced Nickel‐Catalyzed Negishi Cross‐Couplings by Exogenous‐Photosensitizer‐Free Photocatalysis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (28)
                                     , 8473-8477. <a href="https://doi.org/10.1002/anie.201802656" title="DOI URL">https://doi.org/10.1002/anie.201802656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201802656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201802656%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DVisible%2525E2%252580%252590Light%2525E2%252580%252590Induced%252BNickel%2525E2%252580%252590Catalyzed%252BNegishi%252BCross%2525E2%252580%252590Couplings%252Bby%252BExogenous%2525E2%252580%252590Photosensitizer%2525E2%252580%252590Free%252BPhotocatalysis%26aulast%3DAbdiaj%26aufirst%3DIrini%26date%3D2018%26date%3D2018%26volume%3D57%26issue%3D28%26spage%3D8473%26epage%3D8477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">4-(Hetero)Arylpiperidines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 155-193. <a href="https://doi.org/10.1002/9781118686263.ch5" title="DOI URL">https://doi.org/10.1002/9781118686263.ch5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch5%26sid%3Dliteratum%253Aachs%26atitle%3D4-%252528Hetero%252529Arylpiperidines%26date%3D2018%26date%3D2018%26spage%3D155%26epage%3D193%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zenghui  Ye</span>, <span class="hlFld-ContribAuthor ">Mingruo  Ding</span>, <span class="hlFld-ContribAuthor ">Yanqi  Wu</span>, <span class="hlFld-ContribAuthor ">Yong  Li</span>, <span class="hlFld-ContribAuthor ">Wenkai  Hua</span>, <span class="hlFld-ContribAuthor ">Fengzhi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Electrochemical synthesis of 1,2,4-triazole-fused heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2018,</strong> <em>20 </em>
                                    (8)
                                     , 1732-1737. <a href="https://doi.org/10.1039/C7GC03739B" title="DOI URL">https://doi.org/10.1039/C7GC03739B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7GC03739B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7GC03739B%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DElectrochemical%252Bsynthesis%252Bof%252B1%25252C2%25252C4-triazole-fused%252Bheterocycles%26aulast%3DYe%26aufirst%3DZenghui%26date%3D2018%26date%3D2018%26volume%3D20%26issue%3D8%26spage%3D1732%26epage%3D1737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lazhar  Zribi</span>, <span class="hlFld-ContribAuthor ">Fathi  Zribi</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Fakher  Chabchoub</span>, <span class="hlFld-ContribAuthor ">Lhassane  Ismaili</span>. </span><span class="cited-content_cbyCitation_article-title">Facile one-pot synthesis of new [1,2,4]triazolo[1,5-
              a
              ]pyridine derivatives by ultrasonic irradiation. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2017,</strong> <em>47 </em>
                                    (21)
                                     , 1934-1939. <a href="https://doi.org/10.1080/00397911.2017.1357078" title="DOI URL">https://doi.org/10.1080/00397911.2017.1357078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2017.1357078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2017.1357078%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DFacile%252Bone-pot%252Bsynthesis%252Bof%252Bnew%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-%252Ba%252B%25255Dpyridine%252Bderivatives%252Bby%252Bultrasonic%252Birradiation%26aulast%3DZribi%26aufirst%3DLazhar%26date%3D2017%26date%3D2017%26volume%3D47%26issue%3D21%26spage%3D1934%26epage%3D1939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Frederik J.R.  Rombouts</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Gregor  Macdonald</span>, <span class="hlFld-ContribAuthor ">Andres A.  Trabanco</span>. </span><span class="cited-content_cbyCitation_article-title">Industrial medicinal chemistry insights: neuroscience hit generation at Janssen. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2017,</strong> <em>22 </em>
                                    (10)
                                     , 1478-1488. <a href="https://doi.org/10.1016/j.drudis.2017.05.013" title="DOI URL">https://doi.org/10.1016/j.drudis.2017.05.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2017.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2017.05.013%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DIndustrial%252Bmedicinal%252Bchemistry%252Binsights%25253A%252Bneuroscience%252Bhit%252Bgeneration%252Bat%252BJanssen%26aulast%3DTresadern%26aufirst%3DGary%26date%3D2017%26volume%3D22%26issue%3D10%26spage%3D1478%26epage%3D1488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Maarten L.J.  Doornbos</span>, <span class="hlFld-ContribAuthor ">Arnau  Cordomí</span>, <span class="hlFld-ContribAuthor ">Luc  Peeters</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pardo</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Structure</span><span> <strong>2017,</strong> <em>25 </em>
                                    (7)
                                     , 1153-1162.e4. <a href="https://doi.org/10.1016/j.str.2017.05.021" title="DOI URL">https://doi.org/10.1016/j.str.2017.05.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.str.2017.05.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.str.2017.05.021%26sid%3Dliteratum%253Aachs%26jtitle%3DStructure%26atitle%3DMolecular%252BSwitches%252Bof%252BAllosteric%252BModulation%252Bof%252Bthe%252BMetabotropic%252BGlutamate%252B2%252BReceptor%26aulast%3DP%25C3%25A9rez-Benito%26aufirst%3DLaura%26date%3D2017%26volume%3D25%26issue%3D7%26spage%3D1153%26epage%3D1162.e4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cameron S.  Metcalf</span>, <span class="hlFld-ContribAuthor ">Brian D.  Klein</span>, <span class="hlFld-ContribAuthor ">Misty D.  Smith</span>, <span class="hlFld-ContribAuthor ">Tim  Pruess</span>, <span class="hlFld-ContribAuthor ">Marc  Ceusters</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Stefan  Pype</span>, <span class="hlFld-ContribAuthor ">Nancy  Van Osselaer</span>, <span class="hlFld-ContribAuthor ">Roy  Twyman</span>, <span class="hlFld-ContribAuthor ">H. Steve  White</span>. </span><span class="cited-content_cbyCitation_article-title">Efficacy of mGlu
              2
              -positive allosteric modulators alone and in combination with levetiracetam in the mouse 6 Hz model of psychomotor seizures. </span><span class="cited-content_cbyCitation_journal-name">Epilepsia</span><span> <strong>2017,</strong> <em>58 </em>
                                    (3)
                                     , 484-493. <a href="https://doi.org/10.1111/epi.13659" title="DOI URL">https://doi.org/10.1111/epi.13659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/epi.13659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fepi.13659%26sid%3Dliteratum%253Aachs%26jtitle%3DEpilepsia%26atitle%3DEfficacy%252Bof%252BmGlu%252B2%252B-positive%252Ballosteric%252Bmodulators%252Balone%252Band%252Bin%252Bcombination%252Bwith%252Blevetiracetam%252Bin%252Bthe%252Bmouse%252B6%252BHz%252Bmodel%252Bof%252Bpsychomotor%252Bseizures%26aulast%3DMetcalf%26aufirst%3DCameron%2BS.%26date%3D2017%26date%3D2017%26volume%3D58%26issue%3D3%26spage%3D484%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mendi A.  Higgins</span>, <span class="hlFld-ContribAuthor ">Lawrence R.  Marcin</span>, <span class="hlFld-ContribAuthor ">F.  Christopher Zusi</span>, <span class="hlFld-ContribAuthor ">Robert  Gentles</span>, <span class="hlFld-ContribAuthor ">Min  Ding</span>, <span class="hlFld-ContribAuthor ">Bradley C.  Pearce</span>, <span class="hlFld-ContribAuthor ">Amy  Easton</span>, <span class="hlFld-ContribAuthor ">Walter A.  Kostich</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Seager</span>, <span class="hlFld-ContribAuthor ">Clotilde  Bourin</span>, <span class="hlFld-ContribAuthor ">Linda J.  Bristow</span>, <span class="hlFld-ContribAuthor ">Kim A.  Johnson</span>, <span class="hlFld-ContribAuthor ">Regina  Miller</span>, <span class="hlFld-ContribAuthor ">John  Hogan</span>, <span class="hlFld-ContribAuthor ">Valerie  Whiterock</span>, <span class="hlFld-ContribAuthor ">Michael  Gulianello</span>, <span class="hlFld-ContribAuthor ">Meredith  Ferrante</span>, <span class="hlFld-ContribAuthor ">Yanling  Huang</span>, <span class="hlFld-ContribAuthor ">Adam  Hendricson</span>, <span class="hlFld-ContribAuthor ">Andrew  Alt</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, <span class="hlFld-ContribAuthor ">Joanne J.  Bronson</span>. </span><span class="cited-content_cbyCitation_article-title">Triazolopyridine ethers as potent, orally active mGlu2 positive allosteric modulators for treating schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (2)
                                     , 496-513. <a href="https://doi.org/10.1016/j.bmc.2016.11.018" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.11.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.11.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DTriazolopyridine%252Bethers%252Bas%252Bpotent%25252C%252Borally%252Bactive%252BmGlu2%252Bpositive%252Ballosteric%252Bmodulators%252Bfor%252Btreating%252Bschizophrenia%26aulast%3DHiggins%26aufirst%3DMendi%2BA.%26date%3D2017%26volume%3D25%26issue%3D2%26spage%3D496%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabrina  Kreft</span>, <span class="hlFld-ContribAuthor ">Dirk  Bier</span>, <span class="hlFld-ContribAuthor ">Marcus H.  Holschbach</span>, <span class="hlFld-ContribAuthor ">Annette  Schulze</span>, <span class="hlFld-ContribAuthor ">Heinz H.  Coenen</span>. </span><span class="cited-content_cbyCitation_article-title">New potent A1 adenosine receptor radioligands for positron emission tomography. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2017,</strong> <em>44 </em>, 69-77. <a href="https://doi.org/10.1016/j.nucmedbio.2016.09.004" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2016.09.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2016.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2016.09.004%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DNew%252Bpotent%252BA1%252Badenosine%252Breceptor%252Bradioligands%252Bfor%252Bpositron%252Bemission%252Btomography%26aulast%3DKreft%26aufirst%3DSabrina%26date%3D2017%26volume%3D44%26spage%3D69%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chaobin  Jin</span>, <span class="hlFld-ContribAuthor ">Shutao  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the medicinal chemistry of group II and group III mGlu receptors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 501-515. <a href="https://doi.org/10.1039/C6MD00612D" title="DOI URL">https://doi.org/10.1039/C6MD00612D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00612D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00612D%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bmedicinal%252Bchemistry%252Bof%252Bgroup%252BII%252Band%252Bgroup%252BIII%252BmGlu%252Breceptors%26aulast%3DJin%26aufirst%3DChaobin%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D3%26spage%3D501%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gil  Leurquin-Sterk</span>, <span class="hlFld-ContribAuthor ">Sofie  Celen</span>, <span class="hlFld-ContribAuthor ">Koen  Van Laere</span>, <span class="hlFld-ContribAuthor ">Michel  Koole</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>, <span class="hlFld-ContribAuthor ">Xavier  Langlois</span>, <span class="hlFld-ContribAuthor ">Anne  Van Hecken</span>, <span class="hlFld-ContribAuthor ">Paula  te Riele</span>, <span class="hlFld-ContribAuthor ">Jesús  Alcázar</span>, <span class="hlFld-ContribAuthor ">Alfons  Verbruggen</span>, <span class="hlFld-ContribAuthor ">Jan  de Hoon</span>, <span class="hlFld-ContribAuthor ">Jose-Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Mark E.  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of
              11
              C-JNJ-42491293, A Novel Radioligand for mGluR2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2017,</strong> <em>58 </em>
                                    (1)
                                     , 110-116. <a href="https://doi.org/10.2967/jnumed.116.176628" title="DOI URL">https://doi.org/10.2967/jnumed.116.176628</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.116.176628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.116.176628%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DWhat%252BWe%252BObserve%252BIn%252BVivo%252BIs%252BNot%252BAlways%252BWhat%252BWe%252BSee%252BIn%252BVitro%25253A%252BDevelopment%252Band%252BValidation%252Bof%252B11%252BC-JNJ-42491293%25252C%252BA%252BNovel%252BRadioligand%252Bfor%252BmGluR2%26aulast%3DLeurquin-Sterk%26aufirst%3DGil%26date%3D2017%26date%3D2016%26volume%3D58%26issue%3D1%26spage%3D110%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chad M.  Kormos</span>, <span class="hlFld-ContribAuthor ">Moses G.  Gichinga</span>, <span class="hlFld-ContribAuthor ">Scott P.  Runyon</span>, <span class="hlFld-ContribAuthor ">James B.  Thomas</span>, <span class="hlFld-ContribAuthor ">S. Wayne  Mascarella</span>, <span class="hlFld-ContribAuthor ">Ann M.  Decker</span>, <span class="hlFld-ContribAuthor ">Hernán A.  Navarro</span>, <span class="hlFld-ContribAuthor ">F. Ivy  Carroll</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of replacement of the 3-hydroxyphenyl group with pyridine or thiophene bioisosteres. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (16)
                                     , 3842-3848. <a href="https://doi.org/10.1016/j.bmc.2016.06.029" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.06.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.06.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.06.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bpharmacological%252Bevaluation%252Bof%252BJDTic%252Banalogs%252Bto%252Bexamine%252Bthe%252Bsignificance%252Bof%252Breplacement%252Bof%252Bthe%252B3-hydroxyphenyl%252Bgroup%252Bwith%252Bpyridine%252Bor%252Bthiophene%252Bbioisosteres%26aulast%3DKormos%26aufirst%3DChad%2BM.%26date%3D2016%26volume%3D24%26issue%3D16%26spage%3D3842%26epage%3D3848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ertong  Li</span>, <span class="hlFld-ContribAuthor ">Zhiyuan  Hu</span>, <span class="hlFld-ContribAuthor ">Lina  Song</span>, <span class="hlFld-ContribAuthor ">Wenquan  Yu</span>, <span class="hlFld-ContribAuthor ">Junbiao  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 1,2,4-Triazolo[4,3-
              a
              ]pyridines and Related Heterocycles by Sequential Condensation and Iodine-Mediated Oxidative Cyclization. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2016,</strong> <em>22 </em>
                                    (31)
                                     , 11022-11027. <a href="https://doi.org/10.1002/chem.201601744" title="DOI URL">https://doi.org/10.1002/chem.201601744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201601744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201601744%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DSynthesis%252Bof%252B1%25252C2%25252C4-Triazolo%25255B4%25252C3-%252Ba%252B%25255Dpyridines%252Band%252BRelated%252BHeterocycles%252Bby%252BSequential%252BCondensation%252Band%252BIodine-Mediated%252BOxidative%252BCyclization%26aulast%3DLi%26aufirst%3DErtong%26date%3D2016%26date%3D2016%26volume%3D22%26issue%3D31%26spage%3D11022%26epage%3D11027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ganesh  Gopalakrishna</span>, <span class="hlFld-ContribAuthor ">Muaid H.  Ithman</span>, <span class="hlFld-ContribAuthor ">John  Lauriello</span>. </span><span class="cited-content_cbyCitation_article-title">Update on New and Emerging Treatments for Schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">Psychiatric Clinics of North America</span><span> <strong>2016,</strong> <em>39 </em>
                                    (2)
                                     , 217-238. <a href="https://doi.org/10.1016/j.psc.2016.01.005" title="DOI URL">https://doi.org/10.1016/j.psc.2016.01.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.psc.2016.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.psc.2016.01.005%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychiatric%2520Clinics%2520of%2520North%2520America%26atitle%3DUpdate%252Bon%252BNew%252Band%252BEmerging%252BTreatments%252Bfor%252BSchizophrenia%26aulast%3DGopalakrishna%26aufirst%3DGanesh%26date%3D2016%26volume%3D39%26issue%3D2%26spage%3D217%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maarten L J  Doornbos</span>, <span class="hlFld-ContribAuthor ">Laura  Pérez-Benito</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Thea  Mulder-Krieger</span>, <span class="hlFld-ContribAuthor ">Ilse  Biesmans</span>, <span class="hlFld-ContribAuthor ">Andrés A  Trabanco</span>, <span class="hlFld-ContribAuthor ">Jose María  Cid</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Adriaan P  IJzerman</span>, <span class="hlFld-ContribAuthor ">Laura H  Heitman</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2016,</strong> <em>173 </em>
                                    (3)
                                     , 588-600. <a href="https://doi.org/10.1111/bph.13390" title="DOI URL">https://doi.org/10.1111/bph.13390</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.13390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.13390%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DMolecular%252Bmechanism%252Bof%252Bpositive%252Ballosteric%252Bmodulation%252Bof%252Bthe%252Bmetabotropic%252Bglutamate%252Breceptor%252B2%252Bby%252BJNJ-46281222%26aulast%3DDoornbos%26aufirst%3DMaarten%2BL%2BJ%26date%3D2016%26date%3D2016%26volume%3D173%26issue%3D3%26spage%3D588%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdallah  Ahnaou</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Jose M.  Cid</span>, <span class="hlFld-ContribAuthor ">Wilhelmus H.  Drinkenburg</span>, . </span><span class="cited-content_cbyCitation_article-title">mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in Rats. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (12)
                                     , e0144017. <a href="https://doi.org/10.1371/journal.pone.0144017" title="DOI URL">https://doi.org/10.1371/journal.pone.0144017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0144017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0144017%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DmGlu2%252BReceptor%252BAgonism%25252C%252Bbut%252BNot%252BPositive%252BAllosteric%252BModulation%25252C%252BElicits%252BRapid%252BTolerance%252Btowards%252BTheir%252BPrimary%252BEfficacy%252Bon%252BSleep%252BMeasures%252Bin%252BRats%26aulast%3DAhnaou%26aufirst%3DAbdallah%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D12%26spage%3De0144017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xing-Hai  Liu</span>, <span class="hlFld-ContribAuthor ">Zhi-Wen  Zhai</span>, <span class="hlFld-ContribAuthor ">Xiao-Yan  Xu</span>, <span class="hlFld-ContribAuthor ">Ming-Yan  Yang</span>, <span class="hlFld-ContribAuthor ">Zhao-Hui  Sun</span>, <span class="hlFld-ContribAuthor ">Jian-Quan  Weng</span>, <span class="hlFld-ContribAuthor ">Cheng-Xia  Tan</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Facile and efficient synthesis and herbicidal activity determination of novel 1,2,4-triazolo[4,3- a ]pyridin-3(2 H )-one derivatives via microwave irradiation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (23)
                                     , 5524-5528. <a href="https://doi.org/10.1016/j.bmcl.2015.10.064" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.10.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.10.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.10.064%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFacile%252Band%252Befficient%252Bsynthesis%252Band%252Bherbicidal%252Bactivity%252Bdetermination%252Bof%252Bnovel%252B1%25252C2%25252C4-triazolo%25255B4%25252C3-%252Ba%252B%25255Dpyridin-3%2525282%252BH%252B%252529-one%252Bderivatives%252Bvia%252Bmicrowave%252Birradiation%26aulast%3DLiu%26aufirst%3DXing-Hai%26date%3D2015%26volume%3D25%26issue%3D23%26spage%3D5524%26epage%3D5528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng-Lin  Li</span>, <span class="hlFld-ContribAuthor ">Xi-Quan  Hu</span>, <span class="hlFld-ContribAuthor ">Feng  Li</span>, <span class="hlFld-ContribAuthor ">Wen-Jun  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neuro-Psychopharmacology and Biological Psychiatry</span><span> <strong>2015,</strong> <em>60 </em>, 66-76. <a href="https://doi.org/10.1016/j.pnpbp.2015.02.012" title="DOI URL">https://doi.org/10.1016/j.pnpbp.2015.02.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pnpbp.2015.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pnpbp.2015.02.012%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neuro-Psychopharmacology%2520and%2520Biological%2520Psychiatry%26atitle%3DPerspectives%252Bon%252Bthe%252BmGluR2%25252F3%252Bagonists%252Bas%252Ba%252Btherapeutic%252Btarget%252Bfor%252Bschizophrenia%25253A%252BStill%252Bpromising%252Bor%252Ba%252Bdead%252Bend%25253F%26aulast%3DLi%26aufirst%3DMeng-Lin%26date%3D2015%26volume%3D60%26spage%3D66%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar  Delgado</span>, <span class="hlFld-ContribAuthor ">Francisca  Delgado</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Vega</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>. </span><span class="cited-content_cbyCitation_article-title">N-bridged 5,6-bicyclic pyridines: Recent applications in central nervous system disorders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>97 </em>, 719-731. <a href="https://doi.org/10.1016/j.ejmech.2014.12.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.12.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.12.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.12.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-bridged%252B5%25252C6-bicyclic%252Bpyridines%25253A%252BRecent%252Bapplications%252Bin%252Bcentral%252Bnervous%252Bsystem%252Bdisorders%26aulast%3DDelgado%26aufirst%3DOscar%26date%3D2015%26volume%3D97%26spage%3D719%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Pritchett</span>, <span class="hlFld-ContribAuthor ">Aarti  Jagannath</span>, <span class="hlFld-ContribAuthor ">Laurence A.  Brown</span>, <span class="hlFld-ContribAuthor ">Shu K. E.  Tam</span>, <span class="hlFld-ContribAuthor ">Sibah  Hasan</span>, <span class="hlFld-ContribAuthor ">Silvia  Gatti</span>, <span class="hlFld-ContribAuthor ">Paul J.  Harrison</span>, <span class="hlFld-ContribAuthor ">David M.  Bannerman</span>, <span class="hlFld-ContribAuthor ">Russell G.  Foster</span>, <span class="hlFld-ContribAuthor ">Stuart N.  Peirson</span>, . </span><span class="cited-content_cbyCitation_article-title">Deletion of Metabotropic Glutamate Receptors 2 and 3 (mGlu2 & mGlu3) in Mice Disrupts Sleep and Wheel-Running Activity, and Increases the Sensitivity of the Circadian System to Light. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (5)
                                     , e0125523. <a href="https://doi.org/10.1371/journal.pone.0125523" title="DOI URL">https://doi.org/10.1371/journal.pone.0125523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0125523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0125523%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DDeletion%252Bof%252BMetabotropic%252BGlutamate%252BReceptors%252B2%252Band%252B3%252B%252528mGlu2%252B%252526%252BmGlu3%252529%252Bin%252BMice%252BDisrupts%252BSleep%252Band%252BWheel-Running%252BActivity%25252C%252Band%252BIncreases%252Bthe%252BSensitivity%252Bof%252Bthe%252BCircadian%252BSystem%252Bto%252BLight%26aulast%3DPritchett%26aufirst%3DDavid%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D5%26spage%3De0125523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A  Farinha</span>, <span class="hlFld-ContribAuthor ">H  Lavreysen</span>, <span class="hlFld-ContribAuthor ">L  Peeters</span>, <span class="hlFld-ContribAuthor ">B  Russo</span>, <span class="hlFld-ContribAuthor ">S  Masure</span>, <span class="hlFld-ContribAuthor ">A A  Trabanco</span>, <span class="hlFld-ContribAuthor ">J  Cid</span>, <span class="hlFld-ContribAuthor ">G  Tresadern</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2015,</strong> <em>172 </em>
                                    (9)
                                     , 2383-2396. <a href="https://doi.org/10.1111/bph.13065" title="DOI URL">https://doi.org/10.1111/bph.13065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.13065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.13065%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DMolecular%252Bdeterminants%252Bof%252Bpositive%252Ballosteric%252Bmodulation%252Bof%252Bthe%252Bhuman%252Bmetabotropic%252Bglutamate%252Breceptor%252B2%26aulast%3DFarinha%26aufirst%3DA%26date%3D2015%26date%3D2015%26volume%3D172%26issue%3D9%26spage%3D2383%26epage%3D2396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Xavier  Langlois</span>, <span class="hlFld-ContribAuthor ">Luc Ver  Donck</span>, <span class="hlFld-ContribAuthor ">José María Cid  Nuñez</span>, <span class="hlFld-ContribAuthor ">Stefan  Pype</span>, <span class="hlFld-ContribAuthor ">Robert  Lütjens</span>, <span class="hlFld-ContribAuthor ">Anton  Megens</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Research & Perspectives</span><span> <strong>2015,</strong> <em>3 </em>
                                    (2)
                                     , e00097. <a href="https://doi.org/10.1002/prp2.97" title="DOI URL">https://doi.org/10.1002/prp2.97</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prp2.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprp2.97%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Research%2520%2526%2520Perspectives%26atitle%3DPreclinical%252Bevaluation%252Bof%252Bthe%252Bantipsychotic%252Bpotential%252Bof%252Bthe%252BmGlu2-positive%252Ballosteric%252Bmodulator%252BJNJ-40411813%26aulast%3DLavreysen%26aufirst%3DHilde%26date%3D2015%26date%3D2015%26volume%3D3%26issue%3D2%26spage%3De00097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">José-Maria  Cid</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR design of triazolopyridine mGlu2 receptor positive allosteric modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2014,</strong> <em>53 </em>, 82-91. <a href="https://doi.org/10.1016/j.jmgm.2014.07.006" title="DOI URL">https://doi.org/10.1016/j.jmgm.2014.07.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2014.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2014.07.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DQSAR%252Bdesign%252Bof%252Btriazolopyridine%252BmGlu2%252Breceptor%252Bpositive%252Ballosteric%252Bmodulators%26aulast%3DTresadern%26aufirst%3DGary%26date%3D2014%26volume%3D53%26spage%3D82%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tine  Wyckhuys</span>, <span class="hlFld-ContribAuthor ">Leonie  wyffels</span>, <span class="hlFld-ContribAuthor ">Xavier  Langlois</span>, <span class="hlFld-ContribAuthor ">Mark  Schmidt</span>, <span class="hlFld-ContribAuthor ">Sigrid  Stroobants</span>, <span class="hlFld-ContribAuthor ">Steven  Staelens</span>. </span><span class="cited-content_cbyCitation_article-title">The [
              18
              F]FDG
              μ
              PET Readout of a Brain Activation Model to Evaluate the Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator JNJ-42153605. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2014,</strong> <em>350 </em>
                                    (2)
                                     , 375-386. <a href="https://doi.org/10.1124/jpet.114.213959" title="DOI URL">https://doi.org/10.1124/jpet.114.213959</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.114.213959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.114.213959%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DThe%252B%25255B%252B18%252BF%25255DFDG%252B%2525CE%2525BC%252BPET%252BReadout%252Bof%252Ba%252BBrain%252BActivation%252BModel%252Bto%252BEvaluate%252Bthe%252BMetabotropic%252BGlutamate%252BReceptor%252B2%252BPositive%252BAllosteric%252BModulator%252BJNJ-42153605%26aulast%3DWyckhuys%26aufirst%3DTine%26date%3D2014%26date%3D2014%26volume%3D350%26issue%3D2%26spage%3D375%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anton A.H.P.  Megens</span>, <span class="hlFld-ContribAuthor ">Herman M.R.  Hendrickx</span>, <span class="hlFld-ContribAuthor ">Koen A.  Hens</span>, <span class="hlFld-ContribAuthor ">Willem J.-P.E.  Talloen</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>. </span><span class="cited-content_cbyCitation_article-title">mGlu2 receptor-mediated modulation of conditioned avoidance behavior in rats. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2014,</strong> <em>727 </em>, 130-139. <a href="https://doi.org/10.1016/j.ejphar.2014.01.044" title="DOI URL">https://doi.org/10.1016/j.ejphar.2014.01.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2014.01.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2014.01.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DmGlu2%252Breceptor-mediated%252Bmodulation%252Bof%252Bconditioned%252Bavoidance%252Bbehavior%252Bin%252Brats%26aulast%3DMegens%26aufirst%3DAnton%2BA.H.P.%26date%3D2014%26volume%3D727%26spage%3D130%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José M.  Cid</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>. </span><span class="cited-content_cbyCitation_article-title">Metabotropic Glutamate Receptor 2 Activators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 101-142. <a href="https://doi.org/10.1007/7355_2014_48" title="DOI URL">https://doi.org/10.1007/7355_2014_48</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_48%26sid%3Dliteratum%253Aachs%26atitle%3DMetabotropic%252BGlutamate%252BReceptor%252B2%252BActivators%26aulast%3DCid%26aufirst%3DJos%25C3%25A9%2BM.%26date%3D2014%26date%3D2014%26spage%3D101%26epage%3D142%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSmall%252BMolecule%252BTherapeutics%252Bfor%252BSchizophrenia%26aulast%3DCelanire%26aufirst%3DSylvain%26date%3D2015%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyuki  Nishiyama</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Takuya  Sugimoto</span>, <span class="hlFld-ContribAuthor ">Toshio  Sasai</span>, <span class="hlFld-ContribAuthor ">Naoyuki  Asakawa</span>, <span class="hlFld-ContribAuthor ">Satoshi  Ueno</span>, <span class="hlFld-ContribAuthor ">Yoshitaka  Tominaga</span>, <span class="hlFld-ContribAuthor ">Takashi  Yaegashi</span>, <span class="hlFld-ContribAuthor ">Masato  Nagaoka</span>, <span class="hlFld-ContribAuthor ">Takeshi  Matsuzaki</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Kogure</span>, <span class="hlFld-ContribAuthor ">Mariko  Kitajima</span>, <span class="hlFld-ContribAuthor ">Hiromitsu  Takayama</span>. </span><span class="cited-content_cbyCitation_article-title">4-Chlorocolchicine derivatives bearing a thiourea side chain at the C-7 position as potent anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2014,</strong> <em>5 </em>
                                    (4)
                                     , 452. <a href="https://doi.org/10.1039/c3md00287j" title="DOI URL">https://doi.org/10.1039/c3md00287j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3md00287j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3md00287j%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3D4-Chlorocolchicine%252Bderivatives%252Bbearing%252Ba%252Bthiourea%252Bside%252Bchain%252Bat%252Bthe%252BC-7%252Bposition%252Bas%252Bpotent%252Banticancer%252Bagents%26aulast%3DNishiyama%26aufirst%3DHiroyuki%26date%3D2014%26volume%3D5%26issue%3D4%26spage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrés A  Trabanco</span>, <span class="hlFld-ContribAuthor ">José María  Cid</span>. </span><span class="cited-content_cbyCitation_article-title">mGluR2 positive allosteric modulators: a patent review (2009 – present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (5)
                                     , 629-647. <a href="https://doi.org/10.1517/13543776.2013.777043" title="DOI URL">https://doi.org/10.1517/13543776.2013.777043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.777043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.777043%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DmGluR2%252Bpositive%252Ballosteric%252Bmodulators%25253A%252Ba%252Bpatent%252Breview%252B%2525282009%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3DTrabanco%26aufirst%3DAndr%25C3%25A9s%2BA%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D5%26spage%3D629%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tara L.S.  Kishbaugh</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 319-355. <a href="https://doi.org/10.1016/B978-0-08-099406-2.00006-6" title="DOI URL">https://doi.org/10.1016/B978-0-08-099406-2.00006-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-099406-2.00006-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-099406-2.00006-6%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%26aulast%3DKishbaugh%26aufirst%3DTara%2BL.S.%26date%3D2013%26spage%3D319%26epage%3D355%26pub%3DElsevier%26date%3D2013%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Structures of mGlu2 PAM reported molecules (<b>1</b>–<b>3</b>). (b) Evolution from pyridone series to 1,2,4-triazolopyridine series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, DMF, rt, 1 h; (b) NH<sub>2</sub>NH<sub>2</sub>, THF, 160 °C, 15 min, microwave; (c) EtC(OEt)<sub>3</sub>, xylenes, 180 °C, 2 h; (d) (i) R<sup>1</sup>COCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> or CHCl<sub>3</sub>, rt, 1–16 h; (ii) POCl<sub>3</sub>, CH<sub>3</sub>CN, 150 °C, 10 min, microwave; (e) CF<sub>3</sub>CH<sub>2</sub>CO<sub>2</sub>H, DIPEA, CCl<sub>3</sub>CN, PS-PPh<sub>3</sub>, 1,2-dichloroethane, 150 °C, 18 min, microwave; (f) HC(OEt)<sub>3</sub>, xylenes, 180 °C, 2 h; (g) CH<sub>2</sub>O, pyrrolidine, AcOH, 80 °C, 16 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIPEA, CH<sub>3</sub>CN, 110 °C, 16 h; (b) NH<sub>2</sub>NH<sub>2</sub>, EtOH, 160 °C, 20 min, microwave; (c) (i) R<sup>1</sup>COCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) POCl<sub>3</sub>, CH<sub>3</sub>CN, 150 °C, 10 min, microwave; (d) Et(OEt)<sub>3</sub>, xylenes, 180 °C, 2 h; (e) (i) CF<sub>3</sub>CH<sub>2</sub>CO<sub>2</sub>H, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) CCl<sub>3</sub>CN, PS-Ph<sub>3</sub>P, DIPEA, 1,2-dichloroethane, 100 °C, 16 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NH<sub>2</sub>NH<sub>2</sub>, 1,4-dioxane, 70 °C, 16 h; (b) CyPrCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (c) 160 °C, 180 min; (d) Pd(AcO)<sub>2</sub>, BINAP, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 95 °C, 16 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnOH, NaH, DMF, rt, 1 h; (b) NH<sub>2</sub>NH<sub>2</sub>, 1,4-dioxane, 160 °C, 30 min, microwave; (c) (i) CyPrCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) POCl<sub>3</sub>, CH<sub>3</sub>CN, 150 °C, 5 min, microwave; (d) amine, DIPEA, CH<sub>3</sub>CN, 90–180 °C, 10 min to 24 h.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>30</b>, NaH, DMF, rt, 1 h or <b>35</b>, DIPEA, CH<sub>3</sub>CN, 110 °C, 4 h; (b) NH<sub>2</sub>NH<sub>2</sub>, THF, 160 °C, 45 min, microwave; (c) (i) R<sup>1</sup>COCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) POCl<sub>3</sub>, MeCN, 150 °C, 10 min; (d) (i) CyPrCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (ii) CCl<sub>3</sub>CN, PS-Ph<sub>3</sub>P, PS-DIPEA, 1,2-dichloroethane, 150 °C, 10 min, microwave.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) mGlu2 PAM pEC<sub>50</sub> activity versus clogP (Biobyte). (b) mGlu2 PAM pEC<sub>50</sub> activity versus log <i>D</i> at pH 7.4 (ACD, version 12.0). Molecules are color-coded by order of registration in our internal database, the earliest compounds being blue and later compounds red. Plots combine data generated from several previously reported series: pyridones, isoquinolones, imidazopyridines, and triazolopyridines reported here. Inactive compounds for which exact pEC<sub>50</sub> could not be determined because of concentration limits were removed from the analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Plot of LLE versus MW. (b) Plot of LELP versus MW. Molecules are color-coded by order of registration in our internal database, the earliest compounds being blue and later compounds red. Molecule <b>20</b> is highlighted in green. Plots combine data generated from several previously reported series: pyridones, isoquinolones, imidazopyridines, and triazolopyridines reported here. Inactive compounds for which exact pEC<sub>50</sub> could not be determined because of concentration limits were removed from the analysis. To account for basic compounds, ACDLabs, version 12.0, log <i>D</i> at pH 7.4 was used for LLE and LELP calculations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of oral administration of <b>20</b> (3 mg/kg) or vehicle (20% CD + 2H2T) on sleep–wake organization in rats during 20 consecutive hours. Mean percentage of occurrence per minute is indicated for each sleep–wake state. Small bar charts indicate amounts of vigilance states in min (plus SEM) during the first 2 h postadministration: ROL, REM sleep onset latency; ∗, <i>p</i> < 0.05; Wilcoxon–Mann–Whitney rank sum tests compared with vehicle values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/medium/jm-2012-010724_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of <b>20</b> on PCP-induced locomotor activity in mice. The gray horizontal bar represents the activity level measured in solvent treated control mice not challenged with PCP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3010724/production/images/large/jm-2012-010724_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3010724&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i63">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61445" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61445" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 60 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, J. P.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors: physiology, pharmacology, and disease</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1146%2Fannurev.pharmtox.011008.145533" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=20055706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVelurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=295-322&author=C.+M.+Niswenderauthor=J.+P.+Conn&title=Metabotropic+glutamate+receptors%3A+physiology%2C+pharmacology%2C+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptors: physiology, pharmacology, and disease</span></div><div class="casAuthors">Niswender, Colleen M.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">295-322</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The metabotropic glutamate receptors (mGluRs) are family C G-protein-coupled receptors that participate in the modulation of synaptic transmission and neuronal excitability throughout the central nervous system.  The mGluRs bind glutamate within a large extracellular domain and transmit signals through the receptor protein to intracellular signaling partners.  A great deal of progress was made in detg. the mechanisms by which mGluRs are activated, proteins with which they interact, and orthosteric and allosteric ligands that can modulate receptor activity.  The widespread expression of mGluRs makes these receptors particularly attractive drug targets, and recent studies continue to validate the therapeutic utility of mGluR ligands in neurol. and psychiatric disorders such as Alzheimer's disease, Parkinson's disease, anxiety, depression, and schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9idcZk-YH9LVg90H21EOLACvtfcHk0liX4zwI3n2J7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVelurg%253D&md5=4e7c2fa7dec6b3e3227e32fb7653423b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.011008.145533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.011008.145533%26sid%3Dliteratum%253Aachs%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DJ.%2BP.%26atitle%3DMetabotropic%2520glutamate%2520receptors%253A%2520physiology%252C%2520pharmacology%252C%2520and%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2010%26volume%3D50%26spage%3D295%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Pilc, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span> </span><span class="NLM_article-title">Mood disorders: regulation by metabotropic glutamate receptors</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">997</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2008&pages=997-1006&author=A.+Pilcauthor=S.+Chakiauthor=G.+Nowakauthor=J.+M.+Witkin&title=Mood+disorders%3A+regulation+by+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPilc%26aufirst%3DA.%26aulast%3DChaki%26aufirst%3DS.%26aulast%3DNowak%26aufirst%3DG.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26atitle%3DMood%2520disorders%253A%2520regulation%2520by%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D75%26spage%3D997%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Lüscher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K. M.</span><span> </span><span class="NLM_article-title">Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2010&pages=445-459&author=C.+L%C3%BCscherauthor=K.+M.+Huber&title=Group+1+mGluR-dependent+synaptic+long-term+depression%3A+mechanisms+and+implications+for+circuitry+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25BCscher%26aufirst%3DC.%26aulast%3DHuber%26aufirst%3DK.%2BM.%26atitle%3DGroup%25201%2520mGluR-dependent%2520synaptic%2520long-term%2520depression%253A%2520mechanisms%2520and%2520implications%2520for%2520circuitry%2520and%2520disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D65%26spage%3D445%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors as therapeutic targets for schizophrenia</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1461</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=1461-1472&author=P.+N.+Vinsonauthor=P.+J.+Conn&title=Metabotropic+glutamate+receptors+as+therapeutic+targets+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520as%2520therapeutic%2520targets%2520for%2520schizophrenia%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D1461%26epage%3D1472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Chiechio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors and the control of chronic pain</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1016%2Fj.coph.2011.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=22040745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=28-34&author=S.+Chiechioauthor=F.+Nicoletti&title=Metabotropic+glutamate+receptors+and+the+control+of+chronic+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptors and the control of chronic pain</span></div><div class="casAuthors">Chiechio, Santina; Nicoletti, Ferdinando</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-34</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past two decades metabotropic glutamate (mGlu) receptor ligands have been investigated for their potential therapeutic effects in different disorders of the central nervous system (CNS), including anxiety, depression, schizophrenia, and neurodegenerative diseases.  In addn., it has been widely demonstrated that mGlu receptors are able to modulate pain transmission both in inflammatory and neuropathic pain models.  A large no. of preclin. studies combining the use of selective ligands with the knockout strategy have revealed more details about the role of the different mGlu receptor subtypes in the modulation of pain information.  This review will address the role of mGlu receptors in pain sensitivity focusing on different strategies to achieve pain control by targeting specific mGlu receptor subtypes.  Specifically, pharmacol. interventions aimed at inhibiting group I mGlu receptor-mediated signaling and/or potentiating groups II and III mGlu receptor signaling together with an epigenetic approach leading to an increased expression of mGlu2 receptors will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbB81DKFAZW7Vg90H21EOLACvtfcHk0li6VKyq813Rhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSntbk%253D&md5=7c5a28309126537e2cda089e75aa017b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2011.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2011.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DChiechio%26aufirst%3DS.%26aulast%3DNicoletti%26aufirst%3DF.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520and%2520the%2520control%2520of%2520chronic%2520pain%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2012%26volume%3D12%26spage%3D28%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Foster, O. M.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor ligands as potential therapeutics for addiction</span> <span class="citation_source-journal">Curr. Drug Abuse Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.2174%2F1874473710902010083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=19630739" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=83-98&author=O.+M.+Foster&title=Metabotropic+glutamate+receptor+ligands+as+potential+therapeutics+for+addiction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1874473710902010083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1874473710902010083%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DO.%2BM.%26atitle%3DMetabotropic%2520glutamate%2520receptor%2520ligands%2520as%2520potential%2520therapeutics%2520for%2520addiction%26jtitle%3DCurr.%2520Drug%2520Abuse%2520Rev.%26date%3D2009%26volume%3D2%26spage%3D83%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Johnson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span> </span><span class="NLM_article-title">Glutamate receptors as therapeutic targets for Parkinson’s disease</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.2174%2F187152709789824606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=19702565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGqt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=475-491&author=K.+A.+Johnsonauthor=P.+J.+Connauthor=C.+M.+Niswender&title=Glutamate+receptors+as+therapeutic+targets+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptors as therapeutic targets for Parkinson's disease</span></div><div class="casAuthors">Johnson, Kari A.; Conn, P. Jeffrey; Niswender, Colleen M.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">475-491</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor symptoms including tremor and bradykinesia.  The primary pathophysiol. underlying PD is the degeneration of dopaminergic neurons of the substantia nigra pars compacta.  Loss of these neurons causes pathol. changes in neurotransmission in the basal ganglia motor circuit.  The ability of ionotropic and metabotropic glutamate receptors to modulate neurotransmission throughout the basal ganglia suggests that these receptors may be targets for reversing the effects of altered neurotransmission in PD.  Studies in animal models suggest that modulating the activity of these receptors may alleviate the primary motor symptoms of PD as well as side effects induced by dopamine replacement therapy.  Moreover, glutamate receptor ligands may slow disease progression by delaying progressive dopamine neuron degeneration.  Antagonists of NMDA receptors have shown promise in reversing motor symptoms, levodopa-induced dyskinesias, and neurodegeneration in preclin. PD models.  The effects of drugs targeting AMPA receptors are more complex; while antagonists of these receptors exhibit utility in the treatment of levodopa-induced dyskinesias, AMPA receptor potentiators show promise for neuroprotection.  Pharmacol. modulation of metabotropic glutamate receptors (mGluRs) may hold even more promise for PD treatment due to the ability of mGluRs to fine-tune neurotransmission.  Antagonists of mGluR5, as well as activators of group II mGluRs and mGluR4, have shown promise in several animal models of PD.  These drugs reverse motor deficits in addn. to providing protection against neurodegeneration.  Glutamate receptors therefore represent exciting targets for the development of novel pharmacol. therapies for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTN40JchWl97Vg90H21EOLACvtfcHk0li6VKyq813Rhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGqt7fM&md5=112813ce19be89395c36a72276105d07</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F187152709789824606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152709789824606%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26atitle%3DGlutamate%2520receptors%2520as%2520therapeutic%2520targets%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2009%26volume%3D8%26spage%3D475%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Watkins, J. C.</span><span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">l</span>-Glutamate as a central neurotransmitter: looking back</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1042%2F0300-5127%3A0280297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=10961913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVeitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=297-310&author=J.+C.+Watkins&title=l-Glutamate+as+a+central+neurotransmitter%3A+looking+back"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">L-Glutamate as a central neurotransmitter: looking back</span></div><div class="casAuthors">Watkins, J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-310</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review, with 114 refs.  The high concn. in brain of unbound L-glutamic acid (in its anionic form, L-glutamate) fueled considerable speculation as to its role in central nervous function more than 50 yr ago.  Claims in the 1940s that it could improve cognitive acuity in patients with mental impairment were particularly intriguing, though later refuted.  In the early 1950s Hayashi found that L-glutamate could cause convulsions and proposed that it might be a central synaptic transmitter.  Soon thereafter, Curtis and colleagues showed that L-glutamate depolarized and excited central neurons, as expected for an excitatory transmitter; however, various aspects of the action of L-glutamate seemed to argue strongly against a transmitter function.  This neg. view prevailed for some 20 yr, before compelling evidence for such a role was adduced.  Over the last two decades, extensive research has revealed a host of glutamate receptor subtypes, subserving several different functions in excitatory synaptic transmission.  This paper gives a very brief and personal over-view of the development of the field over the last 50 yr from a mainly pharmacol. stand-point.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTJ2Xbf1GO6rVg90H21EOLACvtfcHk0li6VKyq813Rhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVeitLk%253D&md5=feb7517645ed59e3eaa0179c4ac6bd60</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1042%2F0300-5127%3A0280297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252F0300-5127%253A0280297%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DJ.%2BC.%26atitle%3Dl-Glutamate%2520as%2520a%2520central%2520neurotransmitter%253A%2520looking%2520back%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2000%26volume%3D28%26spage%3D297%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kew, J. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. A.</span><span> </span><span class="NLM_article-title">Ionotropic and metabotropic glutamate receptor structure and pharmacology</span> <span class="citation_source-journal">Psyhopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1007%2Fs00213-005-2200-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=15731895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtV2itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=4-29&author=J.+N.+C.+Kewauthor=J.+A.+Kemp&title=Ionotropic+and+metabotropic+glutamate+receptor+structure+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Ionotropic and metabotropic glutamate receptor structure and pharmacology</span></div><div class="casAuthors">Kew, James N. C.; Kemp, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-29</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Rationale: L-Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS) and mediates its actions via activation of both ionotropic and metabotropic receptor families.  The development of selective ligands, including competitive agonists and antagonists and pos. and neg. allosteric modulators, has enabled investigation of the functional roles of glutamate receptor family members.  Objective: In this review we describe the subunit structure and compn. of the ionotropic and metabotropic glutamate receptors and discuss their pharmacol., particularly with respect to selective tools useful for investigation of their function in the CNS.  Results: A large no. of ligands are now available that are selective either for glutamate receptor subfamilies or for particular receptor subtypes.  Such ligands have enabled considerable advances in the elucidation of the physiol. and pathophysiol. roles of receptor family members.  Furthermore, efficacy in animal models of neurol. and psychiatric disorders has supported the progression of several glutamatergic ligands into clin. studies.  These include ionotropic glutamate receptor antagonists, which have entered clin. trials for disorders including epilepsy and ischemic stroke, α-amino-3-hydroxy-5-methyl-4-isoazolepropionic acid (AMPA) receptor pos. allosteric modulators which are under evaluation as cognitive enhancers, and metabotropic glutamate receptor 2 (mGluR2) agonists which are undergoing clin. evaluation as anxiolytics.  Furthermore, preclin. studies have illustrated therapeutic potential for ligands selective for other receptor subtypes in various disorders.  These include mGluR1 antagonists in pain, mGluR5 antagonists in anxiety, pain and drug abuse and mGluR5 pos. allosteric modulators in schizophrenia.  Conclusions: Selective pharmacol. tools have enabled the study of glutamate receptors.  However, pharmacol. coverage of the family is incomplete and considerable scope remains for the development of novel ligands, particularly those with in vivo utility, and for the their use together with existing tools for the further investigation of the roles of receptor family members in CNS function and as potentially novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEJ0YO_TO0PbVg90H21EOLACvtfcHk0liip5XHf4imVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtV2itbY%253D&md5=e9ac822d32082f7779cc202c59db4247</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00213-005-2200-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-005-2200-z%26sid%3Dliteratum%253Aachs%26aulast%3DKew%26aufirst%3DJ.%2BN.%2BC.%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26atitle%3DIonotropic%2520and%2520metabotropic%2520glutamate%2520receptor%2520structure%2520and%2520pharmacology%26jtitle%3DPsyhopharmacology%26date%3D2005%26volume%3D179%26spage%3D4%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labesse, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pin, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondard, P.</span><span> </span><span class="NLM_article-title">Interdomain movements in metabotropic glutamate receptor activation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">15480</span><span class="NLM_x">–</span> <span class="NLM_lpage">15485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=15480-15485&author=S.+Huangauthor=J.+Caoauthor=M.+Jiangauthor=G.+Labesseauthor=J.+Liuauthor=J.-P.+Pinauthor=P.+Rondard&title=Interdomain+movements+in+metabotropic+glutamate+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DLabesse%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPin%26aufirst%3DJ.-P.%26aulast%3DRondard%26aufirst%3DP.%26atitle%3DInterdomain%2520movements%2520in%2520metabotropic%2520glutamate%2520receptor%2520activation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D15480%26epage%3D15485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Pin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezeau, L.</span><span> </span><span class="NLM_article-title">Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1016%2FS0163-7258%2803%2900038-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=12782243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktVOqsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2003&pages=325-354&author=J.+P.+Pinauthor=T.+Galvezauthor=L.+Prezeau&title=Evolution%2C+structure%2C+and+activation+mechanism+of+family+3%2FC+G-protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors</span></div><div class="casAuthors">Pin, Jean-Philippe; Galvez, Thierry; Prezeau, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">325-354</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  G-protein-coupled receptors (GPCRs) represent one of the largest gene families in the animal genome.  These receptors can be classified into several groups based on the sequence similarity of their common heptahelical domain.  The family 3 (or C) GPCRs are receptors for the main neurotransmitters glutamate and γ-aminobutyric acid, for Ca2+, for sweet and amino acid taste compds., and for some pheromone mols., as well as for odorants in fish.  Although none of these family 3 receptors have been found in plants, members have been identified in ancient organisms, such as slime molds (Dictyostelium) and sponges.  Like any other GPCRs, family 3 receptors possess a transmembrane heptahelical domain responsible for G-protein activation.  However, most of these identified receptors also possess a large extracellular domain that is responsible for ligand recognition, is structurally similar to bacterial periplasmic proteins involved in the transport of small mols., and is called a Venus Flytrap module.  The recent resoln. of the structure of this binding domain in one of these receptors, the metabotropic glutamate 1 receptor, together with the recent demonstration that these receptors are dimers, revealed a unique mechanism of activation for these GPCRs.  Such data open new possibilities in the development of drugs aimed at modulating these receptors, and raise a no. of interesting questions on the activation mechanism of the other GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqNRDDmZSLFrVg90H21EOLACvtfcHk0liip5XHf4imVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktVOqsb8%253D&md5=33ed658debc421c5dbd63a8b6dbf56b1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2803%2900038-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252803%252900038-X%26sid%3Dliteratum%253Aachs%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DGalvez%26aufirst%3DT.%26aulast%3DPrezeau%26aufirst%3DL.%26atitle%3DEvolution%252C%2520structure%252C%2520and%2520activation%2520mechanism%2520of%2520family%25203%252FC%2520G-protein-coupled%2520receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2003%26volume%3D98%26spage%3D325%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Brauner-Osborne, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellendorph, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. A.</span><span> </span><span class="NLM_article-title">Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.2174%2F138945007779315614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=17266540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252FmtF2kuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=169-184&author=H.+Brauner-Osborneauthor=P.+Wellendorphauthor=A.+A.+Jensen&title=Structure%2C+pharmacology+and+therapeutic+prospects+of+family+C+G-protein+coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors</span></div><div class="casAuthors">Brauner-Osborne Hans; Wellendorph Petrine; Jensen Anders A</div><div class="citationInfo"><span class="NLM_cas:title">Current drug targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Family C of G-protein coupled receptors (GPCRs) from humans is constituted by eight metabotropic glutamate (mGlu(1-8)) receptors, two heterodimeric gamma-aminobutyric acid(B) (GABA(B)) receptors, a calcium-sensing receptor (CaR), three taste (T1R) receptors, a promiscuous L-alpha-amino acid receptor (GPRC6A), and five orphan receptors.  Aside from the orphan receptors, the family C GPCRs are characterised by a large amino-terminal domain, which bind the endogenous orthosteric agonists.  Recently, a number of allosteric modulators binding to the seven transmembrane domains of the receptors have also been reported.  Family C GPCRs regulate a number of important physiological functions and are thus intensively pursued as drug targets.  So far, two drugs acting at family C receptors (the GABA(B) agonist baclofen and the positive allosteric CaR modulator cinacalcet) have been marketed.  Cinacalcet is the first allosteric GPCR modulator to enter the market, which demonstrates that the therapeutic principle of allosteric modulation can also be extended to this important drug target class.  In this review we outline the structure and function of family C GPCRs with particular focus on the ligand binding sites, and we present the most important pharmacological agents and the therapeutic prospects of the receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMO1HRaArq6WxpATR2EQURfW6udTcc2ebZ3q8-TpifILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252FmtF2kuw%253D%253D&md5=242ec346ee4fd59c033b5574983fd164</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F138945007779315614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945007779315614%26sid%3Dliteratum%253Aachs%26aulast%3DBrauner-Osborne%26aufirst%3DH.%26aulast%3DWellendorph%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26atitle%3DStructure%252C%2520pharmacology%2520and%2520therapeutic%2520prospects%2520of%2520family%2520C%2520G-protein%2520coupled%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2007%26volume%3D8%26spage%3D169%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Cartmell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Regulation of neurotransmitter release by metabotropic glutamate receptors</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">889</span><span class="NLM_x">–</span> <span class="NLM_lpage">907</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1046%2Fj.1471-4159.2000.0750889.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=10936169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2000&pages=889-907&author=J.+Cartmellauthor=D.+D.+Schoepp&title=Regulation+of+neurotransmitter+release+by+metabotropic+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of neurotransmitter release by metabotropic glutamate receptors</span></div><div class="casAuthors">Cartmell, Jayne; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">889-907</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review, with ∼145 refs.  The G protein-coupled metabotropic glutamate (mGlu) receptors are differentially localized at various synapses throughout the brain.  Depending on the receptor subtype, they appear to be localized at presynaptic and/or postsynaptic sites, including glial as well as neuronal elements.  The heterogeneous distribution of these receptors on glutamate and nonglutamate neurons/cells thus allows modulation of synaptic transmission by a no. of different mechanisms.  Electrophysiol. studies have demonstrated that the activation of mGlu receptors can modulate the activity of Ca2+ or K+ channels, or interfere with release processes downstream of Ca2+ entry, and consequently regulate neuronal synaptic activity.  Such changes evoked by mGlu receptors can ultimately regulate transmitter release at both glutamatergic and nonglutamatergic synapses.  Increasing neurochem. evidence has emerged, obtained from in vitro and in vivo studies, showing modulation of the release of a variety of transmitters by mGlu receptors.  This review addresses the neurochem. evidence for mGlu receptor-mediated regulation of neurotransmitters, such as excitatory and inhibitory amino acids, monoamines, and neuropeptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrRIHmsUn6YbVg90H21EOLACvtfcHk0lh15160UpjDuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtFykurY%253D&md5=15379bf75d0949789eeaeaf4f9485460</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0750889.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0750889.x%26sid%3Dliteratum%253Aachs%26aulast%3DCartmell%26aufirst%3DJ.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DRegulation%2520of%2520neurotransmitter%2520release%2520by%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DJ.%2520Neurochem.%26date%3D2000%26volume%3D75%26spage%3D889%26epage%3D907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ohishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shigemoto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, N.</span><span> </span><span class="NLM_article-title">Distribution of the messenger RNA for metabotropic glutamate receptor, mGlu2, in the central nervous system of the rat</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1018</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=1009-1018&author=H.+Ohishiauthor=R.+Shigemotoauthor=S.+Nakanishiauthor=N.+Mizuno&title=Distribution+of+the+messenger+RNA+for+metabotropic+glutamate+receptor%2C+mGlu2%2C+in+the+central+nervous+system+of+the+rat"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhishi%26aufirst%3DH.%26aulast%3DShigemoto%26aufirst%3DR.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DMizuno%26aufirst%3DN.%26atitle%3DDistribution%2520of%2520the%2520messenger%2520RNA%2520for%2520metabotropic%2520glutamate%2520receptor%252C%2520mGlu2%252C%2520in%2520the%2520central%2520nervous%2520system%2520of%2520the%2520rat%26jtitle%3DNeuroscience%26date%3D1993%26volume%3D53%26spage%3D1009%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Richards, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Messer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brockhaus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span> </span><span class="NLM_article-title">Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [<sup>3</sup>H]LY354740 binding in vitro and quantitative radioautography: correlation with the sites of synthesis, expression, and agonist stimulation of [<sup>35</sup>S]GTPγS binding</span> <span class="citation_source-journal">J. Comp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">487</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1002%2Fcne.20538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=15861463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVGhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=487&publication_year=2005&pages=15-27&author=G.+Richardsauthor=J.+Messerauthor=P.+Malherbeauthor=R.+Pinkauthor=M.+Brockhausauthor=H.+Stadlerauthor=J.+Wichmannauthor=H.+J.+Schaffhauserauthor=V.+Mutel&title=Distribution+and+abundance+of+metabotropic+glutamate+receptor+subtype+2+in+rat+brain+revealed+by+%5B3H%5DLY354740+binding+in+vitro+and+quantitative+radioautography%3A+correlation+with+the+sites+of+synthesis%2C+expression%2C+and+agonist+stimulation+of+%5B35S%5DGTP%CE%B3S+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [3H]LY354740 binding in vitro and quantitative radioautography: Correlation with the sites of synthesis, expression, and agonist stimulation of [35S]GTPγS binding</span></div><div class="casAuthors">Richards, Grayson; Messer, Juerg; Malherbe, Pari; Pink, Richard; Brockhaus, Manfred; Stadler, Heinz; Wichmann, Juergen; Schaffhauser, Herve; Mutel, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Comparative Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">487</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-27</span>CODEN:
                <span class="NLM_cas:coden">JCNEAM</span>;
        ISSN:<span class="NLM_cas:issn">0021-9967</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Until recently, there was a lack of selective radioligands for the subtypes of metabotropic glutamate (mGlu) receptors.  [3H]LY 354740 ((+)-2-aminobicyclo[3,1,0]hexane-2,6-dicarboxylic acid), a selective agonist for group II receptors (mGlu2 and -3, which are neg. coupled to cAMP prodn.), has now been used to map their brain distribution and abundance by in vitro binding and quant. radioautog.  The selective cation dependence of its binding allowed the discrimination between mGlu2 and mGlu3 receptor labeling.  Thus, in the presence of Ca2+ and Mg2+ ions, the agonist bound selectively to mGlu2 receptors as evidenced by: (1) the correlative distribution and abundance of binding sites (highest in the lacunosum moleculare of the hippocampus and lowest in white matter) with mGlu2 receptor mRNA and protein revealed by in situ hybridization histochem. and immunohistochem., resp.; (2) its selective pharmacol.; and (3) the distribution of LY 354740-stimulated [35S]GTPγS binding (25-97% above basal, according to the brain region), revealing G protein-coupled receptor coupling to Gi proteins.  Nonspecific binding (in the presence of 10 μM DCG-IV, a group II-selective, mGlu2-preferring, receptor agonist) was <10% of total.  In adjacent sections, the distribution of binding sites for [3H]DCG-IV was very similar.  This extensive study paves the way for investigations of the regional expression and regulation of mGlu2 receptors in human CNS diseases, such as Alzheimer's disease, which may reveal their functional roles and identify potential therapeutic drug targets.  Indeed, it has recently been demonstrated (Higgins et al. [2004]) that pharmacol. manipulation of mGlu2 receptors influences cognitive performance in the rodent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV2ub35EbJUbVg90H21EOLACvtfcHk0lh15160UpjDuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVGhs7k%253D&md5=711b9b109da0ea76161bbe8a629b1336</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcne.20538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcne.20538%26sid%3Dliteratum%253Aachs%26aulast%3DRichards%26aufirst%3DG.%26aulast%3DMesser%26aufirst%3DJ.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DPink%26aufirst%3DR.%26aulast%3DBrockhaus%26aufirst%3DM.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DSchaffhauser%26aufirst%3DH.%2BJ.%26aulast%3DMutel%26aufirst%3DV.%26atitle%3DDistribution%2520and%2520abundance%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25202%2520in%2520rat%2520brain%2520revealed%2520by%2520%255B3H%255DLY354740%2520binding%2520in%2520vitro%2520and%2520quantitative%2520radioautography%253A%2520correlation%2520with%2520the%2520sites%2520of%2520synthesis%252C%2520expression%252C%2520and%2520agonist%2520stimulation%2520of%2520%255B35S%255DGTP%25CE%25B3S%2520binding%26jtitle%3DJ.%2520Comp.%2520Neurol.%26date%3D2005%26volume%3D487%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daggett, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffhauser, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span> </span><span class="NLM_article-title">Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: implication in emotional responses and central disinhibition</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1197</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1016%2Fj.brainres.2007.12.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=18242587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVaqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1197&publication_year=2008&pages=47-62&author=G.+Guauthor=D.+S.+Lorrainauthor=H.+Weiauthor=R.+L.+Coleauthor=X.+Zhangauthor=L.+P.+Daggettauthor=H.+J.+Schaffhauserauthor=L.+J.+Bristowauthor=S.+M.+Lechner&title=Distribution+of+metabotropic+glutamate+2+and+3+receptors+in+the+rat+forebrain%3A+implication+in+emotional+responses+and+central+disinhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition</span></div><div class="casAuthors">Gu, Guibao; Lorrain, Daniel S.; Wei, Hongbing; Cole, Rebecca L.; Zhang, Xin; Daggett, Lorrie P.; Schaffhauser, Herve J.; Bristow, Linda J.; Lechner, Sandra M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-62</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The receptor localization of metabotropic glutamate receptors (mGlu) 2 and 3 was examd. by using in situ hybridization and a well-characterized mGlu2-selective antibody in the rat forebrain.  The mGlu2 was highly and discretely expressed in cell bodies in almost all of the key regions of the limbic system in the forebrain, including the midline and intralaminar structures of the thalamus, the assocn. cortices, the dentate gyrus of the hippocampus, the medial mammillary nucleus, and the lateral and basolateral nuclei of the amygdala.  Moreover, presynaptic mGlu2 terminals were found in most of the forebrain structures, esp. in the lateral part of the central nucleus of the amygdala, and the CA1 region of the hippocampus.  Although some overlaps exist, such as in the hippocampus and the amygdala, the expression of mGlu3 mRNA, however, appeared to be more disperse, compared with that of mGlu2 mRNA.  These distribution results support previous behavioral studies that the mGlu2 and 3 receptors may play important roles in emotional responses.  In addn. to its expression in glia, mGlu3 was distinctively expressed in cells in the GABAergic reticular nucleus of the thalamus.  Local infusion of a non-selective mGlu2/3 agonist, LY 379268, in the reticular nucleus of the thalamus, significantly reduced GABA release, suggesting that mGlu3 may also play a role in central disinhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5fnpYDrcWc7Vg90H21EOLACvtfcHk0liryTww0yd6Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVaqsrs%253D&md5=48befca37fcd63a7a5b86562a5672826</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2007.12.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2007.12.057%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DG.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DCole%26aufirst%3DR.%2BL.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDaggett%26aufirst%3DL.%2BP.%26aulast%3DSchaffhauser%26aufirst%3DH.%2BJ.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26atitle%3DDistribution%2520of%2520metabotropic%2520glutamate%25202%2520and%25203%2520receptors%2520in%2520the%2520rat%2520forebrain%253A%2520implication%2520in%2520emotional%2520responses%2520and%2520central%2520disinhibition%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1197%26spage%3D47%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ghose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potts, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis-Amezcua, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamminga, C. A.</span><span> </span><span class="NLM_article-title">Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1176%2Fappi.ajp.2009.08091445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=19487395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A280%3ADC%252BD1MvlvVWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2009&pages=812-820&author=S.+Ghoseauthor=K.+A.+Gleasonauthor=B.+W.+Pottsauthor=K.+Lewis-Amezcuaauthor=C.+A.+Tamminga&title=Differential+expression+of+metabotropic+glutamate+receptors+2+and+3+in+schizophrenia%3A+a+mechanism+for+antipsychotic+drug+action%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?</span></div><div class="casAuthors">Ghose Subroto; Gleason Kelly A; Potts Bryan W; Lewis-Amezcua Kelly; Tamminga Carol A</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">812-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Preclinical and clinical data implicate the group II metabotropic glutamate receptors mGluR2 and mGluR3 in the pathophysiology of schizophrenia.  Moreover, a recent phase II clinical trial demonstrated the antipsychotic efficacy of a mGluR2/mGluR3 agonist.  The purpose of the present study was to distinguish the expression of mGluR2 and mGluR3 receptor proteins in schizophrenia and to quantify glutamate carboxypeptidase II (GCP II) in order to explore a role for the metabotropic receptors in schizophrenia therapeutics.  GCP II is an enzyme that metabolizes N-acetyl-aspartyl-glutamate (NAAG), which is the only known specific endogenous agonist of mGluR3 in the mammalian brain.  METHOD:  The normal expression levels of mGluR2, mGluR3, and GCP II were determined for 10 regions of the postmortem human brain using specific antibodies.  Differences in expression levels of each protein were examined in the dorsolateral prefrontal cortex, temporal cortex, and motor cortex in 15 postmortem schizophrenia subjects and 15 postmortem matched normal comparison subjects.  Chronic antipsychotic treatment in rodents was conducted to examine the potential effect of antipsychotic drugs on expression of the three proteins.  RESULTS:  Findings revealed a significant increase in GCP II protein and a reduction in mGluR3 protein in the dorsolateral prefrontal cortex in schizophrenia subjects, with mGluR2 protein levels unchanged.  Chronic antipsychotic treatment in rodents did not influence GCP II or mGluR3 levels.  CONCLUSIONS:  Increased GCP II expression and low mGluR3 expression in the dorsolateral prefrontal cortex suggest that NAAG-mediated signaling is impaired in this brain region in schizophrenia.  Further, these data implicate the mGluR3 receptor in the antipsychotic action of mGluR2/mGluR3 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRH7FPLGZ5fKrHHuJhbyicZfW6udTcc2ebvot7ThSOicLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvlvVWltg%253D%253D&md5=b2f45d5fc6ff54baa76c335b0fa08c4c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2009.08091445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2009.08091445%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DS.%26aulast%3DGleason%26aufirst%3DK.%2BA.%26aulast%3DPotts%26aufirst%3DB.%2BW.%26aulast%3DLewis-Amezcua%26aufirst%3DK.%26aulast%3DTamminga%26aufirst%3DC.%2BA.%26atitle%3DDifferential%2520expression%2520of%2520metabotropic%2520glutamate%2520receptors%25202%2520and%25203%2520in%2520schizophrenia%253A%2520a%2520mechanism%2520for%2520antipsychotic%2520drug%2520action%253F%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2009%26volume%3D166%26spage%3D812%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Shigeyuki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirohiko, H.</span><span> </span><span class="NLM_article-title">Targeting of metabotropic glutamate receptors for the treatment of schizophrenia</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.2174%2F138161211795049570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=21355835" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=94-102&author=C.+Shigeyukiauthor=H.+Hirohiko&title=Targeting+of+metabotropic+glutamate+receptors+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F138161211795049570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161211795049570%26sid%3Dliteratum%253Aachs%26aulast%3DShigeyuki%26aufirst%3DC.%26aulast%3DHirohiko%26aufirst%3DH.%26atitle%3DTargeting%2520of%2520metabotropic%2520glutamate%2520receptors%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2011%26volume%3D17%26spage%3D94%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valli, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salhoff, C .R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alt, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robey, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffey, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic roperties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">528</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9606756" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=528-537&author=J.+A.+Monnauthor=M.+J.+Valliauthor=S.+M.+Masseyauthor=R.+A.+Wrightauthor=C+.R.+Salhoffauthor=B.+G.+Johnsonauthor=T.+Howeauthor=C.+A.+Altauthor=G.+A.+Rhodesauthor=R.+L.+Robeyauthor=K.+R.+Griffeyauthor=J.+P.+Tizzanoauthor=M.+J.+Kallmanauthor=D.+R.+Heltonauthor=D.+D.+Schoepp&title=Design%2C+synthesis%2C+and+pharmacological+characterization+of+%28%2B%29-2-aminobicyclo%5B3.1.0%5Dhexane-2%2C6-dicarboxylic+acid+%28LY354740%29%3A+a+potent%2C+selective%2C+and+orally+active+group+2+metabotropic+glutamate+receptor+agonist+possessing+anticonvulsant+and+anxiolytic+roperties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm9606756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9606756%26sid%3Dliteratum%253Aachs%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DValli%26aufirst%3DM.%2BJ.%26aulast%3DMassey%26aufirst%3DS.%2BM.%26aulast%3DWright%26aufirst%3DR.%2BA.%26aulast%3DSalhoff%26aufirst%3DC%2B.R.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DAlt%26aufirst%3DC.%2BA.%26aulast%3DRhodes%26aufirst%3DG.%2BA.%26aulast%3DRobey%26aufirst%3DR.%2BL.%26aulast%3DGriffey%26aufirst%3DK.%2BR.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DKallman%26aufirst%3DM.%2BJ.%26aulast%3DHelton%26aufirst%3DD.%2BR.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520pharmacological%2520characterization%2520of%2520%2528%252B%2529-2-aminobicyclo%255B3.1.0%255Dhexane-2%252C6-dicarboxylic%2520acid%2520%2528LY354740%2529%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520group%25202%2520metabotropic%2520glutamate%2520receptor%2520agonist%2520possessing%2520anticonvulsant%2520and%2520anxiolytic%2520roperties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D528%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Swanson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bures, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Glutamate receptors as novel targets for anxiety and stress disorders</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=131-144&author=C.+J.+Swansonauthor=M.+Buresauthor=M.+P.+Johnsonauthor=A.+M.+Lindenauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Glutamate+receptors+as+novel+targets+for+anxiety+and+stress+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DC.%2BJ.%26aulast%3DBures%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DLinden%26aufirst%3DA.%2BM.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DGlutamate%2520receptors%2520as%2520novel%2520targets%2520for%2520anxiety%2520and%2520stress%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D131%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinzie, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span> </span><span class="NLM_article-title">Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1473</span><span class="NLM_x">–</span> <span class="NLM_lpage">1483</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=1473-1483&author=M.+J.+Fellauthor=D.+L.+McKinzieauthor=J.+A.+Monnauthor=K.+A.+Svensson&title=Group+II+metabotropic+glutamate+receptor+agonists+and+positive+allosteric+modulators+as+novel+treatments+for+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DMcKinzie%26aufirst%3DD.%2BL.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26atitle%3DGroup%2520II%2520metabotropic%2520glutamate%2520receptor%2520agonists%2520and%2520positive%2520allosteric%2520modulators%2520as%2520novel%2520treatments%2520for%2520schizophrenia%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D1473%26epage%3D1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Patil, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreev, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avedisova, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardenstein, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurovich, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morozova, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosolov, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neznanov, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reznik, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smulevich, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tochilov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1038%2Fnm1632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=17767166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSgtrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1102-1107&author=S.+T.+Patilauthor=L.+Zhangauthor=F.+Martenyiauthor=S.+L.+Loweauthor=K.+A.+Jacksonauthor=B.+V.+Andreevauthor=A.+S.+Avedisovaauthor=L.+M.+Bardensteinauthor=I.+Y.+Gurovichauthor=M.+A.+Morozovaauthor=S.+N.+Mosolovauthor=N.+G.+Neznanovauthor=A.+M.+Reznikauthor=A.+B.+Smulevichauthor=V.+A.+Tochilovauthor=B.+G.+Johnsonauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Activation+of+mGlu2%2F3+receptors+as+a+new+approach+to+treat+schizophrenia%3A+a+randomized+phase+2+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial</span></div><div class="casAuthors">Patil, Sandeep T.; Zhang, Lu; Martenyi, Ferenc; Lowe, Stephen L.; Jackson, Kimberley A.; Andreev, Boris V.; Avedisova, Alla S.; Bardenstein, Leonid M.; Gurovich, Issak Y.; Morozova, Margarita A.; Mosolov, Sergey N.; Neznanov, Nikolai G.; Reznik, Alexander M.; Smulevich, Anatoly B.; Tochilov, Vladimir A.; Johnson, Bryan G.; Monn, James A.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1102-1107</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Schizophrenia is a chronic, complex and heterogeneous mental disorder, with pathol. features of disrupted neuronal excitability and plasticity within limbic structures of the brain.  These pathol. features manifest behaviorally as pos. symptoms (including hallucinations, delusions and thought disorder), neg. symptoms (such as social withdrawal, apathy and emotional blunting) and other psychopathol. symptoms (such as psychomotor retardation, lack of insight, poor attention and impulse control).  Altered glutamate neurotransmission has for decades been linked to schizophrenia, but all commonly prescribed antipsychotics act on dopamine receptors.  LY404039 is a selective agonist for metabotropic glutamate 2/3 (mGlu2/3) receptors and has shown antipsychotic potential in animal studies.  With data from rodents, we provide new evidence that mGlu2/3 receptor agonists work by a distinct mechanism different from that of olanzapine.  To clin. test this mechanism, an oral prodrug of LY404039 (LY2140023) was evaluated in schizophrenic patients with olanzapine as an active control in a randomized, three-armed, double-blind, placebo-controlled study.  Treatment with LY2140023, like treatment with olanzapine, was safe and well-tolerated; treated patients showed statistically significant improvements in both pos. and neg. symptoms of schizophrenia compared to placebo (P < 0.001 at week 4).  Notably, patients treated with LY2140023 did not differ from placebo-treated patients with respect to prolactin elevation, extrapyramidal symptoms or wt. gain.  These data suggest that mGlu2/3 receptor agonists have antipsychotic properties and may provide a new alternative for the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYtB0jdSzAQrVg90H21EOLACvtfcHk0lidbYBVVLCLBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSgtrvF&md5=afab88e888cba7e72e14c4e949f894d7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnm1632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1632%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DK.%2BA.%26aulast%3DAndreev%26aufirst%3DB.%2BV.%26aulast%3DAvedisova%26aufirst%3DA.%2BS.%26aulast%3DBardenstein%26aufirst%3DL.%2BM.%26aulast%3DGurovich%26aufirst%3DI.%2BY.%26aulast%3DMorozova%26aufirst%3DM.%2BA.%26aulast%3DMosolov%26aufirst%3DS.%2BN.%26aulast%3DNeznanov%26aufirst%3DN.%2BG.%26aulast%3DReznik%26aufirst%3DA.%2BM.%26aulast%3DSmulevich%26aufirst%3DA.%2BB.%26aulast%3DTochilov%26aufirst%3DV.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DActivation%2520of%2520mGlu2%252F3%2520receptors%2520as%2520a%2520new%2520approach%2520to%2520treat%2520schizophrenia%253A%2520a%2520randomized%2520phase%25202%2520clinical%2520trial%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D1102%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span>During the preparation of this manuscript Eli Lilly and Company announced in a press release (August 29, 2012) the decision to stop the clinical studies investigating LY2140023 for the treatment of patients suffering from schizophrenia. The press release mentioned that the decision was made after a recently conducted independent futility analysis concluded that HBBN, the second of Lilly’s two pivotal studies, was unlikely to be positive in its primary efficacy endpoint if enrolled to completion. The decision was not based on any safety signals. <a href="https://investor.lilly.com/releaseDetail.cfm?ReleaseID=703018" class="extLink">https://investor.lilly.com/releaseDetail.cfm?ReleaseID=703018</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=During+the+preparation+of+this+manuscript+Eli+Lilly+and+Company+announced+in+a+press+release+%28August+29%2C+2012%29+the+decision+to+stop+the+clinical+studies+investigating+LY2140023+for+the+treatment+of+patients+suffering+from+schizophrenia.+The+press+release+mentioned+that+the+decision+was+made+after+a+recently+conducted+independent+futility+analysis+concluded+that+HBBN%2C+the+second+of+Lilly%E2%80%99s+two+pivotal+studies%2C+was+unlikely+to+be+positive+in+its+primary+efficacy+endpoint+if+enrolled+to+completion.+The+decision+was+not+based+on+any+safety+signals.+https%3A%2F%2Finvestor.lilly.com%2FreleaseDetail.cfm%3FReleaseID%3D703018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Pin, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prezeau, L.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators for γ-aminobutyric acid<sub>B</sub> receptors open new routes for the development of drugs targeting family 3 G-protein-coupled receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=881-884&author=J.+P.+Pinauthor=M.-L.+Parmentierauthor=L.+Prezeau&title=Positive+allosteric+modulators+for+%CE%B3-aminobutyric+acidB+receptors+open+new+routes+for+the+development+of+drugs+targeting+family+3+G-protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DParmentier%26aufirst%3DM.-L.%26aulast%3DPrezeau%26aufirst%3DL.%26atitle%3DPositive%2520allosteric%2520modulators%2520for%2520%25CE%25B3-aminobutyric%2520acidB%2520receptors%2520open%2520new%2520routes%2520for%2520the%2520development%2520of%2520drugs%2520targeting%2520family%25203%2520G-protein-coupled%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D881%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Gjoni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, S.</span><span> </span><span class="NLM_article-title">Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABA<sub>B</sub> receptor desensitization</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=1293-1299&author=T.+Gjoniauthor=S.+Urwyler&title=Receptor+activation+involving+positive+allosteric+modulation%2C+unlike+full+agonism%2C+does+not+result+in+GABAB+receptor+desensitization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGjoni%26aufirst%3DT.%26aulast%3DUrwyler%26aufirst%3DS.%26atitle%3DReceptor%2520activation%2520involving%2520positive%2520allosteric%2520modulation%252C%2520unlike%2520full%2520agonism%252C%2520does%2520not%2520result%2520in%2520GABAB%2520receptor%2520desensitization%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D1293%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Urwyler, S.</span><span> </span><span class="NLM_article-title">Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=59-126&author=S.+Urwyler&title=Allosteric+modulation+of+family+C+G-protein-coupled+receptors%3A+from+molecular+insights+to+therapeutic+perspectives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrwyler%26aufirst%3DS.%26atitle%3DAllosteric%2520modulation%2520of%2520family%2520C%2520G-protein-coupled%2520receptors%253A%2520from%2520molecular%2520insights%2520to%2520therapeutic%2520perspectives%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26spage%3D59%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span> </span><span class="NLM_article-title">Progress in the development of positive allosteric modulators of the metabotropic glutamate receptor 2</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.2174%2F092986711793979706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=21110815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslahs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=47-68&author=A.+A.+Trabancoauthor=J.+M.+Cidauthor=H.+Lavreysenauthor=G.+J.+Macdonaldauthor=G.+Tresadern&title=Progress+in+the+development+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of positive allosteric modulators of the metabotropic glutamate receptor 2</span></div><div class="casAuthors">Trabanco, A. A.; Cid, J. M.; Lavreysen, H.; MacDonald, G. J.; Tresadern, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-68</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The metabotropic glutamate type 2 (mGlu2) receptor is a G-protein coupled receptor (GPCR) expressed on presynaptic nerve terminals where it neg. modulates glutamate and GABA release.  Mixed mGlu2/mGlu3 orthosteric agonists such as LY354740 have shown activity in a range of preclin. animal models of anxiety and schizophrenia.  Clin. work with LY354740 demonstrated activity in a CO2 inhalation study suggesting application in the treatment of anxiety related disorders.  Subsequently, a related prodrug LY2140023 demonstrated improvements in pos. and neg. symptoms in patients suffering from schizophrenia.  These mols. exhibit combined mGlu2/mGlu3 activity although there is evidence from knock-out studies that preclin. anti-psychotic effects may be mediated via the mGlu2 receptor.  An alternative avenue for modulating GPCRs is to act via allosteric mechanisms, binding at a different site from the orthosteric agonist.  Since the first discovery of mGlu2 pos. allosteric modulators (PAMs) such as 2,2,2-TEMPS and BINA, multiple families of mGlu2 modulators have been reported and several have entered into clin. development.  This review focuses on recent advances in the development of novel mGlu2 PAMs by anal. of compds. disclosed in research articles and patent literature between 2007 and 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkHtOXKWJY9rVg90H21EOLACvtfcHk0lg1hHAWvzdnSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslahs7g%253D&md5=b4059bdfb0001b97cde8ec0e30032a48</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F092986711793979706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711793979706%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DTresadern%26aufirst%3DG.%26atitle%3DProgress%2520in%2520the%2520development%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D47%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furnari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behaj, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thollon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Addona, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of <i>N</i>-propyl-8-chloro-6-substituted isoquinolones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">976</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=971-976&author=A.+A.+Trabancoauthor=G.+Duveyauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=P.+Cluzeauauthor=V.+Nhemauthor=R.+Furnariauthor=N.+Behajauthor=G.+Poulainauthor=T.+Finnauthor=H.+Lavreysenauthor=S.+Poliauthor=A.+Rauxauthor=Y.+Thollonauthor=N.+Poirierauthor=D.+D%E2%80%99Addonaauthor=J.+I.+Andresauthor=R.+Lutjensauthor=E.+Le+Poulauthor=H.+Imogaiauthor=J.-P.+Rocher&title=New+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2+%28mGluR2%29%3A+identification+and+synthesis+of+N-propyl-8-chloro-6-substituted+isoquinolones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFurnari%26aufirst%3DR.%26aulast%3DBehaj%26aufirst%3DN.%26aulast%3DPoulain%26aufirst%3DG.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DThollon%26aufirst%3DY.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DD%25E2%2580%2599Addona%26aufirst%3DD.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DNew%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGluR2%2529%253A%2520identification%2520and%2520synthesis%2520of%2520N-propyl-8-chloro-6-substituted%2520isoquinolones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D971%26epage%3D976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furnari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behaj, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thollon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Addona, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of <i>N</i>-propyl-5-substituted isoquinolones</span> <span class="citation_source-journal">Med. Chem. Commum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1039%2Fc0md00200c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1yktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=132-139&author=A.+A.+Trabancoauthor=G.+Duveyauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=P.+Cluzeauauthor=V.+Nhemauthor=R.+Furnariauthor=N.+Behajauthor=G.+Poulainauthor=T.+Finnauthor=S.+Poliauthor=H.+Lavreysenauthor=A.+Rauxauthor=Y.+Thollonauthor=N.+Poirierauthor=D.+D%E2%80%99Addonaauthor=J.+I.+Andr%C3%A9sauthor=R.+Lutjensauthor=E.+Le+Poulauthor=H.+Imogaiauthor=J.-P.+Rocher&title=New+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2+%28mGluR2%29%3A+identification+and+synthesis+of+N-propyl-5-substituted+isoquinolones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2). Identification and synthesis of N-propyl-5-substituted isoquinolones</span></div><div class="casAuthors">Trabanco, Andres A.; Duvey, Guillaume; Cid, Jose Maria; Macdonald, Gregor J.; Cluzeau, Philippe; Nhem, Vanthea; Furnari, Rocco; Behaj, Nadia; Poulain, Geraldine; Finn, Terry; Poli, Sonia; Lavreysen, Hilde; Raux, Alexandre; Thollon, Yves; Poirier, Nicolas; D'Addona, David; Andres, Jose Ignacio; Lutjens, Robert; Le Poul, Emmanuel; Imogai, Hassan; Rocher, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-139</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of N-propyl-5-substituted isoquinolones was identified as pos. allosteric modulators (PAM) of metabotropic glutamate receptor 2 (mGluR2) via high-throughput screening (HTS).  The subsequent synthesis and preliminary SAR exploration that led to the identification of compd. 20 are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2w5fK6sXL07Vg90H21EOLACvtfcHk0lg1hHAWvzdnSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1yktbg%253D&md5=f729cbf8bcdeb592859e3e921c089be1</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2Fc0md00200c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0md00200c%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFurnari%26aufirst%3DR.%26aulast%3DBehaj%26aufirst%3DN.%26aulast%3DPoulain%26aufirst%3DG.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DThollon%26aufirst%3DY.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DD%25E2%2580%2599Addona%26aufirst%3DD.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DNew%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520%2528mGluR2%2529%253A%2520identification%2520and%2520synthesis%2520of%2520N-propyl-5-substituted%2520isoquinolones%26jtitle%3DMed.%2520Chem.%2520Commum.%26date%3D2011%26volume%3D2%26spage%3D132%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macary, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urios, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epping-Jordan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamelot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derouet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzábal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">Discovery of 1,5-disubstituted pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn1000638" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgsbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=788-795&author=J.+M.+Cidauthor=G.+Duveyauthor=P.+Cluzeauauthor=V.+Nhemauthor=K.+Macaryauthor=A.+Rauxauthor=N.+Poirierauthor=J.+Mullerauthor=C.+Boleaauthor=T.+Finnauthor=I.+Uriosauthor=M.+Epping-Jordanauthor=E.+Chamelotauthor=F.+Derouetauthor=F.+Girardauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=E.+Matesanzauthor=H.+Lavreysenauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=J.+Oyarz%C3%A1balauthor=G.+Tresadernauthor=A.+A.+Trabancoauthor=J.+I.+Andr%C3%A9sauthor=E.+Le+Poulauthor=H.+Imogaiauthor=R.+Lutjensauthor=J.-P.+Rocher&title=Discovery+of+1%2C5-disubstituted+pyridones%3A+a+new+class+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,5-Disubstituted Pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor</span></div><div class="casAuthors">Cid, Jose Maria; Duvey, Guillaume; Cluzeau, Philippe; Nhem, Vanthea; Macary, Karim; Raux, Alexandre; Poirier, Nicolas; Muller, Jessica; Bolea, Christelle; Finn, Terry; Urios, Isabelle; Epping-Jordan, Mark; Chamelot, Emilie; Derouet, Francis; Girard, Francoise; MacDonald, Gregor J.; Vega, Juan Antonio; de Lucas, Ana Isabel; Matesanz, Encarnacion; Lavreysen, Hilde; Linares, Maria Lourdes; Oehlrich, Daniel; Oyarzabal, Julen; Tresadern, Gary; Trabanco, Andres A.; Andres, Jose Ignacio; Le Poul, Emmanuel; Imogai, Hassan; Lutjens, Robert; Rocher, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">788-795</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 1,5-disubstituted pyridones was identified as pos. allosteric modulators (PAMs) of the metabotropic glutamate receptor 2 (mGluR2) via high throughput screening (HTS).  Subsequent SAR exploration led to the identification of several compds. with improved in vitro activity.  Lead compd. 8 (I) was further profiled and found to attenuate the increase in PCP induced locomotor activity in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-saUfhQDgzLVg90H21EOLACvtfcHk0lgTnbX0oMN7BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgsbzO&md5=85204e53809a7efcbd7d9fb5f04a3601</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcn1000638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn1000638%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DMacary%26aufirst%3DK.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DBolea%26aufirst%3DC.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DUrios%26aufirst%3DI.%26aulast%3DEpping-Jordan%26aufirst%3DM.%26aulast%3DChamelot%26aufirst%3DE.%26aulast%3DDerouet%26aufirst%3DF.%26aulast%3DGirard%26aufirst%3DF.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DOyarz%25C3%25A1bal%26aufirst%3DJ.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DDiscovery%2520of%25201%252C5-disubstituted%2520pyridones%253A%2520a%2520new%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D788%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Imogai, H. J.; Cid-Nuñez, J. M.; Duvey, G. A. J.; Bolea, C. M.; Nhem, V.; Finn, T. P.; Le Poul, E. C.; Rocher, J.-P. F. C.; Lutjens, R. J.</span><span> </span><span class="NLM_article-title">Novel Pyridinone Derivatives and Their Preparation, Pharmaceutical Compositions, and Use as Positive Allosteric Modulators of mGluR2-Receptors for Treatment of Various Neurological and Psychiatric Disorders</span>. WO2006030032 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=H.+J.+Imogai&author=J.+M.+Cid-Nu%C3%B1ez&author=G.+A.+J.+Duvey&author=C.+M.+Bolea&author=V.+Nhem&author=T.+P.+Finn&author=E.+C.+Le+Poul&author=J.-P.+F.+C.+Rocher&author=R.+J.+Lutjens&title=Novel+Pyridinone+Derivatives+and+Their+Preparation%2C+Pharmaceutical+Compositions%2C+and+Use+as+Positive+Allosteric+Modulators+of+mGluR2-Receptors+for+Treatment+of+Various+Neurological+and+Psychiatric+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DImogai%26aufirst%3DH.%2BJ.%26atitle%3DNovel%2520Pyridinone%2520Derivatives%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%252C%2520and%2520Use%2520as%2520Positive%2520Allosteric%2520Modulators%2520of%2520mGluR2-Receptors%2520for%2520Treatment%2520of%2520Various%2520Neurological%2520and%2520Psychiatric%2520Disorders%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funary, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Discovery of 1,4-disubstituted 3-cyano-2-pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2388</span><span class="NLM_x">–</span> <span class="NLM_lpage">2405</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2016864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2388-2405&author=J.+M.+Cidauthor=G.+Duveyauthor=G.+Tresadernauthor=V.+Nhemauthor=R.+Funaryauthor=P.+Cluzeauauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=E.+Matesanzauthor=J.+M.+Alonsoauthor=M.+L.+Linaresauthor=J.+I.+Andr%C3%A9sauthor=S.+Poliauthor=R.+Lutjensauthor=H.+Imogaiauthor=J.-P.+Rocherauthor=G.+J.+Macdonaldauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=A.+Ahnaouauthor=W.+Drinkenburgauthor=C.+Mackieauthor=A.+A.+Trabanco&title=Discovery+of+1%2C4-disubstituted+3-cyano-2-pyridones%3A+a+new+class+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm2016864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2016864%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DFunary%26aufirst%3DR.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DRocher%26aufirst%3DJ.-P.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DDiscovery%2520of%25201%252C4-disubstituted%25203-cyano-2-pyridones%253A%2520a%2520new%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2388%26epage%3D2405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; Trabanco-Suárez, A. A.; Macdonald, G. J.; Duvey, G. A. J.; Lutjens, R. J.</span><span> </span><span class="NLM_article-title">Preparation of 3-Cyano-4-(4-tetrahydropyran-phenyl)pyridin-2-one Derivatives as Positive mGluR2 Receptor Modulators</span>. WO 2008107481 A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+M.+Cid-Nu%C3%B1ez&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Macdonald&author=G.+A.+J.+Duvey&author=R.+J.+Lutjens&title=Preparation+of+3-Cyano-4-%284-tetrahydropyran-phenyl%29pyridin-2-one+Derivatives+as+Positive+mGluR2+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26atitle%3DPreparation%2520of%25203-Cyano-4-%25284-tetrahydropyran-phenyl%2529pyridin-2-one%2520Derivatives%2520as%2520Positive%2520mGluR2%2520Receptor%2520Modulators%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Imogai, H. I.; Cid-Nuñez, J. M.; Andrés-Gil, J. I.; Trabanco-Suárez, A. A.; Oyarzábal-Santamarina, J.; Dautzenberg, F. M.; Macdonald, G. J.; Pullan, S. E.; Lutjens, R. J.; Duvey, G. A. J.; Nhem, V.; Finn, T. P.; Melikyan, G.</span><span> </span><span class="NLM_article-title">1,4-Disubstituted 3-Cyanopyridone Derivatives and Their Use as Positive Allosteric Modulators of mGlu2-Receptors and Their Preparation</span>. WO2007104783 A2,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=H.+I.+Imogai&author=J.+M.+Cid-Nu%C3%B1ez&author=J.+I.+Andr%C3%A9s-Gil&author=A.+A.+Trabanco-Su%C3%A1rez&author=J.+Oyarz%C3%A1bal-Santamarina&author=F.+M.+Dautzenberg&author=G.+J.+Macdonald&author=S.+E.+Pullan&author=R.+J.+Lutjens&author=G.+A.+J.+Duvey&author=V.+Nhem&author=T.+P.+Finn&author=G.+Melikyan&title=1%2C4-Disubstituted+3-Cyanopyridone+Derivatives+and+Their+Use+as+Positive+Allosteric+Modulators+of+mGlu2-Receptors+and+Their+Preparation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DImogai%26aufirst%3DH.%2BI.%26atitle%3D1%252C4-Disubstituted%25203-Cyanopyridone%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Positive%2520Allosteric%2520Modulators%2520of%2520mGlu2-Receptors%2520and%2520Their%2520Preparation%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesmans, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Scaffold hopping from pyridones to imidazo[1,2-<i>a</i>]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=175-179&author=G.+Tresadernauthor=J.+M+Cidauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=A.+Garc%C3%ADaauthor=E.+Matesanzauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=I.+Biesmansauthor=A.+A.+Trabanco&title=Scaffold+hopping+from+pyridones+to+imidazo%5B1%2C2-a%5Dpyridines.+New+positive+allosteric+modulators+of+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DBiesmans%26aufirst%3DI.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DScaffold%2520hopping%2520from%2520pyridones%2520to%2520imidazo%255B1%252C2-a%255Dpyridines.%2520New%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D175%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Trabanco, A. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso de Diego, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span> </span><span class="NLM_article-title">Imidazo[1,2-<i>a</i>]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2688</span><span class="NLM_x">–</span> <span class="NLM_lpage">2701</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201561r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2688-2701&author=A.+A+Trabancoauthor=G.+Tresadernauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=E.+Matesanzauthor=A.+Garciaauthor=M.+L.+Linaresauthor=S.+A.+Alonso+de+Diegoauthor=J.+M.+Alonsoauthor=D.+Oehlrichauthor=A.+Ahnaouauthor=W.+Drinkenburgauthor=C.+Mackieauthor=J.+I.+Andresauthor=H.+Lavreysenauthor=J.+M.+Cid&title=Imidazo%5B1%2C2-a%5Dpyridines%3A+orally+active+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm201561r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201561r%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco%26aufirst%3DA.%2BA%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26atitle%3DImidazo%255B1%252C2-a%255Dpyridines%253A%2520orally%2520active%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2688%26epage%3D2701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; Trabanco-Suárez, A. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">Preparation of Indole and Benzoxazine Derivatives as Modulators of Metabotropic Glutamate Receptors for Treating Neurological and Psychiatric Disorders</span>. WO 2010060589 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nu%C3%B1ez&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Macdonald&title=Preparation+of+Indole+and+Benzoxazine+Derivatives+as+Modulators+of+Metabotropic+Glutamate+Receptors+for+Treating+Neurological+and+Psychiatric+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26atitle%3DPreparation%2520of%2520Indole%2520and%2520Benzoxazine%2520Derivatives%2520as%2520Modulators%2520of%2520Metabotropic%2520Glutamate%2520Receptors%2520for%2520Treating%2520Neurological%2520and%2520Psychiatric%2520Disorders%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Trabanco-Suárez, A. A.; Tresadern, G. J.; Vega-Ramiro, J. A.; Cid-Nuñez, J. M..</span><span> </span><span class="NLM_article-title">Preparation of Imidazopyridine Derivatives for Use as mGluR2 Receptor Modulators</span>. WO2009062676 A2,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Tresadern&author=J.+A.+Vega-Ramiro&author=J.+M..+Cid-Nu%C3%B1ez&title=Preparation+of+Imidazopyridine+Derivatives+for+Use+as+mGluR2+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTrabanco-Su%25C3%25A1rez%26aufirst%3DA.%2BA.%26atitle%3DPreparation%2520of%2520Imidazopyridine%2520Derivatives%2520for%2520Use%2520as%2520mGluR2%2520Receptor%2520Modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; Oehlrich, D.; Trabanco-Suárez, A. A.; Tresadern, G. J.; Vega-Ramiro, J. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">1,2,4-Triazolo[4,3-<i>a</i>]pyridine Derivatives and Their Use for the Treatment or Prevention of Neurological Disorders</span>. WO2010130424 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nu%C3%B1ez&author=D.+Oehlrich&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Tresadern&author=J.+A.+Vega-Ramiro&author=G.+J.+Macdonald&title=1%2C2%2C4-Triazolo%5B4%2C3-a%5Dpyridine+Derivatives+and+Their+Use+for+the+Treatment+or+Prevention+of+Neurological+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26atitle%3D1%252C2%252C4-Triazolo%255B4%252C3-a%255Dpyridine%2520Derivatives%2520and%2520Their%2520Use%2520for%2520the%2520Treatment%2520or%2520Prevention%2520of%2520Neurological%2520Disorders%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; De Lucas-Olivares, A. I.; Trabanco-Suárez, A. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">7-Aryl-1,2,4-triazolo[4,3-<i>a</i>]pyridine Derivatives and Their Use as Positive Allosteric Modulators of mGluR2 Receptors</span>. WO2010130423 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nu%C3%B1ez&author=A.+I.+De+Lucas-Olivares&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Macdonald&title=7-Aryl-1%2C2%2C4-triazolo%5B4%2C3-a%5Dpyridine+Derivatives+and+Their+Use+as+Positive+Allosteric+Modulators+of+mGluR2+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26atitle%3D7-Aryl-1%252C2%252C4-triazolo%255B4%252C3-a%255Dpyridine%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Positive%2520Allosteric%2520Modulators%2520of%2520mGluR2%2520Receptors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Cid-Nuñez, J. M.; De Lucas-Olivares, A. I.; Trabanco-Suárez, A. A.; Macdonald, G. J.</span><span> </span><span class="NLM_article-title">1,2,4-Triazolo[4,3-<i>a</i>]pyridine Derivatives and Their Use as Positive Allosteric Modulators of mGluR2 Receptors</span>. WO2010130422 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Cid-Nu%C3%B1ez&author=A.+I.+De+Lucas-Olivares&author=A.+A.+Trabanco-Su%C3%A1rez&author=G.+J.+Macdonald&title=1%2C2%2C4-Triazolo%5B4%2C3-a%5Dpyridine+Derivatives+and+Their+Use+as+Positive+Allosteric+Modulators+of+mGluR2+Receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCid-Nu%25C3%25B1ez%26aufirst%3DJ.%2BM.%26atitle%3D1%252C2%252C4-Triazolo%255B4%252C3-a%255Dpyridine%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Positive%2520Allosteric%2520Modulators%2520of%2520mGluR2%2520Receptors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="note"><p class="first last">The in vitro [<sup>35</sup>S]GTPγS assay provides two measures of compound activity: pEC<sub>50</sub>, which is defined as the negative logarithm of the concentration at which half-maximal potentiation of glutamate is reached, and the maximal increase in observed glutamate response, the % <i>E</i><sub>MAX</sub>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="note"><p class="first last">Compound <b>20</b> shifts the concentration–response curve of glutamate to the left, increasing the potency of glutamate up to ∼25-fold.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a set of simple, interpretable ADMET rules of thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+set+of+simple%2C+interpretable+ADMET+rules+of+thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0lhODy6HoD-f_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520set%2520of%2520simple%252C%2520interpretable%2520ADMET%2520rules%2520of%2520thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lhODy6HoD-f_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Keseru, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1038%2Fnrd2796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=19247303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keseruauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lead discovery strategies on the properties of drug candidates</span></div><div class="casAuthors">Keseru Gyorgy M; Makara Gergely M</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Drug discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite the widespread acceptance of guidelines related to desirable physicochemical properties of potential small-molecule drugs, key properties - such as lipophilicity - of recently developed clinical candidates and advanced lead compounds have been shown to differ significantly from those of historical leads and drugs.  By analysing the physicochemical properties of a large database of hits and corresponding leads identified in the past decade, we show that this undesirable phenomenon can be traced back to the nature of high-throughput screening hits and hit-to-lead optimization practices.  Conceptual and organizational adjustments may be required to enable a smooth lead-evolution process that reduces the chance of high compound-related attrition in clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCjUjH8uzRfyM8MEzWGjS9fW6udTcc2eZGkNeJ7mBHOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D&md5=57f8228cf7f46bd4f3c3ff48f34da32c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnrd2796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2796%26sid%3Dliteratum%253Aachs%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Tarcsay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyiri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span> </span><span class="NLM_article-title">Impact of lipophilic efficiency on compound quality</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1252</span><span class="NLM_x">–</span> <span class="NLM_lpage">1260</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201388p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1252-1260&author=A.+Tarcsayauthor=K.+Nyiriauthor=G.+M.+Keseru&title=Impact+of+lipophilic+efficiency+on+compound+quality"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Lipophilic Efficiency on Compound Quality</span></div><div class="casAuthors">Tarcsay, Akos; Nyiri, Kinga; Keseru, Gyorgy M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1252-1260</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lipophilic efficiency indexes such as LLE and LELP were suggested to support balanced optimization of potency and ADMET profile.  Here we investigated the performance of LLE and LELP on multiple data sets representing different stages of drug discovery including fragment and HTS hits and leads, development candidates, phase II compds., and launched drugs.  Analyzing their impact on ADME and safety properties and binding thermodn., we found that both LLE and LELP help identifying better quality compds.  LLE is sensible for the development stages but does not prefer fragment-type hits, while LELP has an advantage for this class of compds. and discriminates preferred starting points effectively.  Both LLE and LELP have significant impact on ADME and safety profiles; however, LELP outperforms LLE in risk assessment at least on the present data set.  On the basis of the results reported here, monitoring lipophilic efficiency metrics could contribute significantly to compd. quality and might improve the output of medicinal chem. programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxB8xs6-5DL7Vg90H21EOLACvtfcHk0liYpt6_Tgfj_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVKjsQ%253D%253D&md5=2536abef781f52806013016971c78bcb</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm201388p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201388p%26sid%3Dliteratum%253Aachs%26aulast%3DTarcsay%26aufirst%3DA.%26aulast%3DNyiri%26aufirst%3DK.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26atitle%3DImpact%2520of%2520lipophilic%2520efficiency%2520on%2520compound%2520quality%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1252%26epage%3D1260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="note"><p class="first last">Molecule <b>20</b> had a calculated (ACD, version 12.0) log <i>D</i> at pH 7.4 of 2.65, subtracted from the in vitro potency of 15 nM (pEC<sub>50</sub> of 7.82), and yielded an LLE of 5.2. However, some caution may be needed, as the experimental log <i>P</i> was 4.4 (pH 7.0, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), suggesting a discrepancy between experiment and theory in this case.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="note"><p class="first last">The CEREP selectivity screen was performed on the following targets: 5HT<sub>1A</sub>, 5HT<sub>2A</sub>, 5HT<sub>3</sub>, 5HT<sub>5A</sub>, 5HT<sub>6</sub>, 5HT<sub>7</sub>, A<sub>1</sub>, A<sub>2A</sub>, A<sub>3</sub>, AT<sub>1</sub>, β<sub>1</sub>, BK<sub>2</sub>, CCKA, CCR<sub>1</sub>, D<sub>1</sub>, D<sub>2</sub>, DAT, ETA, GAL<sub>2</sub>, H<sub>1</sub>, H<sub>2</sub>, IL<sub>8B</sub>, CXCR<sub>2</sub>, M<sub>1</sub>, M<sub>2</sub>, M<sub>3</sub>, MC<sub>4</sub>, NET, NK<sub>2</sub>, NK<sub>3</sub>, NPY<sub>1</sub>, NPY<sub>2</sub>, NT<sub>1</sub>, OP<sub>1</sub>, OP<sub>3</sub>, ORL<sub>1</sub>, V<sub>1</sub>A, VIP, SST, 5HT<sub>1B</sub>, α<sub>1</sub>, α<sub>2</sub>, BZD, CaCH, CICH, GABA, KCH, NaCH, SKCaCH.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Lopez-Rodriguez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina-Ceja, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales-Villagram, A.</span><span> </span><span class="NLM_article-title">Changes in extracellular glutamate levels in rat orbitofrontal cortex during sleep and wakefulness</span> <span class="citation_source-journal">Arch. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1016%2Fj.arcmed.2006.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=17174723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlaktLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2007&pages=52-55&author=F.+Lopez-Rodriguezauthor=L.+Medina-Cejaauthor=C.+L.+Wilsonauthor=D.+Jhungauthor=A.+Morales-Villagram&title=Changes+in+extracellular+glutamate+levels+in+rat+orbitofrontal+cortex+during+sleep+and+wakefulness"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Changes in Extracellular Glutamate Levels in Rat Orbitofrontal Cortex During Sleep and Wakefulness</span></div><div class="casAuthors">Lopez-Rodriguez, Faustino; Medina-Ceja, Laura; Wilson, Charles L.; Jhung, Donald; Morales-Villagran, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Medical Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-55</span>CODEN:
                <span class="NLM_cas:coden">AEDEER</span>;
        ISSN:<span class="NLM_cas:issn">0188-4409</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: Functional neuroimaging studies have shown that limbic and paralimbic areas display increased activity during REM sleep when compared to wakefulness.  This increase in limbic activity is specific to the REM period of sleep.  PET scanners do not provide a neurochem. explanation for this increased activity during REM sleep.  In order to better understand the neurochem. basis of this increase, extracellular glutamate levels were measured in the rat orbitofrontal cortex during the stages of sleep and wakefulness.  Methods: EEG and EMG activity were registered to score the behavioral state in epochs of 15 s into three stages: wakefulness, non-REM sleep and rapid eye movement (REM) sleep.  To correlate the glutamate concn. of the orbitofrontal cortex with sleep-wake states, 1-min dialyzate samples were taken and classified as wakefulness, non-REM or REM sleep if all four of the 15-s epochs occurring during the collection of that sample and after correction for dead time corresponded to the resp. state.  High-performance liq. chromatog. (HPLC) with electrochem. detection was used to measure glutamate levels.  Results: Glutamate levels of the orbitofrontal cortex were increased during REM sleep, diminished during wakefulness, and the lowest levels were found during non-REM sleep.  Conclusions: These findings demonstrate an increase in the concn. of the excitatory neurotransmitter glutamate in the orbitofrontal cortex during REM sleep, which could be related to the increased activity in paralimbic structures obsd. in humans using functional neuroimaging, as well as to the proposed role of REM sleep on retention of emotional memories.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC9ZgyRujy3bVg90H21EOLACvtfcHk0liYpt6_Tgfj_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlaktLnJ&md5=254195f095ab0cf0ff9b71c26c4589c4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2006.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2006.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DLopez-Rodriguez%26aufirst%3DF.%26aulast%3DMedina-Ceja%26aufirst%3DL.%26aulast%3DWilson%26aufirst%3DC.%2BL.%26aulast%3DJhung%26aufirst%3DD.%26aulast%3DMorales-Villagram%26aufirst%3DA.%26atitle%3DChanges%2520in%2520extracellular%2520glutamate%2520levels%2520in%2520rat%2520orbitofrontal%2520cortex%2520during%2520sleep%2520and%2520wakefulness%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2007%26volume%3D38%26spage%3D52%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dautzenberg, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibelin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steckler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W. H. I. M.</span><span> </span><span class="NLM_article-title">Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep–wake architecture</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">603</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1016%2Fj.ejphar.2008.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=19046965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=603&publication_year=2009&pages=62-72&author=A.+Ahnaouauthor=F.+M.+Dautzenbergauthor=H.+Geysauthor=H.+Imogaiauthor=A.+Gibelinauthor=D.+Moecharsauthor=T.+Stecklerauthor=W.+H.+I.+M.+Drinkenburg&title=Modulation+of+group+II+metabotropic+glutamate+receptor+%28mGlu2%29+elicits+common+changes+in+rat+and+mice+sleep%E2%80%93wake+architecture"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture</span></div><div class="casAuthors">Ahnaou, Abdellah; Dautzenberg, Frank M.; Geys, Helena; Imogai, Hassan; Gibelin, Antoine; Moechars, Dieder; Steckler, Thomas; Drinkenburg, Wilhelmus H. I. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">603</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">62-72</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Compiling pharmacol. evidence implicates metabotropic glutamate mGlu2 receptors in the regulation of emotional states and suggests pos. modulators as a novel therapeutic approach of Anxiety/Depression and Schizophrenia.  Here, we investigated s.c. effects of the metabotropic glutamate mGlu2/3 agonist (LY354740) on sleep-wake architecture in rat.  To confirm the specific effects on rapid eye movement (REM) sleep were mediated via metabotropic glutamate mGlu2 receptors, we characterized the sleep-wake cycles in metabotropic glutamate mGlu2 receptor deficient mice (mGlu2R-/-) and their arousal response to LY354740.  We furthermore examd. effects on sleep behavior in rats of the pos. allosteric modulator, biphenyl-indanone A (BINA) alone and in combination with LY354740 at sub-EDs.  LY354740 (1, 3 and 10 mg/kg) dose-dependently suppressed REM sleep and prolonged its onset latency.  Metabotropic glutamate mGlu2R-/- and their wild type (WT) littermates exhibited similar spontaneous sleep-wake phenotype, while LY354740 (10 mg/kg) significantly affected REM sleep variables in WT but not in the mutant.  In rats, BINA (1, 3, 10, 20, 40 mg/kg) dose-dependently suppressed REM sleep, lengthened its onset latency and slightly enhanced passive waking.  Addnl., combined treatment elicited a synergistic action on REM sleep variables.  Our findings show common changes of REM sleep variables following modulation of metabotropic glutamate mGlu2 receptor and support an active role of this receptor in the regulation of REM sleep.  The synergistic action of BINA on LY354740's effects on sleep pattern implies that pos. modulators would tune the endogenous glutamate tone suggesting potential benefit in the treatment of psychiatric disorders, in which REM sleep overdrive is manifested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlUXqoXCoqp7Vg90H21EOLACvtfcHk0liYpt6_Tgfj_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjsbg%253D&md5=eb1e676deebb6b39aad64cf14a281bf2</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDautzenberg%26aufirst%3DF.%2BM.%26aulast%3DGeys%26aufirst%3DH.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DGibelin%26aufirst%3DA.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DSteckler%26aufirst%3DT.%26aulast%3DDrinkenburg%26aufirst%3DW.%2BH.%2BI.%2BM.%26atitle%3DModulation%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520%2528mGlu2%2529%2520elicits%2520common%2520changes%2520in%2520rat%2520and%2520mice%2520sleep%25E2%2580%2593wake%2520architecture%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D603%26spage%3D62%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Feinberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darchia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, I. G.</span><span> </span><span class="NLM_article-title">The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2<i>S</i>-2-amino-2-(1<i>S</i>,2<i>S</i>-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist LY379268 [(−)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">826</span><span class="NLM_x">–</span> <span class="NLM_lpage">833</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1124%2Fjpet.104.076547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=15383637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVCntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2005&pages=826-833&author=I.+Feinbergauthor=D.+D.+Schoeppauthor=K.-C.+Hsiehauthor=N.+Darchiaauthor=I.+G.+Campbell&title=The+metabotropic+glutamate+%28mGLU%292%2F3+receptor+antagonist+LY341495+%5B2S-2-amino-2-%281S%2C2S-2-carboxycyclopropyl-1-yl%29-3-%28xanth-9-yl%29propanoic+acid%5D+stimulates+waking+and+fast+electroencephalogram+power+and+blocks+the+effects+of+the+mGLU2%2F3+receptor+agonist+LY379268+%5B%28%E2%88%92%29-2-oxa-4-aminobicyclo%5B3.1.0%5Dhexane-4%2C6-dicarboxylate%5D+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist LY379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats</span></div><div class="casAuthors">Feinberg, I.; Schoepp, D. D.; Hsieh, K.-C.; Darchia, N.; Campbell, I. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">826-833</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The highly selective metabotropic glutamate (mGlu)2/3 receptor agonist LY379268 completely suppresses rapid eye movement (REM) sleep and strongly depresses theta (6-10 Hz) and high-frequency (10-60 Hz) power in the waking and nonrapid eye movement (NREM) EEG, effects consistent with depressed brain excitation (arousal).  We hypothesized the selective mGlu2/3 receptor antagonist LY341495 given alone would (1) increase arousal, producing sleep-wake EEG effects opposite those of LY379268, and (2) block/reverse the effects of LY379268 when the drugs are coadministered.  Rats with implanted electrodes were injected with 1, 5, or 10 mg/kg LY341495 at hour 5.5 of the dark period.  In the coadministration study the rats received the same dose of LY341495 followed 30 min later by 1 mg/kg LY379268.  LY341495 alone increased waking by reducing NREM and REM sleep.  LY341495 also depressed low-frequency and stimulated high-frequency EEG power.  It produced a sharp spike in theta power in waking but not NREM sleep, a striking state-dependent difference in pharmacol. response.  These changes indicate that blocking mGlu2/3 receptors increases brain arousal.  Moreover, they show that mGlu2/3 receptors actively support arousal even in the absence of heightened glutamate excitation.  The coadministration expt. demonstrates that LY341495 is selective in vivo since it dose-dependently attenuates or reverses the sleep-wake EEG effects of the highly selective mGlu2/3 receptor agonist LY379268.  The capacity of mGlu2/3 receptor agonists and antagonists to alter the sleep wake balance suggests they could be developed to enhance sleep or sustain arousal.  Their opposing actions on theta EEG could test the putative role of these oscillations in memory consolidation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLNwVF62Xe7rVg90H21EOLACvtfcHk0lg_ej8i3vcpUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVCntL0%253D&md5=595e80a40d89c0a600e6226a9026f8ce</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.076547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.076547%26sid%3Dliteratum%253Aachs%26aulast%3DFeinberg%26aufirst%3DI.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26aulast%3DHsieh%26aufirst%3DK.-C.%26aulast%3DDarchia%26aufirst%3DN.%26aulast%3DCampbell%26aufirst%3DI.%2BG.%26atitle%3DThe%2520metabotropic%2520glutamate%2520%2528mGLU%25292%252F3%2520receptor%2520antagonist%2520LY341495%2520%255B2S-2-amino-2-%25281S%252C2S-2-carboxycyclopropyl-1-yl%2529-3-%2528xanth-9-yl%2529propanoic%2520acid%255D%2520stimulates%2520waking%2520and%2520fast%2520electroencephalogram%2520power%2520and%2520blocks%2520the%2520effects%2520of%2520the%2520mGLU2%252F3%2520receptor%2520agonist%2520LY379268%2520%255B%2528%25E2%2588%2592%2529-2-oxa-4-aminobicyclo%255B3.1.0%255Dhexane-4%252C6-dicarboxylate%255D%2520in%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D312%26spage%3D826%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rorick-Kehn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overshiner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaney, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benvenga, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deanna, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlow, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luecke, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wafford, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgar, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quets, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolayev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhugh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khilevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckstein, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackermann, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catlow, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher-Wisniewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schkeryantz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span> </span><span class="NLM_article-title"><i>N</i>-(4-((2-(Trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1<i>H</i>-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm3010724&amp;key=10.1124%2Fjpet.110.172957" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm3010724&amp;key=20947638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm3010724&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1erug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=165-177&author=M.+J.+Fellauthor=J.+M.+Witkinauthor=J.+F.+Falconeauthor=J.+S.+Katnerauthor=K.+W.+Perryauthor=J.+Hartauthor=L.+Rorick-Kehnauthor=C.+D.+Overshinerauthor=K.+Rasmussenauthor=S.+F.+Chaneyauthor=M.+J.+Benvengaauthor=X.+L.+Deannaauthor=L.+Marlowauthor=L.+K.+Thompsonauthor=S.+K.+Lueckeauthor=K.+A.+Waffordauthor=W.+F.+Seidelauthor=D.+M.+Edgarauthor=A.+T.+Quetsauthor=C.+C.+Felderauthor=X.+Wangauthor=B.+A.+Heinzauthor=A.+Nikolayevauthor=M.-S.+Kuoauthor=D.+Mayhughauthor=A.+Khilevichauthor=D.+Zhangauthor=P.+J.+Ebertauthor=J.+A.+Ecksteinauthor=B.+L.+Ackermannauthor=S.+P.+Swansonauthor=J.+T.+Catlowauthor=R.+A.+Deanauthor=K.+Jacksonauthor=S.+Tauscher-Wisniewskiauthor=G.+J.+Marekauthor=J.+M.+Schkeryantzauthor=K.+A.+Svensson&title=N-%284-%28%282-%28Trifluoromethyl%29-3-hydroxy-4-%28isobutyryl%29phenoxy%29methyl%29benzyl%29-1-methyl-1H-imidazole-4-carboxamide+%28THIIC%29%2C+a+novel+metabotropic+glutamate+2+potentiator+with+potential+anxiolytic%2Fantidepressant+properties%3A+in+vivo+profiling+suggests+a+link+between+behavioral+and+central+nervous+system+neurochemical+changes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes</span></div><div class="casAuthors">Fell, Matthew J.; Witkin, Jeffrey M.; Falcone, Julie F.; Katner, Jason S.; Perry, Kenneth W.; Hart, John; Rorick-Kehn, Linda; Overshiner, Carl D.; Rasmussen, Kurt; Chaney, Stephen F.; Benvenga, Mark J.; Li, Xia; Marlow, Deanna L.; Thompson, Linda K.; Luecke, Susan K.; Wafford, Keith A.; Seidel, Wesley F.; Edgar, Dale M.; Quets, Anne T.; Felder, Christian C.; Wang, XuShan; Heinz, Beverly A.; Nikolayev, Alexander; Kuo, Ming-Shang; Mayhugh, Daniel; Khilevich, Albert; Zhang, Deyi; Ebert, Philip J.; Eckstein, James A.; Ackermann, Bradley L.; Swanson, Steven P.; Catlow, John T.; Dean, Robert A.; Jackson, Kimberley; Tauscher-Wisniewski, Sitra; Marek, Gerard J.; Schkeryantz, Jeffrey M.; Svensson, Kjell A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">165-177</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The normalization of excessive glutamatergic neurotransmission through the activation of metabotropic glutamate 2 (mGlu2) receptors may have therapeutic potential in a variety of psychiatric disorders, including anxiety/depression and schizophrenia.  Here, we characterize the pharmacol. properties of N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a structurally novel, potent, and selective allosteric potentiator of human and rat mGlu2 receptors (EC50 = 23 and 13 nM, resp.).  THIIC produced anxiolytic-like efficacy in the rat stress-induced hyperthermia assay and the mouse stress-induced elevation of cerebellar cGMP and marble-burying assays.  THIIC also produced robust activity in three assays that detect antidepressant-like activity, including the mouse forced-swim test, the rat differential reinforcement of low rate 72-s assay, and the rat dominant-submissive test, with a maximal response similar to that of impiramine.  Effects of THIIC in the forced-swim test and marble burying were deleted in mGlu2 receptor null mice.  Anal. of sleep EEG showed that THIIC had a sleep-promoting profile with increased non-rapid eye movement (REM) and decreased REM sleep.  THIIC also decreased the dark phase increase in extracellular histamine in the medial prefrontal cortex and decreased levels of the histamine metabolite tele-methylhistamine (t-MeHA) in rat cerebrospinal fluid.  Collectively, these results indicate that the novel mGlu2-pos. allosteric modulator THIIC has robust activity in models used to predict anxiolytic/antidepressant efficacy, substantiating, at least with this mol., differentiation in the biol. impact of mGlu2 potentiation vs. mGlu2/3 orthosteric agonism.  In addn., we provide evidence that sleep EEG and CSF t-MeHA might function as viable biomarker approaches to facilitate the translational development of THIIC and other mGlu2 potentiators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocfm6DC8ijJrVg90H21EOLACvtfcHk0lg_ej8i3vcpUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1erug%253D%253D&md5=ab138f946460f041067c5330a1b5217a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.172957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.172957%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DKatner%26aufirst%3DJ.%2BS.%26aulast%3DPerry%26aufirst%3DK.%2BW.%26aulast%3DHart%26aufirst%3DJ.%26aulast%3DRorick-Kehn%26aufirst%3DL.%26aulast%3DOvershiner%26aufirst%3DC.%2BD.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DChaney%26aufirst%3DS.%2BF.%26aulast%3DBenvenga%26aufirst%3DM.%2BJ.%26aulast%3DDeanna%26aufirst%3DX.%2BL.%26aulast%3DMarlow%26aufirst%3DL.%26aulast%3DThompson%26aufirst%3DL.%2BK.%26aulast%3DLuecke%26aufirst%3DS.%2BK.%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DSeidel%26aufirst%3DW.%2BF.%26aulast%3DEdgar%26aufirst%3DD.%2BM.%26aulast%3DQuets%26aufirst%3DA.%2BT.%26aulast%3DFelder%26aufirst%3DC.%2BC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHeinz%26aufirst%3DB.%2BA.%26aulast%3DNikolayev%26aufirst%3DA.%26aulast%3DKuo%26aufirst%3DM.-S.%26aulast%3DMayhugh%26aufirst%3DD.%26aulast%3DKhilevich%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DEbert%26aufirst%3DP.%2BJ.%26aulast%3DEckstein%26aufirst%3DJ.%2BA.%26aulast%3DAckermann%26aufirst%3DB.%2BL.%26aulast%3DSwanson%26aufirst%3DS.%2BP.%26aulast%3DCatlow%26aufirst%3DJ.%2BT.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DJackson%26aufirst%3DK.%26aulast%3DTauscher-Wisniewski%26aufirst%3DS.%26aulast%3DMarek%26aufirst%3DG.%2BJ.%26aulast%3DSchkeryantz%26aufirst%3DJ.%2BM.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26atitle%3DN-%25284-%2528%25282-%2528Trifluoromethyl%2529-3-hydroxy-4-%2528isobutyryl%2529phenoxy%2529methyl%2529benzyl%2529-1-methyl-1H-imidazole-4-carboxamide%2520%2528THIIC%2529%252C%2520a%2520novel%2520metabotropic%2520glutamate%25202%2520potentiator%2520with%2520potential%2520anxiolytic%252Fantidepressant%2520properties%253A%2520in%2520vivo%2520profiling%2520suggests%2520a%2520link%2520between%2520behavioral%2520and%2520central%2520nervous%2520system%2520neurochemical%2520changes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D165%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Siok, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shifflett, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocsis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span> </span><span class="NLM_article-title">Comparative analysis of the neurophysiological profile of group II metabotropic glutamate receptor activators and diazepam: effects on hippocampal and cortical EEG patterns in rats</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=226-236&author=C.+J.+Siokauthor=S.+M.+Coganauthor=L.+B.+Shifflettauthor=A.+C.+Doranauthor=B.+Kocsisauthor=M.+Haj%C3%B3s&title=Comparative+analysis+of+the+neurophysiological+profile+of+group+II+metabotropic+glutamate+receptor+activators+and+diazepam%3A+effects+on+hippocampal+and+cortical+EEG+patterns+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiok%26aufirst%3DC.%2BJ.%26aulast%3DCogan%26aufirst%3DS.%2BM.%26aulast%3DShifflett%26aufirst%3DL.%2BB.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DKocsis%26aufirst%3DB.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26atitle%3DComparative%2520analysis%2520of%2520the%2520neurophysiological%2520profile%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520activators%2520and%2520diazepam%253A%2520effects%2520on%2520hippocampal%2520and%2520cortical%2520EEG%2520patterns%2520in%2520rats%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D226%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="note"><p class="first last">Free plasma concentrations were calculated by multiplying total plasma concentrations with plasma free fraction (plasma protein binding (%) of 0.35).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Gleason, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, H. E.</span><span> </span><span class="NLM_article-title">Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=1997&pages=79-84&author=S.+D.+Gleasonauthor=H.+E.+Shannon&title=Blockade+of+phencyclidine-induced+hyperlocomotion+by+olanzapine%2C+clozapine+and+serotonin+receptor+subtype+selective+antagonists+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGleason%26aufirst%3DS.%2BD.%26aulast%3DShannon%26aufirst%3DH.%2BE.%26atitle%3DBlockade%2520of%2520phencyclidine-induced%2520hyperlocomotion%2520by%2520olanzapine%252C%2520clozapine%2520and%2520serotonin%2520receptor%2520subtype%2520selective%2520antagonists%2520in%2520mice%26jtitle%3DPsychopharmacology%26date%3D1997%26volume%3D129%26spage%3D79%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="note"><p class="first last">Affinity of JNJ42153605 for the mGlu2 receptor allosteric binding site was evaluated using a radioligand structurally related analogue developed in house. A manuscript describing the synthesis, in vitro and in vivo characterization of this radioligand, and the development of an in vivo assay to measure mGlu2 receptor occupancy is in preparation and will be reported elsewhere.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span>An internal report on the method is available upon request: <span class="NLM_contrib-group">Beerens, D.</span><span> </span><span class="NLM_article-title">In Vitro Bacterial Reverse Mutation (Plate Incorporation) Assay with JNJ42153605-AAA in <i>Salmonella typhimurium </i>TA98</span>; May<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+Beerens&title=In+Vitro+Bacterial+Reverse+Mutation+%28Plate+Incorporation%29+Assay+with+JNJ42153605-AAA+in+Salmonella+typhimurium+TA98"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBeerens%26aufirst%3DD.%26atitle%3DIn%2520Vitro%2520Bacterial%2520Reverse%2520Mutation%2520%2528Plate%2520Incorporation%2529%2520Assay%2520with%2520JNJ42153605-AAA%2520in%2520Salmonella%2520typhimurium%2520TA98%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Tsutakawa, R. K.</span><span> </span><span class="NLM_article-title">Statistical Methods in Bioassay. Estimation of Relative Potency from Quantal Responses</span>. In  <span class="citation_source-book">Encyclopaedia of Statistical Science</span>; <span class="NLM_contrib-group">Kotz, S.; Jonhson, N. L.</span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1982</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1982&author=R.+K.+Tsutakawaauthor=S.+Kotz&author=N.+L.+Jonhson&title=Encyclopaedia+of+Statistical+Science"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTsutakawa%26aufirst%3DR.%2BK.%26atitle%3DStatistical%2520Methods%2520in%2520Bioassay.%2520Estimation%2520of%2520Relative%2520Potency%2520from%2520Quantal%2520Responses%26btitle%3DEncyclopaedia%2520of%2520Statistical%2520Science%26aulast%3DKotz%26aufirst%3DS.%26pub%3DWiley%26date%3D1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span>An internal report on the method is available upon request: <span class="NLM_contrib-group">Lewi, P. J.; Niemegeers, C. J. E.; Gypen, L. M. J.</span><span> </span><span class="NLM_article-title">First Hand Estimation of the Median Effective Dose (ED<sub>50</sub>) and Its Confidence Interval, Assuming a Linear Log Dose-Response Function</span>. Internal Report N123705/1; Department of Global Medical and Scientific Information, Johnson & Johnson Pharmaceutical Research and Development, a Division of Janssen Pharmaceutica, Turnhoutseweg 30, B-2340 Beerse, Belgium,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=P.+J.+Lewi&author=C.+J.+E.+Niemegeers&author=L.+M.+J.+Gypen&title=First+Hand+Estimation+of+the+Median+Effective+Dose+%28ED50%29+and+Its+Confidence+Interval%2C+Assuming+a+Linear+Log+Dose-Response+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DLewi%26aufirst%3DP.%2BJ.%26atitle%3DFirst%2520Hand%2520Estimation%2520of%2520the%2520Median%2520Effective%2520Dose%2520%2528ED50%2529%2520and%2520Its%2520Confidence%2520Interval%252C%2520Assuming%2520a%2520Linear%2520Log%2520Dose-Response%2520Function%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i59"><a href="/doi/suppl/10.1021/jm3010724">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_41603"></div></div></div></div></div><hr /></hr><p class="last">LCMS methods for the characterization of intermediate and final compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3010724/suppl_file/jm3010724_si_001.pdf">jm3010724_si_001.pdf (148.41 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3010724&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm3010724%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-20%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3010724" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679921fe5f4bd93e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
